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2ABSTRACT
Noxious stimulation of the periphery leads to long-term changes in the excitability of dorsal 
horn neurons of the spinal cord. In the spinal cord the increased excitability of dorsal horn 
neurons requires the activation of a subset of superficial dorsal horn projection neurons that 
express  the  NK1  receptor.  These  lamina  I  neurons  are  crucial  for  the  initiation  and 
maintenance  of persistent  pain  states  and  are  the  origin  of a  spino-bulbo-spinal  loop  that 
drives descending spinal facilitation, in part, via serotonergic axons.
In many areas of the central nervous system some aspects of synaptic plasticity are thought to 
be controlled by the immediate early gene and transcription factor zif268 (also known as Egr- 
1, Krox- 24 and NGF1-A). In the hippocampus, for example, zif268 is necessary for both late- 
LTP (long term potentiation) and learning and memory. In the spinal cord, the expression of 
zif268 is activity dependant and associated with the induction of LTP in the dorsal horn. Here,
I have shown that peripheral inflammation of the hindpaw with Complete Freund’s Adjuvant 
(CFA)  increased  zif268  expression  in  dorsal  hom  neurons  and  was  necessary  for  the 
development  and  maintenance  of  the  inflammatory  pain  state.  In  addition,  descending 
serotonergic  pathways  and  lamina  I  projection  neurons  modulate  spinal  c-fos  and  zif268 
expression following peripheral inflammation. Depletion of spinal serotonin increased c-fos 
expression  without  affecting  zif268  expression  in  the  dorsal  hom  following  peripheral 
inflammation. However, in contrast, the ablation of lamina I NK1  expressing neurons in the 
dorsal hom that project to the brainstem significantly decreased spinal zif268 expression.
The glucocorticoid receptor (GR) and serum- and glucocorticoid inducible kinase  1   (SGK1) 
are  involved  in  synaptic  plasticity  and  are  potential  downstream  targets  of  zif268.  I 
investigated the  behavioural  role  of spinal  GR  following  peripheral  inflammation  and  the 
consequence of altering zif268 levels on GR and SGK1  expression in the dorsal hom. Using 
an antisense approach I show that both SGK1  and GR expression are regulated by zif268. I 
also demonstrated that GR expression in the dorsal hom was crucial for the maintenance of 
inflammatory  pain  states.  While  GR  expression  was  positively  regulated,  SGK1  was 
negatively  regulated  by  zif268  during  the  early  stages  of  peripheral  inflammation.  In 
conclusion, these results indicate that zif268 dependent gene regulation in the dorsal hom is 
pivotal to the maintenance of inflammatory pain states and offer potential new targets for the 
development of future analgesic drugs.
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14CHAPTER 1 
General Introduction1. INTRODUCTION
1.1  Peripheral inflammation and nociceptor sensitisation
Tissue damage  leads to local inflammation and the rapid release of neuroactive  substances 
from surrounding tissue and locally from the bloodstream. These chemicals directly activate 
discrete peripheral sensory organs (nociceptors) that are important for detecting acute noxious 
stimuli and are partly responsible for the development of persistent inflammatory pain states. 
Nociceptors are classified as C-fibres (non-myelinated) or A-fibres (myelinated). Each fibre 
type  can  innervate  a large  area of tissue and can respond to different modalities  including 
mechanical, electrical, thermal and chemical. However, in order to become active they require 
high intensity stimuli that threaten tissue damage. Adenosine triphosphate (ATP), bradykinin 
(BK), H+  and K+  ions released by damaged cells are the only endogenous substances that can 
directly  excite  the  nociceptor;  other  substances  act  by  lowering  the  threshold  of  the 
nociceptor, so that nerve ending become more sensitive to less intense stimuli.  In addition, 
during  inflammation,  the  perineurium  (which  protects  and  isolates  the  nerve  ending)  is 
disrupted, enabling previous impassable large molecules and hydrophobic  peptides to cross 
and interact with potential targets on the primary afferent fibre.
Receptor  phosphorylation  and  gene  expression  are  responsible  for  nociceptor  sensitisation 
following  inflammation  (Fig  1.1).  Triggering  intracellular  pathways  by  activating  protein 
kinase C (PKC), protein kinase A (PKA) and adenyly cyclase (AC), can for example, lead to 
the  increase  phosphorylation  and  expression  of SNS  type  sodium  channels  and  vanilloid 
receptor 1   (TRPV1) in the primary afferent and in the DRG. In addition, prostaglandin (PG) 
and  bradykinin  receptor  interactions  at the  nerve  terminal  leads  to  the  sensitisation  of the 
primary afferent to H+, serotonin and prostaglandins and enhance excitability to both thermal 
and mechanical stimuli during inflammation (Kumazawa et al,  1991; Khan et al,  1992; Lang 
et  al,  1990;  Manning  et  al,  1991;  Neugebauer  et  al,  1989).  Peripheral  inflammation  can 
engage  axon  reflexes.  This  describes  a  process  whereby  the  noxious  activation  of  one 
peripheral branch of a nociceptor results in the antidromic invasion of action potentials into 
adjacent branches of the nociceptor. This results in the release of vasoactive substances from 
the  terminals  of the  nociceptor  and  is  thought  to  underlie  flare  and  the  sensitisation  of 
adjacent nociceptors (Schmidt et al,  1997; Klede et al, 2003). Furthermore, about  10-20% of 
C-fibres are silent nociceptors that do not respond to acute nociceptive stimuli (Schmidt et al, 
1995).  However,  during  inflammation  silent  C-fibres  are  gradually  incorporated  into 
transmitting  noxious  information  to  central  synapses  and  therefore  fully  capable  of
16participating in the development of hyperalgesia by increasing the noxious input onto second 
order  neurons  in  the  dorsal  hom.  Hyperalgesia  is  defined  as  an  increased  response  to  a 
stimulus which is normally painful (IASP).
Ca2*
CB (or opiate)  PGE:
Figure 1.1  Inflammation leads to the activation of multiple intracellular signaling pathways and increases in nociceptor 
sensitivity.  Potentiation of the vanilloid  receptor (TRPV1) and the tetrodotoxin-resistant (TTX-R) voltage-gated sodium 
channels (Na„1.8 and 1.9) can be achieved with direct interactions of the channel with protons (H+) or lipid metabolites, 
i.e.  anandamide  (AEA).  The  binding  of  NGF  and  bradykinin  to  their  putative  receptor  (TrkA  and  BK,  respectively) 
stimulates the  phospholipase C  (PLC-y or PLC-p) signaling  pathway,  the  hydrolysis of plasma  membrane  lipids and 
the  subsequent  stimulation  of  protein  kinase  C  isoforms,  (i.e.  PKC-e).  This  leads  to  the  potentiation  of  TRPV1 
Inflammatory  products  such  as  prostaglandins  (PGE2)  can  enhance  nociceptor  excitability  by  activating  adenylyl 
cyclase  (AC)  and  Gs-coupled  receptors  This  occurs,  in  part,  by  a  cyclic  AMP-dependent  protein  kinase  (PKA)- 
dependent  phosphorylation  of  Nav1   8  and/or  Nav1.9.  Opioids  and  cannabinoids  activating  Gi-coupled  receptors  can 
counteract the  excitability  of the  nociceptors;  producing  peripheral  analgesia.  (Adapted  from  The  Textbook  of  Pain, 
2005).
1.2  Classification of primary afferents
Cutaneous  sensory  fibres  can  be  categorized  into  3  groups  based  upon  the  extent  of 
myelination, conduction velocities and axonal diameter. These are the Ap-, A5- and C-fibres 
AP  are  large  diameter  fibres  that  are  heavily  myelinated  and  have  the  fastest  conduction 
velocity (70-120m/s). In comparison to Ap fibres, AS fibres have a smaller diameter, are less 
densely  myelinated  and  have  a  slower  conduction  velocity  (5-30m/s)  and  respond  to  high 
intensity  stimuli.  C-fibres are  small, non-myelinated  fibres,  have  slow conduction  velocities 
(lm/s)  and  encode  and  transmit  nociceptive  stimuli  (McMahon  and  Koltzenburg,  2005). 
Apart from providing the vast majority of afferent fibres that innervate the viscera,  C-fibres 
also contribute 60-90% of all afferent fibres innervating the skin. The most important C-fibre 
type in the rat is the polymodal  nociceptor,  which is able to respond to thermal,  mechanical 
and  chemical  noxious  stimuli.  The  C-fibre  response  is  dependent  on  the  composition  of 
membrane  receptors  and  the  distinctive  neurochemical  profile  that  is  used  to  differentiate 
between the two variants of C-fibres.
17C-fibre nociceptors can be divided into peptidergic and non-peptidergic neurons based  upon 
the expression of distinct molecular markers (Fig  1.3). Peptidergic neurons contain substance 
P, calcitonin gene related peptide (CGRP) and somatostatin.  In addition, peptidergic neurons 
in rat sensory ganglia also express the TrkA receptor, and is dependent on nerve growth factor 
(NGF) for normal function. Peptidergic neurons make up 50% of all C-fibres and 20% of Ad 
fibres (which together make up 40% of the total neuronal  DRG population). Non-peptidergic 
neurons contain fluoride resistant acid phosphatase (FRAP) and are characterized by binding 
the lectin 1B4 from Griffonia simplicifolia. IB4 positive dorsal root ganglion cells also express 
glial  cell  line-derived  neurotrophic  factor  (GDNF)  receptor  alpha  subunits  and  receptor 
tyrosine  kinase  Ret  and  respond to the  neurotrophin  GDNF  in  adulthood.  Classifying  non- 
peptidergic and peptidergic neurons based upon their ability to bind IB4 could be misleading. 
Several  studies  have  shown  colocalisation  of IB4  or FRAP  and  substance  P  or CGRP  in  a 
small number of primary afferent DRG neurons (Fig  1.3) (Carr et al,  1990; Wang et al,  1994; 
Bergman et al,  1999). The vast majority of visceral afferents are peptidergic (immunoreactive 
for substance P or CGRP), afferents projecting to the skin are half peptidergic, while a small 
number  of afferents  that  project to  muscle  are  able  to  bind  IB4  (Ambalavanar  et  al  2003; 
Plenderleith  &  Snow  1993).  Furthermore,  and  in  general,  the  termination  pattern  of  IB4 
positive and IB4 negative nociceptors are different. The central projections of IB4 containing 
afferents project primarily to lamina II (inner).  When stained and viewed from the transverse 
plane,  IB4  appears  as  a  distinct  band  across  the  dorsal  hom.  In  comparison  peptidergic 
neurons that do not bind IB4, project to lamina I and lamina II (outer) of the dorsal hom (Fig 
1.2) (Silverman and Kruger,  1988) and terminate on projection neurons (Torsney et al, 2006).
Figure  1.2.  The  termination  pattern  of  the  two  main  nociceptive  C-fibre  types  in  the  dorsal  horn.  The  peptide  and 
neurotransmitter content  of these  C-fibre  types  differ from  each  other.  The  termination  site  in  the  dorsal  hom  also 
differs,  although  they  innervate  similar peripheral tissues.  (FRAP;  fluoride-resistant acid  phosphatase;  TrkA;  tyrosine 
kinase receptor A, SP; substance P; CGRP;  calcitonin-gene-related peptide). Adapted from Hunt and Mantyh (2001).
Laminae I ♦ ll-outer 
Laminae ll-inner
Parabrachial area
Thalamus
Ret
IB-4 
FRAP  ^>2X3
18The role of A5 fibres during  inflammation  is  less well  understood.  In general,  A5 fibres are 
activated by high threshold stimuli that are higher than those for C fibre activation. A5 fibres 
can  be  classified  primarily  into  two  general  types.  Type  I  are  high  threshold,  rapidly- 
conducting  mechanoreceptors  and  respond  weakly  to  high  intensity  heat  or  cold  (and 
chemical) stimuli (Handwerker and Kobal,  1993; Simone and Kajander,  1997). Type I  fibres 
can  become  more  heat-responsive  if  sensitised  by  rapid  repetitive  thermal  stimulation  or 
following  tissue  damage.  In  doing  so,  they  show  sustained  responses  to  thermal  stimuli  of 
long duration and slow latencies. The second class of A5-fibre is type II. This class has been 
extensively  examined  in  primate  skin  and  respond  more  rapidly  to  noxious  heat owing to a 
lower response threshold (in comparison to type I) (Beydoun et al,  1996; Treede et al,  1990). 
In addition, type II A6-fibres are more responsive to cooling than mechanical stimuli, and are 
capable of encoding the intensity of the stimuli (Craig et al.,  1996).
Some  AP  fibres  also  respond  to  noxious  stimulation.  They  are  believed  to  contribute  to 
chronic  pain  by  lowering their activation thresholds  (Djouhri  and  Lawson,  2004).  Both  the 
superficial  layer of the dorsal hom (lamina  I  and  II  (outer)) and  lamina V are innervated  by 
high threshold A-fibres. In comparison low threshold A-fibres terminate in deeper layers (III- 
V).  A-fibres  signal  precise  localisation  and  discrimination of the  quality  of noxious  stimuli 
and are important for triggering precise reflex withdrawal responses. A-fibres also respond to 
noxious mechanical  stimuli  with a higher frequency  in comparison with C-fibre nociceptors 
and as such A-fibres are believed to provide information concerning the intensity of noxious 
mechanical  stimuli  to  a greater extent than C-fibres  (Garell  et al,  1996;  Slugg et  al,  2000). 
Although information coding chemogenic pain is considered to be carried by C-fibres, A-fibre 
nociceptors may also play a functional role. Studies have shown that several chemical stimuli 
including bradykinin, capsaicin, histamine and serotonin can activate the A-fibre nociceptors 
(Davis et al,  1993; Ringkamp et al, 2001).
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Figure  1.3.  Pie  chart  describing  the  three  main  populations  of  DRG  cells  in  rodents.  Large  diameter  cells  are 
myelinated  and  express  high  levels  of  neurofilament  (NF200).  Small  cells  are  mainly  unmyelinated,  generally 
nociceptive  and  divided  into  peptidergic  (substance  P  and  calcitonin  gene-related  peptide,  (CGRP)  and  non- 
peptidergic (IB4-positive) neurons. The arrows represent different growth factor receptors present on a given neuronal 
population.  In general neuronal populations overlap.  BDNF,  brain-derived neurotrophic factor;  FRAP, fluoride-resistant 
acid  phosphatase;  GFRa,  Glial  cell  line-derived  factor  receptor  a;  TrkA,  tyrosine  kinase  receptor  A;  TrkC,  tyrosine 
kinase receptor C; TRPV1,  vanilloid receptor 1; VIP,  vasoactive intestinal polypeptide (Kidd and Urban,  2001  adapted 
from J.V.Priestley).
191.3 Peripheral innervation of the dorsal horn
The spinal  dorsal hom receives input from the peripheral  fibres signalling both non-noxious 
and noxious stimulation.  In  1952, Rexed divided the dorsal hom into six laminae based upon 
cell shape, size and density. Lamina I, also known as the marginal layer is the most dorsal of 
all the laminae in the dorsal hom and contain both projection neurons and intemeurons. Even 
though  this  layer  contains  the  highest  density  of  projection  neurons  in  the  dorsal  hom, 
projection neurons only  make  up 5% of all  cells  in lamina I  with the rest being made  up of 
intemeurons. Lamina II, also known as the substantia gelatinosa is divided into two layers (II 
inner and II outer) and receives substantial C fibre input and as a such appears under bright-field 
microscopy as a translucent band.  Lamina III also contains densely packed intemeurons and 
contains many myelinated fibres which make it possible to distinguish the transition between 
lamina II and lamina III. Lamina IV-V1  contains a range of different size neurons with some 
being projection neurons. The borders between these layers are more difficult to distinguish.
Innervation of the superficial dorsal hom from the periphery is predominantly high threshold 
A- and C-fibre (Fig  1.4). The spinal projections of AS fibres in the cat was first described in 
1979 (Light and Perl,  1979) and were shown to terminate primarily in lamina I and lamina II 
(outer) with some fibres bifurcating and innervating deeper regions including lamina IV  and 
V.  This  arrangement  was  later  confirmed  in  rodents  (Woodbury  et  al,  2004)  where  high 
threshold myelinated fibres were also seen to terminate in lamina I  and II  (outer).  In support 
of this, a recent study (Torsney et al, 2006) revealed that NK1  receptor expressing neurons in 
the  superficial  dorsal  hom  received  high  threshold  AS  and  C-fibre  monosynaptic  input.  In 
general neurons that lacked the NK1  receptor in lamina I  received polysynaptic  inputs from 
the periphery.  In addition,  Torsney  et al  (2006) using  spinal  cord  slice preparations  showed 
that a large number of NK1  expressing lamina I projection neurons also received polysynaptic 
inputs that were capable of being activated by low threshold AB fibre stimulation.  However, 
this was only possible following the application of bicuculline and strychnine, suggesting that 
under non-pathological conditions this pathway is under GABAergic inhibition. Furthermore, 
disinhibition  also  increased  the  EPSC  response  in  NK1  expressing  projection  neurons 
following stimulation of the dorsal root with AS and AB fibre strengths. This led the authors 
to  suggest  that  under  pathological  conditions  low-threshold  A-beta  fibres  could  activate 
“nociceptive-specific”  neurons.  These  authors  therefore  suggested  that  hyperalgesia  and 
allodynia could in part be explained by the activation of nocispecific pain pathways by non­
nociceptive  stimuli.  Allodynia  is  defined  as  a  pain  caused  by  a  stimulus  which  does  not 
normally provoke pain (IASP).
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Figure 1.4. Schematic diagram showing  innervations to the dorsal hom from the periphery.  The predominant inputs 
into the superficial layer of the dorsal hom are nociceptive and include both C- and A6 -fibres. A6 -fibres also project 
to lamina V,  these neurons in this layer are wide-dynamic in nature and can code for stimuli strength  HTMR,  high 
threshold mechanoreceptor, CLTMR; C-fibre low threshold mechanoreceptor.  (Adapted from Todd and Koerber, The 
Textbook of Pain, 2005).
1.4  Morphology of lamina 1 neurons
Neurons  in  lamina  1   generally  fall  into  three  morphologies;  fusiform,  multipolar  and 
pyramidal. At present, it is not clear if direct correlations exists between cell morphology and 
cell  function.  Studies  on  feline  lamina  I  neurons  (Han  et  al,  1998)  have  indicated  that  all 
fusiform  cells  are  nociceptive  specific  (NS;  responsive  to  heat  and/or  pinch),  while  all 
pyramidal cells are cooling specific and the multipolar cells are a mixture of cells that are heat 
/pinch/cold  responsive  (60%)  with  the  remaining  (40%)  being  NS  cells.  In  support  of this 
notion,  a  study  on  primate  lamina  1   cells  have  revealed  that  the  majority  of fusiform  and 
multipolar  cells  are  NK1  positive,  while  pyramidal  cells  are  in  general,  devoid  of NK1 
expression (Yu et al,  1999). Little correlation was seen between cell morphology and function 
in NK1  positive cells in the rat. Using c-fos as a marker of noxious neuronal activity (Hunt et 
al,  1987), Todd et al (2002) discovered that formalin  injection caused an up-regulation of c- 
fos  in  all  morphological  classes.  Noxious  heat  stimulation  to  activate  lamina  I  projection 
neurons to the parabrachial  nucleus induced c-fos expression  in all cell  morphologies to the 
same  proportion.  In  contrast to  noxious  heat,  noxious  cold  induced  c-fos  expression  in  the 
majority  of pyramidal  cells,  but  only  in the  minority  of fusiform  and  pyramidal  cells.  This
21result led Todd et al  (2005) to suggest that  in  some  cases correlations do exist  between  cell 
morphology and function in the rat.
1.5 Lamina I neurokinin 1 (NK1) receptor positive projection neurons
The  importance  of the  NK1  receptor  in  nociceptive  processing  in  the  spinal  cord  has  been 
shown  by  a number of studies  (including  King  et  al,  2000,  Martinez-Caro  and  Laird,  2001, 
Laird et al,  2000,  Bester et al,  2001,  Laird  et al,  2001,  and  Suzuki  et al,  2002).  The  cells  in 
lamina I  that express the NK1  receptor can  intensity code for a number of different noxious 
stimuli  (Doyle  and  Hunt,  1999)  and  have  been  shown  to  play  a  fundamental  role  in 
maintaining chronic pain states. After noxious stimulation, substance P (SP) is released from 
a number of nerve terminals including primary afferents (Duggan et al,  1988). SP is then free 
to  bind  onto  the  NK1  receptor  located  on  the  post-synaptic  membrane.  The  binding  of SP 
causes the NK1  receptor to internalise. Substance P can be artificially conjugated to saporin (a 
cytotoxin)  forming  SP-SAP.  This  compound  is  lethal  to  any  cells  that  express  the  NK1 
receptor.  By  using  intrathecal  SP-SAP,  Mantyh  et  al  (1997)  found  that,  whilst  retaining the 
ability  to  code  acute  pain,  the  ablation  of NK1  cells  in  lamina  I  reduced  capsaicin  induced 
thermal  and  mechanical  hyperalgesia  (by  60-85%).  This  result  was  remarkable  considering 
that  fact  that  NK1  cells  only  make  up  -5%   of  neuronal  cells  in  lamina  I.  In  addition, 
mechanical  allodynia associated with CFA  induced  peripheral  inflammation  was  attenuated, 
as well  as mechanical  and thermal  hyperalgesia associated with spared nerve  ligation  (SNL) 
(a model of neuropathic pain). The effectiveness of the NK1  neurons at maintaining persistent 
pain states can be seen by the fact that intrathecal  injections of SP-SAP thirty days before or 
seven days after SNL can both reduce mechanical allodynia (Nichols, et al  1999).
1.6 Ascending projections from the spinal cord
1.6.1  Spinal-projections to the forebrain
Early  retrograde  labelling  studies  that  injected  neuronal  tracers  into  distinct  regions  of the 
brain  using  horseradish  peroxidase,  wheat  germ  agglutinin-HRP  or  fluorogold  revealed  that 
both the superficial and the deep layers of the spinal dorsal hom send ascending projections to 
the  brain.  However these  studies  often  used  large  amounts  of neuronal  tracers  that  made  it 
difficult to precisely identify individual thalamic targets from individual laminae of the dorsal 
hom.  More  recently,  a  detailed  anterograde  study  (Gauriau  and  Bernard,  2003)  using  high 
resolution  neuronal  tracers  injected  into  discreet  spinal  cord  laminae  revealed  that  the
22thalamic termination  pattern  of the  superficial  laminae  were  uniquely  different  from  deep 
dorsal  horn neurons.  Examination of the  forebrain revealed  clear labelling  in  a number of 
contralateral caudal thalamic nuclei following neuronal labelling of the superficial laminae of 
the dorsal  horn.  In particular the posterior group triangular part (PoT),  the posterior group 
(Po) and the ventral  posterior lateral thalamic nuclei  (VPL) were densely  innervated.  To a 
lesser extent the mediodorsal thalamic nuclei (MD) was also  labelled.  In addition, the MD 
relays  lamina I  inputs to the rostral  cingulate and the frontal cortex.  The  exact role  of the 
lamina  I  projections to the  VPL/VPM  in  nociception  is  unclear.  However,  the  VPL/VPM 
system  belongs  to  the  primary  thalamus  that  is  generally  considered  to  relay  tactile 
information from the gracile  and the cuneate nuclei towards the  somatotopically  organised 
somatosensory cortex SI.  Since tactile input to the dorsal column nuclei is conveyed from the 
periphery  by  AC  fibres,  the  authors  speculated  that  the  overlay  of nociceptive  and  non­
nociceptive  inputs  in  SI  may  be  concerned  with  the  spatial  localisation  of pain  during 
peripheral noxious stimulation.
As well as receiving innervations from the parabrachial nucleus, the ventral posterior nucleus 
of the thalamus, parvicellular part (VPPC) also receives direct input from lamina I projection 
neurons.  The  VPPC  innervates  the  insular  cortex  and  is  believed  to  be  involved  with 
assessment and environmental salience of noxious stimuli. The PoT projects to the amygdala, 
(LeDoux et al,  1990),  insula and SII and is thought to be involved with the emotional  and 
discriminative component of pain (Gauriau and Bernard, 2003).
Neurons  belonging  to  deep  laminae  of the  spinal  dorsal  horn  contribute  to  nociceptive 
processing and have the ability to encode peripheral stimuli from low to high intensities (i.e. 
wide-dynamic range).  Projection neurons from this region have been seen to  innervate the 
contralateral centrolateral thalamic nucleus (CL).  The CL in turn project to the motor cortex. 
In addition, and unlike the superficial laminae, the VPL and the Po were found to be sparsely 
innervated by deep laminae of the dorsal horn (Gauriau and Bernard, 2003). Away from the 
thalamus,  deeper laminae of the dorsal  horn also innervate the hypothalamus and striatum. 
Hypothalamic  nuclei  with  dense  labelling  include  the  posterior  and  lateral  hypothalamic 
nuclei and the paraventricular hypothalamic nucleus (PVN). The central amygdaloid nucleus 
and the substantia innominata dorsalis (SID) are also innervated by deep dorsal horn neurons. 
Electrophysiological  recordings  have  shown  that  noxious  stimulation  can  activate  SID 
neurons (Bernard  et al,  1992).  Moreover,  the  SID targets the central  amygdaloid  structure 
(Bourgeais  et  al,  2001)  (which  is  also  the  termination  point  of the  spino-parabrachial- 
amygdaloid pathway), and is believed to be involved with the generation of fear, anxiety and 
alertness during painful conditions.
231.6.2 Spinal projections to the brainstem
The parabrachial  nucleus  (Pb) receives  extensive projections  from  spinal  lamina I  neurons 
(Fig  1.5) (Bernard et al,  1995; Craig,  1995) and are specifically excited by noxious stimuli 
(Bester et al., 2000). A number of Pb neurons are capable of encoding noxious thermal and 
mechanical stimuli and in a restricted subgroup cooling as well (Menendez et al,  1996). The 
activation of Pb neurons can be generated by the electrical stimulation of either A5 fibres or 
C-fibres  (Bernard  and  Besson,  1990;  Bester  et  al,  1995;  Bernard  et  al,  1996)  as  well  as 
visceral  stimulation with algogenic substances.  Moreover, some Pb neurons can respond to 
both visceral and cutaneous stimuli, a response that may reflect the large receptive fields of 
the  Pb  (Bernard  et  al.  1994).  The  lateral  parabrachial  nuclei  are  densely  innervated  by 
projections from the nucleus of the solitary tract (NTS). The NTS receives inputs from lamina 
I  and  is  important  for  vital  physiological  functions  including  cardiovascular  reflexes  and 
respiration and may function to integrate nociceptive and cardio-respiratory afferents (Boscan 
et  al,  2002).  A  large  proportion  (-60%)  of Pb  neurons  project  to  the  amygdala  and  the 
hypothalamus and are specifically activated by noxious stimuli and may make contributions 
to the autonomic and emotional homeostatic aspects of pain.  Lamina I neurons also project to 
other brainstem sites including the PAG.
Raboisson et al (1996) have shown that the caudal reticular nuclei -  lateral reticular nucleus 
(LRN),  the  subnucleus  reticularis  dorsalis  (SRD),  the  gigantocellular/lateral 
paragigantocellular  reticular  nuclei  (NGc)  are  densely  innervated  by  deep  dorsal  horn 
neurons. Since the LRN is part of the motor reticular area. Projections to these areas suggest 
that deep dorsal horn layers are involved with generating the motor reactions that are required 
during noxious events. In agreement the SRD is also part of the reticular area that can encode 
the  intensity of noxious stimulation and send projections back to the deep dorsal horn, the 
ventral horn and to motor areas of the brainstem (Bernard et al, 1990; Villanueva et al, 1995).
Broadly  speaking  projections  from  lamina  I  innervate  areas  of the  brain  concerned  with 
homeostasis, discrimination, affect and cognition. In contrast, projections from deeper layers 
of the dorsal horn directly innervate brain areas concerned primarily with motor actions and 
are likely to contribute to arousal and the generation of motor responses following noxious 
stimulation.  There is, however, some overlap between deep and superficial spinal projection 
pathways
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Figure  1.5.  The spino-parabrachial  nucleus  pathway.  The  parabrachial  nucleus (PBN)  is regarded  as an  important 
locus for integrating nociceptive information from visceral and cutaneous origin, as well as playing an  important role 
in physiological functions such as blood pressure regulation. The strong projections to the amygdala,  hypothalamus 
and the periaquectual  gray  suggest that the spino-parabrachial  pathway from  lamina  I  could  modulate  autonomic, 
homeostatic and emotional component of pain. Thick and thin continuous lines with arrowheads, dense and medium 
‘second  order  projection’  respectively  (from  lamina  I  (LI)  and  NTS);  thick  and  thin  dotted  lines  with  arrowheads, 
dense  and  medium  ‘third/fourth  order  projections’,  respectively  (from  PBI,  VMH  and  CeLC)  (BSTL;  lateral  bed 
nucleus of the stria terminalis). (Taken from Gauriau and Bernard, 2001).
1.7  Spino-PAG projection neurons
1.7.1  The PAG
The PAG,  along with the amygdala,  are involved with the emotional  aspect of nociception. 
Spino-parabrachial projection neurons can support long term potentiation (LTP) (Ikeda et al,
251999) and changes in the second order neuron could enhance nociceptive transmission to the 
parabrachial  nucleus.  The  parabrachial  nucleus  is  known  to  act  as  a  nociceptive  and 
autonomic  relay  station,  both  receiving  and  sending  nociceptive  information  to  other  key 
areas  of the  brain.  Pain  can  elicit  a  number  of effects  including  affective  and  emotional 
behaviours, as well as influencing autonomic homeostatic adaptations to noxious conditions.
Projections from the PB terminate in the lateral, dorsomedial and ventrolateral columns of the 
PAG.  Recent  studies  have  revealed  that  different  nuclei  of the  PAG  are  activated  during 
different environmental circumstances.  The lateral column is responsible for processing the 
active emotional coping behaviours that include the  ‘fight (engagement) or flight’  response 
(Bandler  &  Shipley,  1994).  The  dorsomedial  column  is  involved  with  strong  aversive 
behaviours. In comparison, the ventrolateral column is activated during inescapable persistent 
pain  and  is  vital  for  passive  emotional  coping  behaviours.  These  include  disengagement, 
withdrawal  from  the  external  environment  and  the  co-ordination  of autonomic  and  motor 
support that produces behaviours associated with recuperation and quiescence. Physiological 
symptoms include hypotension and bradycardia (Keay and Bandler, 2001, 2002).
The  dorsolateral  and the  ventrolateral  column of the  PAG  can be  selectively  activated  by 
different peripheral fibres (Parry et al, 2001). Selective activation of C-fibre or A5-fibre units 
using different rates of heating produced  differential  c-fos  expression  in the  PAG.  C-fibre 
activation increased c-fos expression predominantly in the ventrolateral column of the caudal 
PAG  (Mangan  et  al.  1999;  Lumb,  2002)  while  a  greater response  was  seen in the  lateral 
region  following  A8-fibre  activation  (in  comparison  with  C-fibre  activation).  This  would 
suggest that first pain and  second pain have different representations  in the PAG  and that 
these regions can be selectively activated by different peripheral fibre types.
1.7.2  The hypothalamus
The hypothalamus receives a number of projections from the parabrachial nucleus. Areas that 
are  heavily  innervated  include  the  ventromedial  nucleus,  the  retrochiasmatic  area,  the 
periventricular and the median preoptic area. To a lesser extent, projections are also sent to 
the paraventricular nucleus (PVN) (Bester et al,  1997). The ventromedial nucleus projects to 
the  PAG and has been shown to  be important for aggressive behaviours.  Lesioning  of this 
area reduced aggressive behaviours and territorial behaviours in rodents (Albert et al,  1985; 
Adams,  1971).  As  such,  the  PB-Hypothalamic  tract  could  play  an  important  role  in  the 
defensive or aggressive behavioural response during noxious stimulation.  Projections to the 
PVN  indicate  a  potential  role  for  the  neuroendocrine  system  during  noxious  stimulation.
26Activation of the PVN could enhance glucocorticoid (corticosterones) release that aids in the 
breakdown of substances vital for metabolic reactions. In doing so, this provides the energy 
needed for the flight or fight response. Projections from the PB also extend to large portions 
of the ventrolateral medulla (VLM) of the brainstem. The VLM is important for modulating 
the cardiovascular system (Chamberlin and Saper,  1992,  1994). Projections from the PB to 
the VLM may provide a supporting role to direct projections from lamina I of the dorsal horn 
to  the  VLM.  Studies  have  shown that  during  noxious  stimulation  the  expression  of c-fos 
increases in the VLM (Pinto et al, 2006) and that, in an indirect manner, the VLM can inhibit 
nociceptive activity in the dorsal horn by activating spinal alpha 2-adrenoreceptors (Tavares 
et al, 1996).
1.8  Descending projections from the rostral ventromedial medulla (RVM)
1.8.1  RVM cell types
The PAG has been shown to send projections to the RVM, a structure  which sends  direct 
projections to the dorsal horn and participates in the facilitation and inhibition of nociceptive 
traffic through the dorsal horn. Cells in the RVM can be classified into three classes based 
upon their electrophysiological response to noxious stimuli. These are ‘on’ ‘off and ‘neutral’ 
cells. ‘O ff’cells are thought to exert descending inhibition since the activity levels of this cell 
type is high when nociceptive information is inhibited and because activity decreases during 
nociceptive  transmission  before  a tail  flick  response.  The  firing  rate  of ‘off  cells  can  be 
enhanced by blocking GABA mediated synaptic transmission in the RVM and has led to the 
suggestion that release of GABA from local inhibitory neurons modulate the activity of ‘off 
cells  in  the  RVM  (Heinricher  and  Tortorici,  1994;  Reichling  and  Basbaum,  1990). 
Conversely, ‘on’ cells can be activated just before tail flick using noxious stimuli but not with 
non-noxious stimuli (Fields, 2000;  Ossipov and Porreca 2005) and are thought to  facilitate 
chronic pain states
Anatomical  studies  have  shown  that  a number  of spinal  cord  laminae  receive  descending 
input from the RVM.  These include lamina I, II, and V of the dorsal horn and VII, VIII, and 
X of the ventral horn with  ‘on’ and  ‘off  cells project to most of these layers (Fields, et al, 
1991,  1995). The main pathway in which the RVM can communicate with the dorsal horn is 
through the  dorsolateral  funiculus  (DLF)  (Jones  and  Gebhart,  1997;  Gebhart  and  Randic, 
1990).  Disruption  of the  DLF  can  negate  descending  inhibition  as  well  as  descending 
facilitation. During non-pathological conditions the spinal cord is under a constant tonic net 
inhibition  with  both  the  inhibitory  and  facilitatory  components  being  in  fine  balance.
27However,  with the  development  of persistent  inflammatory  conditions  from  an acute  pain 
state, this balance is perturbed gradually allowing for net facilitation to occur. In support of 
this idea, studies have shown that a stage dependent switch occurs in the dorsal horn. Studies 
comparing acute monoarthritis (24h-48h post CFA ankle injection) with chronic monoathritis 
(3-4wks)  have  shown  that  descending  inhibition  is  enhanced  during  the  first  few  hours 
(following induction) of the pain state (Cervero et al,  1991;  Schaible et al,  1991;  Ren and 
Dubner,  1996).  However,  as  the  pain  state  develops  this  inhibition  is  gradually  lost  and 
facilitation begins to increase.
A number of studies have demonstrated that stimulation of RVM nuclei including the nucleus 
raphe magnus (NRM), the nucleus raphe pallidus, the nucleus raphe obscurus and adjacent 
nuclei  of the  reticular  formation,  such  as  the  NGc  and  the  NGc-alpha  can  activate  the 
descending inhibitory pathways to the spinal cord in rodents (Azami et al,  1982; Brodie and 
Proudfit, 1984; Light et al,  1986). The descending RVM system was classically considered to 
consist mainly of serotonergic neurons (Bowker et al,  1981), however, neuronal populations 
in the  raphe  nuclei  are  not  homogeneous  populations  of serotonergic  neurons.  A  number 
(-60%) of RVM neurons that project to the spinal cord are GABAergic (Hama et al,  1997) 
and  are  capable  of  modulating  spinal  sensory  systems  (Millan,  2002).  In  addition, 
neurotransmitters  such  as  GABA,  somatostatin  and  enkephalin  co-exist  in  RVM-spinal 
serotonergic neurons (Millan, 2002).  Descending inhibition from the RVM is thought to be 
via  GABAergic  and/or  glycinergic  neurons  and  does  not  require  some  5-HT  receptor 
subtypes. For example, studies (Kato et al, 2006) that activated RVM projection neurons to 
the  substantia  gelatinosa  of the  dorsal  horn  revealed  that  1)  descending  inhibition  is  via 
monosynaptic  thinly  myelinated  fibres  that  are  GABAergic  or/and  glycinergic.  2)  The 
application of GABA  receptor antagonist,  bicuculline,  and the  glycine receptor antagonist, 
strychnine, completely suppressed RVM  induced IPSCs in SG neurons.  3) Ondansetron (5- 
HT3 receptor antagonist) and ketanserine (5-HT2A receptor antagonist) had no effect in SG 
IPSCs and 4) depolarisation of SG  neurons  using paw  pinch  were depressed  during  RVM 
electrical stimulation.
1.8.2  Descending serotonergic neurons
Serotonergic neurons make up one fifth of the total number of neurons in the RVM with a 
large proportion projecting to the dorsal horn. Owing to the large array of serotonin receptor 
(5-HTR) subtypes expressed in the dorsal horn, serotonin (5-HT) released into the dorsal horn 
can be both pro- and anti-nociceptive. Electrical stimulation of the RVM promotes the release 
of serotonin  into  the  dorsal  horn  and  causes  analgesia  which  is  reversible  by  serotonin
28antagonists (Le Bars,  1988).  The direct application of serotonin inhibits nociceptive dorsal 
horn neurons (Hylden and Wilcox,  1983). This effect is largely mediated by the activation of 
the  5-HT1  and  5-HT2  receptors  in  the  dorsal  horn,  but  also  by  the  activation  of spinal 
GABAergic  inhibitory  neurons  (that  express  the  5-HT3  receptor)  (Alhaider  et  al,  1991). 
Furthermore, spinal 5-HT3 receptors have been implicated as having a role in facilitating pain 
states.  The  intrathecal  injection  of ondansetron (a  5-HT3  receptor  antagonist)  was  seen to 
reduce pain behaviour associated with the formalin model (Oyama et al, 1996).
1.9  Serotonin receptors
The serotonin receptor consists of 14 different subtype and are, in general, G-protein coupled 
receptors. Depending on the subtype, serotonin receptors can be facilitatory or inhibitory. For 
instance, the  5-HT1  receptors are a large family that are negatively  coupled with adenylyl 
cyclase through the  G; family  of G  proteins.  This  is also the  case  for the  5-HT4  receptor 
subtype.  Dual  coupling  with  potassium  channels  and adenylyl  cyclase  characterises the  G, 
linked receptors, and occurs in other members of the 5-HT1 receptor family. The activation of 
potassium channels and the inhibition of calcium channels leads to the hyperpolarisation of 
the neuron and reduces neuronal activity
The 5-HT2 receptor family are coupled to phospholipase C (PLC) and is in general excitatory 
owing  to  the  closure  of  potassium  channels.  PLC  is  a  membrane-bound  enzyme  and 
responsible for the degradation of inositol lipid, phosphatidylinositol 4, 5-bisphosphate (PIP2), 
with the production of inositol  1, 4, 5-triphosphate (IP3) and diacylglycerol (DAG). IP3  causes 
the release of calcium  from  intracellular storage site by  interacting with specific  receptors. 
The increase of cellular calcium induces multiple effects in the cell,  including activation of 
important  enzymes  which  are  responsible  for  phosphorylating  protein  substrates  such  as 
membrane  receptors  in  the  cell.  DAG  activates  another  kinase  family,  protein  kinase  C 
(PKC). PKC regulates numerous processes of cell function.
The  5-HT3  receptor  is  different  from  other  5-HT  receptors  by  being  ligand  gated.  The 
receptor forms an ion channel that regulates ion flux in a G-protein-independent manner. The 
5-HT3 receptor is a member of the ligand-gated ion channel and was first found on peripheral 
sensory neurons including C-fibre neurons that innervate the dorsal horn where they mediate 
excitation and regulate neurotransmitter release.
The  release  of  5-HT  from  descending  pathways  can  act  on  a  number  of  5-HTRs 
Immunohistochemical studies have revealed positive staining for 5-HT 1  A, 5-HT IB, 5-HT ID
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et al,  1998; Maricq et al,  1991; Maxwell et al, 2003).  The 5-HT3A receptor subtype is found 
on axon terminals of both IB4 and CGRP expressing primary afferents and also terminals of 
non-primary  afferent  origin.  Moreover,  it  appears  that  the  receptor  is  not  located  on 
GABAergic  or serotonergic neurons  in the dorsal  horn,  but on primary  afferent  fibres  and 
intemeurons (Maxwell et al, 2003) Although the relative percentages are small in comparison 
with  the  overall  number  of primary  afferents,  the  expression  of the  receptor  on  primary 
afferents  could  provide  a  possible  mechanism  by  which  this  receptor  could  be  pro­
nociceptive. Electrophysiological recordings from the dorsal horn suggest that 5-HT3 receptor 
does not play a functional role in normal acute nociceptive processing but is activated under 
peripheral  inflammatory  conditions  (formalin)  (Green  et  al,  2000).  The  5-HT3  receptor 
antagonist  ondansetron  significantly  reduced  second  phase  formalin  response  but  did  not 
affect carrageenan hyperalgesia. An explanation for this is that carregeenan, unlike formalin is 
a much weaker stimulus  and might not be  adequate to provoke  a descending  serotonergic 
response.
Recently, there  is evidence to suggest that some lamina I NK1  positive projection neurons 
form  direct  contacts  with  5-HT3A  receptor  positive  afferents  (Conte  et  al,  2005).  This 
anatomical arrangement would allow descending serotonergic neurons to facilitate pain states 
by increasing neurotransmitter release from 5-HT3A positive afferents and enhance activity in 
lamina I projection neurons.  Lamina I NK1  projection neurons form part of a spino-bulbo- 
spinal loop and provides a mechanism whereby descending pathways can modulate the levels 
of excitation in the dorsal horn neurons. The serotonergic pathway only makes up part of the 
descending  component  but  has  been  shown  to  be  both  anti-  and  pro-nociceptive.  By 
selectively antagonising the 5-HT3 receptor with intrathecal ondansetron it was found that it 
was  possible to  facilitate  both thermal  and  mechanical  stimuli.  Furthermore  the  receptive 
fields of deep dorsal horn neurons were also altered. A similar result can also be ascertained 
by  ablating  NK1  lamina  I  projection  neurons  suggesting  that  5-HT3  receptors  on  these 
neurons could play a role in pain facilitation (Suzuki et al, 2002; Suzuki et al, 2005). The 5- 
HT3  receptor  (mRNA)  have  been  found  in  (non-capsacin  sensitive,  non-IB4)  small  cell 
bodied  neurons  and  in  myelinated  primary  afferents  of the  dorsal  root  ganglion.  5-HT3 
receptor protein are expressed in; peptidergic unmyelinated primary afferent fibres, excitatory 
intemeurons and lamina I projection neurons of the dorsal hom. Electrophysiological studies 
using 5-HT3 agonists have suggested that 5-HT3 receptors are present in neurons that can be 
activated by noxious chemical and natural  stimuli (Zeitz et al, 2002; Conte et al, 2005). As 
such  it  has  been  suggested  that  spinally  expressed  5-HT3  receptors  in  the  dorsal  hom
30including lamina I projection neurons may play a pivotal role in facilitating persistent pain 
states during pathological conditions.
1.10  Dorsal horn: synaptic plasticity and long term potentiation (LTP)
Synaptic efficacy in the dorsal hom can be modulated in a use dependent manner. Changes in 
synaptic  efficacy  can  have  profound  effects  on  nociceptive  processing  in  the  dorsal  hom. 
Many dorsal hom neurons including neurons that project to the parabrachial nucleus and the 
periaqueductal grey (PAG) can be sensitised following high intensity peripheral stimulation 
leading to a prolonged enhancement  in  synaptic efficacy  and neuronal  excitability.  This  is 
known as central sensitisation. Central sensitisation can take various forms, including wind­
up,  classic  heterosynaptic  sensitisation,  classic  homosynaptic  sensitisation,  long  term 
potentiation (LTP) and transcription-dependent central sensitisation.
1.10.1 Wind-up
Repetitive noxious C-fibre stimulation at the same strength can result in prolonged discharge 
in dorsal hom neurons.  This phenomenon  is termed wind-up and results  in the progressive 
increase in the number of action potentials generated in second order neurons in the dorsal 
hom per unit stimulus. NMDA receptors and NK1  receptors are required for the generation of 
wind-up,  although  other receptors  such  as  calcium  channels  and  potassium  channels  have 
been implicated as well. Wind-up is a form of activity dependent plasticity that is extremely 
short lived. Wind-up manifests itself over the course of the stimulus and does not last beyond 
this point. The behavioural correlate of wind-up has been seen in human studies (Price et al, 
1977) with both thermal and mechanical stimuli. Although the stimulus strength remained the 
same,  repetitive  stimulation  increased  the  pain  experienced  by  human  volunteers.  This 
occurrence has led some to believe that wind-up is a phenomenon that is part of normal acute 
nociceptive processing (a defensive behaviour to potential tissue damage).
1.10.2 Heterosynaptic central sensitisation
This  form  of  central  sensitisation  can  be  induced  by  intense  noxious  stimulation  with 
capsaicin,  C-fibre  electrical  stimulation  or  tissue  damage.  Following  the  induction,  the 
sensitisation of dorsal hom neurons outlasts the duration of the stimulus. The reduction in the 
threshold  of  second  order  neurons  in  the  dorsal  hom  following  sensitisation  enables 
innocuous  stimuli  (via  low  threshold  sensory  fibres)  to  activate  the  sensitised  cell.  This
31therefore produces behavioural allodynia, and increases the receptive field. The unmasking of 
sub-threshold inputs maybe responsible for the generation of secondary hyperalgesia.
The  maintenance  of  heterosynaptic  central  sensitisation  is  consequence  of  two  general 
mechanisms  1)  post-translational  modifications  on  ion  channels,  receptors  and  regulatory 
proteins 2) trafficking of receptors to the membrane  of the post-synaptic  cell  in the dorsal 
hom.  Post-translational  modifications  to  receptors  and  ion  channels  can  dramatically  alter 
gating kinetics including increasing opening probability and open time durations. In addition, 
the  permeability  of the  membrane  is  further  increased  with  the  increased  trafficking  and 
insertion of receptors into the membrane.  For instance following  inflammation dorsal  hom 
NR1  and NR2 subunits of the NMDA receptor are rapidly phosphorylated (Guo et al, 2002; 
Caudle et al, 2005) resulting in altered channel kinetics (Yu et al,  1997;  Suen, et al,  1998). 
Changes include an increase in the opening probability and a reduction in voltage-dependent 
magnesium block. The phosphorylation of the NMDA receptor can be achieved by activating 
a series of protein kinases including Src (activated by TrkB and EphB) (Simone et al,  1989), 
protein kinase  A  and protein  kinase C  (Chen  and Huang,  1992).  Moreover,  recent  studies 
have shown that dorsal hom AMP  A receptors (GluRl) are readily trafficked and inserted into 
the membrane following noxious stimulation (Galan et al, 2002; Tao et al, 2006) in order to 
strengthen synaptic efficacy.
1.10.3  Transcriptional-dependent central sensitisation
Peripheral  inflammation  increases  afferent  input  into  the  dorsal  hom  and  can  drive 
transcriptional  events  both  peripherally  and  centrally.  Transcription  of key  proteins  in the 
dorsal hom can sustain altered nociceptive functions for long periods of time and maintain 
central  sensitisation  (Woolf  and  Costigan,  1999).  The  release  of neurotransmitters  as  a 
consequence of intense nociceptive activation can result in the activation of NMDA, AMPA, 
NK1 and TrkB receptors in dorsal hom neurons and results in protein kinase A, protein kinase 
C  and  ERK  phosphorylation  (activation).  ERK  activation  can  alter  gene  transcription  by 
regulating the activity of CREB and other IEGs (Adwanikar et al, 2004). Indeed, to support 
this idea, the expression of the immediate early genes (IEGs) such as c-fos and zif268 occurs 
rapidly (2h) and transiently in dorsal hom neurons following peripheral stimulation (Hunt et 
al,  1987;  Rygh  et  al,  2005;  Ji  et  al,  2002)  and  are  known  to  be  important  for  gene 
transcription.  Microarray  studies  have  shown  that  peripheral  inflammation  can  increase 
mRNA expression in the dorsal hom for a number of genes (Rodriguez-Parkitna et al, 2006), 
while other studies have shown that TrkB (mRNA) expression increases  in the dorsal  hom 
following electrical C-fibre stimulation (Woolf and Costigan, 1999).
321.10.4  Long term potentiation
LTP has often been used as a model for central sensitisation. However it remains unclear if 
the two events describe the same phenomenon. LTP is one form of synaptic plasticity and is 
defined as an increase  in  synaptic  strength and excitability  (that outlives the  stimulus that 
induced the event) within a neuron. LTP-like events can be artificially induced in dorsal hom 
neurons  with  high  intensity  stimulation  (including  lamina  I  projection  neurons)  (Liu  and 
Sandkuhler, 1995, 1997; Svendsen et al,  1999; Ikeda et al, 2006).
Hippocampal LTP can be divided into two time dependent components; early LTP (E-LTP) 
and late LTP (L-LTP). Although the temporal distinctions are not always clear as to when the 
onset  of L-LTP  actually  occurs  following  E-LTP  (reviewed  in  Kelleher  et  al  2004),  a 
distinction  which  most  authors  agree  upon  is  that  L-LTP  requires  the  expression  of new 
mRNA and de novo protein synthesis, which E-LTP does not. LTP and central sensitisation 
share a number of characteristics. Importantly, both require the synthesis of the same proteins 
including mediators of LTP such as the NMDA receptor, CaMKII, and group 1  mGluRs (Ji et 
al, 2003; Azkue et al, 2003), as well as a wide range of modulatory proteins. Noxious stimuli 
such  as  electrical  C-fibre  stimulation  in  the  noxious  range,  noxious  skin  heating  or 
subcutaneous  CFA  injection  leads to the  induction of the same  IEGs  seen  in  hippocampal 
LTP such as c-fos, c-jun. Non-noxious stimuli usually fail to induce the expression of these 
IEGs.  Furthermore,  the  intrathecal  administration  of protein  synthesis  inhibitors  such  as 
anisomycin  or  cycloheximide  attenuates  L-LTP  in  the  dorsal  hom  without  effecting  the 
induction or the baseline response (Hu et al, 2003).  Importantly, this also blocked proteins 
that  are  important  for  the  expression  of allodynia  and  hyperalgesia  in  both  the  primary 
afferent (Tohda et al, 2001) and in the dorsal hom (Hou et al,  1997).  By blocking de-novo 
synthesis  in the  dorsal  hom,  cycloheximide  dose  dependently  reduced  formalin  dependent 
spinal  c-fos  expression  and  reduced  nociceptive  responses  in  a  similar  manner  to  c-fos 
antisense treatment (Hou et al, 1997) suggesting a behavioural role for c-fos in nociception.
Another signalling cascade that is important for hippocampal LTP is the MAPK pathway. The 
inhibition of this pathway at time points that are too early for gene expression can prevent the 
induction of hippocampal LTP and also prevent second phase formalin, these results suggest 
that MAPK in the dorsal hom could play a role in amplifying nociceptive processing (Ji et al, 
2003; Karim et al, 2006).  In addition, hippocampal LTP can also be affected by the AMPA 
receptor  subunit  composition.  Calcium  influx  into  hippocampal  neurons  was  found  to  be 
significantly  larger  in  mutant  mice  that  lacked  the  GluR2  subunit.  This  resulted  in 
hippocampal neurons that were more excitable and enhanced  LTP expression (Geriai et al,
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excitability of nociceptive neurons in the dorsal hom. It has been suggested that the excitable 
nature of the neurons located in the superficial layers of the dorsal hom can be enhanced with 
AMPA receptors that lack the GluR2 subunit (Hartmann et al, 2004). AMPA receptors that 
lack  the  GluR2  subunit  are  more  calcium  permeable  in  comparison  with  other  AMPA 
receptors and  are therefore  likely  to mediate  synaptic  changes  that amplify  noxious  input. 
Altering the  neuronal  composition  of calcium  impermeable to  calcium  permeable  subtype 
during  induction  would  increase  calcium  permeability  of  the  cell  and  enhance  gene 
transcription.
1.11  Zif268: an immediate early gene important for synaptic plasticity
Zif268 is an immediately early gene associated with learning and memory in the hippocampus 
(Jones et al, 2001). Zif268 is also expressed spinally. The dorsal hom of naive (unstimulated) 
animals  contains  very  few  zif268  positive  cells.  Zif268  expression  in  the  dorsal  hom  is 
stimulus  dependent  and can  be  induced  with C-fibre  HFS  (Wisden  et  al,  1990),  formalin, 
carrageenan  and CFA  (Koganemaru et al,  2000;  Rahman  et al  2002;  Otahara,  2003).  The 
expression  of zif268  using  these  agents  all  produced  a  similar  time  course,  significant 
increases  were  seen  at  45min  with  peak  expression  occurring  at  approximately  2h  post 
stimulation.  The  levels  returned  to  baseline  values  at  the  6h  time  point.  Concomitantly 
pCREB in the dorsal hom (including lamina I) are also upregulated with the same stimuli (Ji 
and Rupp,  1997;  Impey  et al,  1999;  Ji et al,  2002) following the  same time  course.  Since 
zif268  contains the  CRE  binding  site  in  its  promoter  region  (Sakamoto  et  al,  1991),  it  is 
possible that the increase in pCREB levels in the dorsal hom can contribute to the activation 
of zif268. To support this idea, evidence from learning and memory studies show that pCREB 
often binds to the zif268 promoter with both molecules being essential for long term stability 
of memory traces (Bourtchuladze et al,  1994, also reviewed by Josselyn and Nguyen 2005). 
However it must also be noted that zif268 also contains several SRE sites within its promoter 
region, which may also provide a potential target for Elk-1. Elk-1   is an important molecule 
for gene transcription that lies downstream of ERK. Elk-1  is known to be phosphorylated in 
the dorsal hom following nerve injury (Yu and Yezierski, 2005) as such it may also be an 
important  activator  of  zif268  providing  a  CREB  independent  manner  of  transcription 
(Widmann et al, 1999). It might also be the case that zif268 requires the stimulation from both 
the CREB pathway as well as the Elk-1 pathway for its full activation during the induction of 
chronic pain states, although this has yet to be proven.
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using zif268 knockout animals (Ko et al, 2005). It was noted that the response to acute pain 
was normal in the zif68 knockout animal, indicating that zif268 was unnecessary for normal 
pain transmission. This is not surprising since zif268 is not expressed following acute noxious 
stimulation. Peripheral injection of either formalin or CFA leads to hyperalgesia and allodynia 
to  both  thermal  and  tactile  stimulation.  Formalin  injection  is  accompanied  by  gross 
nocifensive  behaviours  such  as  paw  flinching  and  licking.  These  behaviours  were  also 
significantly reduced with mice that lacked the zif268 gene. Since zif268 has been found to be 
expressed  in other parts of the nervous system  involved with pain processing  (the  anterior 
cingulate  cortex,  the  amygdala,  the  parabrachial  nucleus,  the  periaqueductal  grey  and  the 
hypothalamus (Flerdegen et al,  1991;  Herdegen and Leah,  1998)) it remains  unclear if loci 
other then the dorsal hom contributed to the phenotype.
1.12 Thesis outline
In this thesis I have examined a number of molecular components that have been associated 
with the setting up of persistent pain states.  Initially, I looked at the localization of zif268 and 
found it to be expressed by lamina I  projection neurons.  I then examined the influence of 
descending serotonergic pathways on gene expression in the dorsal hom and finally examined 
the expression of the glucocorticoid receptor (GR) in inflammatory pain states.  Both GR and 
zif268 expression in dorsal hom neurons and the descending serotonergic pathways play an 
important role in maintaining inflammatory pain states.
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Materials and Methods2. MATERIAL AND METHODS
2.1 Animals
Rats were housed 4 per cage. Adult male Sprague-Dawley rats weighing between  180-300g 
were used.  The animals were housed  in artificial  lighting on a  12:12  h light cycle and the 
temperature  was  kept  at  a  constant  temperature  of 21°C.  Food  and  water  were  given  ad 
libitum and all procedures were carried out in accordance with the United Kingdom Animal 
Procedure Act 1986.
2.2 Behaviour assessment -  mechanical allodynia
The  37400  Dynamic  Plantar  Aesthesiometer  (or  mechanical  plantar  test  apparatus)  (Ugo 
Basile, Varese, Italy) was used to test for mechanical allodynia. The apparatus consisted of a 
movable force-actuator situated below a perforated platform upon which the rats are situated. 
A modular Perspex enclosure, with 8 spaces, leaves the animals unrestrained for the duration 
of the experiment.
Animals  were  placed  in  the testing  cage  and  were  habituated  for  lh  every  day  for  7d to 
acclimatize the rats to the test equipment and test environment. Using the mechanical plantar 
test apparatus, animals were tested for their baseline paw withdrawal threshold to mechanical 
stimuli on days 6 and  7 of the habituation period.  An  increasing upwards linear force was 
exerted onto the middle  of the plantar region  on both the right and  left hindpaw  with the 
actuator. The apparatus was calibrated as follows: max force 50g with a linear ramp speed of 
20s (i.e. 0-50g in 20s). Paw withdrawal thresholds were tested four times per paw with each 
ramp  separated by  a 5  min  interval  and the  mean  score taken.  Since  the  maximum  force 
generated  by  the  test  apparatus  was  50g,  any  animals  with  a  threshold  above  50g  were 
excluded from the study, as it was impossible to ascertain the true baseline score. Following 
determining the baseline score, animals were taken to surgery (as described in section 2.5). 
The animals were left to recover for Id and inspected for behavioural abnormalities. The post- 
surgical baseline was then established over the next three days using the same technique as 
described  above.  Three  days  following  mini-pump  insertion,  or  4d  following  a  bolus 
injection, rats received an intraplantar injection of CFA (lOOpl, 50%, Sigma, Poole, UK) into 
the left hindpaw. Changes in paw withdrawal thresholds were assessed a day later for the next 
4d for osmotic pump (zif268 and GR antisense) studies and a week for bolus injection (5, 7 
DHT)  studies.  Behavioural  testing  post-CFA  used  the  same  technique  as  that  used  for
37determining  baseline  values.  Changes  in  paw  withdrawal  thresholds  were  assessed  by 
comparing  post-surgical  baseline  scores  with  post-CFA  scores  for  each  day  Behavioural 
results were presented as either net change from baseline or percentage change from baseline. 
Net change from baseline was determined by subtracting the mean post-surgical baseline from 
the mean score for each animal on each day after CFA. Percentage change from baseline was 
determined by taking the mean score for each animal (for each day) and dividing the score by 
the  appropriate  post-surgical  baseline,  before  being  multiplied  by  100.  Results  were 
statistically analyzed using a two-way ANOVA repeated measures test, Tukey’s post-hoc test 
and paired t-tests.
2.3 Anaesthesia
In order to  induce anaesthesia,  rats  were placed  into a halothane  chamber for about  3min. 
When  unconscious  the  animals  were  then  gently  transferred  onto  a  heat  mat  to  prevent 
hypothermia.  Anaesthesia was maintained by a continuous flow of 2% halothane through a 
specialised mask (flow rate of 1.5L min'1 ). To ensure the animal was adequately anaesthetised 
paw pinch and corneal reflexes were tested. Further procedures were only carried out if these 
responses were negative.
2.4 Retrograde labelling with fluorogold (FG)
2.4.1  Fluorogold as a retrograde tracer (FG)
Fluorogold  (Hydroxystilbamidine)  (FG)  is  a  widely  used  hydrophilic  (Fig  2.1)  retrograde 
label  used  in  neuronal  tracing.  Under  physiological  conditions  FG  has  a  peak  excitation 
wavelength of 325nm  and  emits  a maximum  wavelength at 440nm  (Kobbert  et  al,  2000). 
Fluorogold is a weak base that enables it to diffuse across membranes and into intracellular 
vesicles (lysosomes and endosomes) using the favourable pH gradient. Within vesicles FG is 
-  protonised due to the acidic environment. In this modified form, FG cannot cross back over 
the  lipophilic  membrane  and  is  trapped  and  accumulated.  The  FG  is  then  retrogradely 
transported to the cell body (Wessendorf, 1991).
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Figure 2.1. Chemical structure of FG
382.4.2 Stereotaxis and FG injection into the parabrachial nucleus
Anaesthetised rats were gently transferred onto a stereotaxic frame (Kopf), held in position 
and maintained under anaesthesia. Once stable, a 2cm epidermal incision was made running 
rostro-caudally into the scalp. A Goldstein eye retractor gently held the skin open. Sub-dermal 
tissue was pushed to the side to expose the skull. Target co-ordinates were identified using the 
brain atlas of Paxinos and Watson (1998).  The skull was briefly cleaned with sterile water 
and a Hamilton syringe (Hamilton,  Microliter No 75  with a 26s/25/pst4 needle) filled with 
800nl of 4% fluorogold (Fluorochrome Ltd) was attached to the stereotaxic  frame.  Bregma 
(the point of intersection of 3  skull plates) was then localised under a freestanding surgical 
microscope.  After successfully  locating bregma,  the needle,  now  located  over bregma was 
moved 9.3mm caudally and +/- 1.7mm medio-laterally. The co-ordinates correspond to points 
directly dorsal to each parabrachial nucleus. In order to expose the dura, openings in the skull 
(2mm in diameter) were made at both these co-ordinates using a dental drill (RS model 547 
616).  The  Hamilton syringe  was then  lowered  until the needlepoint was  in touch with the 
dura. The syringe was then advanced 6.7mm ventrally into the parabrachial nucleus and an 
injection of 400nl of FG was given (at a rate of approximately  lOOnl min'1 ). To ensure the 
injection were adequate and to minimise FG drag back, the needle was left in the parabrachial 
nucleus for a further 6 minutes. The same injection technique was used for both sides. Bone 
wax  was  used  to  fill  the  skull  openings  after  the  injection  and  the  sub-dermal  and  the 
epidermal layers were pulled back into position and the skin surgically clipped. The animals 
were left for 3-4d to allow time for the FG to be transported down to the lumbar spinal cord 
before being perfused.
2.5  Intrathecal bolus injections and implantation of osmotic mini-pumps
2.5.1  The cannula
To deliver compounds intrathecally using bolus injections or osmotic pumps (to the lumbar 
spinal cord) it was necessary to cannulate the animals. This method is relatively non-invasive 
compared to other approaches. The cannula used was a 15cm PE-10 polythene tubing (Portex) 
with  an  internal  diameter of 0.28mm  and  an external  diameter of 0.61mm.  To  reduce the 
likelihood of damaging the spinal cord during cannula insertion, the tubing was placed into 
hot water (~80-90°C) and stretched to reduce the diameter of the tubing by 40%. The tubing 
was then rapidly submerged into cold water and held for 1  min to “fix” the length of tubing. 
For  osmotic  pumps  the  cannula  diameter  was  only  reduced  (by  40%)  at  distal  end.  This
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proximal end) to be tightly fitted to the bridging tubing that separates the cannula from the 
osmotic pump.
To ensure the cannula was inserted the correct distant (3cm) into the  intrathecal  space the 
cannula was pre-inserted into the catheter so that the distal tip of the catheter was flush with 
the distal tip of the cannula. A reference point was then created on the cannula using a non­
toxic pen 3 cm from the proximal end of the catheter to aid surgical accuracy (Fig 2.5).
2.5.2 Cannulation
The cannulation technique used was similar to that developed by Pogatzki et al (2000). Adult 
rats weighing between 180-200g were anaesthetised as described above (section 2.3). A small 
rostro-ventral incision (~3cm) was made to the skin along the midline above the lumbo-sacral 
spinal column (Fig 2.5). The incision was made with a scalpel blade (size  15) with the start 
point 2cm above the level of the iliac spine. The incision exposed the underlying muscle but 
did not damage it. To ensure sterility during the surgery, the skin was shaved and swabbed 
with  povidone-iodine  solution  (Betadine,  Seton  Healthcare  Group  Pic,  UK)  before  the 
incision  was  made.  Once  the  incision  was  complete,  a  guide  catheter  (19g  needle)  was 
inserted and directed rostrally (i.e. cranially) into the muscle overlying the spine. The point of 
entry into the muscle was made ~2mm lateral to the midline at the level of the iliac crest. The 
catheter was then advanced approximately 4mm  so that the tip  of the  needle was  residing 
between the gap of the L5  and L6 vertebrae. The cannula was then gently  slid through the 
catheter so that the reference point on the cannula was flush with the proximal  end of the 
catheter. This ensured that the cannula was 3cm inside the intrathecal space and lying dorsal 
of the lumbar 5 (L5) region of the spinal cord. The catheter was then carefully removed from 
the  animal,  ensuring the cannula remained in place.  Correct placement  into  the  intrathecal 
space was accompanied by minor tail and/or hindpaw flick during insertion and the back-flow 
of spinal fluids from the intrathecal space after insertion. However, back-flow of spinal fluids 
is not guaranteed even with correct cannula positioning.
2.5.3 Intrathecal bolus injections via cannulation
For  bolus  injections,  the  cannula  was  pre-filled  with  the  same  solution  as  the  injection 
medium and inserted as described above (section 2.5.2). Injections were made using Hamilton 
syringes (50pl, 705N). The injections consisted of lOpl of drug followed by a  lOpl flush of 
saline.  Both flush and drug were delivered at a rate of ~10|il  min'1 .  The cannula was then
40slowly and carefully removed from the rat and Aureomycin (chlortetracycline hydrochloride 
0.5g, 2%) powder was applied onto the dorsal  layers of the cutaneous maximus muscle to 
prevent infection. The incision was then closed using 4 equally spaced surgical Michel clips 
(size 2x5mm). After closing the animals were left to recover from the effects of anaesthesia 
for  approximately  2h  before  returning  to  their home  cages.  Any  animals  with  any  motor 
deficits or in discomfort were immediately sacrificed.
2.5.3.1 Bolus intrathecal injections of 5, 7 dihydroxytryptamine (5, 7 DHT)
Bolus injections of 5, 7 DHT were given to ablate local serotonergic neurons in the lumbar 
region  of the  spinal  cord.  Firstly,  animals  were  anaesthetised  and  injected  i.p.  with  1ml 
desipramine  hydrochloride  (in  saline,  25mg  kg'1 ,  Sigma,  D3900-SG)  in  order  to  protect 
noradrenergic  axons.  The  animals  were  then  left  to  recover  for  45min  before  being 
anaesthetised  again  and  cannulated.  The  animals  were  injected  with  either  5,  7  DHT 
(dissolved in saline, lOpl, 6pg pi'1 , Fluka) or saline (lOpl, vehicle control) before receiving an 
intrathecal saline flush (lOpl). The animals were left for 3-4d to allow time for the depletion 
(-90%) of serotonin from  local axons  and  separated  into two groups.  The  first group  was 
assessed for behavioural changes (section 2.2) and the second group was immunostained (Fig 
2.6) for 5-HT, c-fos and zif268 following a 2h CFA injection into the intraplantar region of 
the hindpaw (section 2.9 and table 2.2). If applicable, neuronal counts were performed using a 
Nikon E-800 Eclipse microscope and MCID software (section 2.11.2).
2.5.3.2 Bolus intrathecal injections of SP-SAP and SAP
Substance  P-Saporin  (SP-SAP)  specifically  targets  and  ablates  cells  expressing  the  NK1 
receptor. The active component leading to cell death is saporin (SAP) (see Fig 2.2). Animals 
were  cannulated  as  above  (section  2.5.2)  and  injected  with  either  SAP  (vehicle  control) 
(1.0pm,  lOpl,  Advanced  Targeting  Systems)  or  SP-SAP  (1pm,  lOpl,  Advanced  Targeting 
Systems) followed by a saline flush (lOpl). The animals were then left for 28d (Mantyh et al, 
1997; Nichols et al,  1999) before  being briefly  anaesthetised and  injected with CFA  (50% 
lOOpl, Sigma) into the intraplantar region of the hindpaw. 2h later animals were perfused with 
4% PFA (section 2.6). Lumbar spinal cord sections (40pm) were then immunostained for the 
NK1  receptor and zif268  using the three step indirect fluorescence protocol  (Fig 2.6).  The 
primary  antibodies  concentrations  were  used  as  detailed  in  table  2.2.  Following 
immunostaining, zif268 and NK1  positive neurons were counted as described below (section 
2.11.2).
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Figure 2.2. Substance P and saporin mediates NK1  receptor positive cell ablation. Since saporin is a type 1  RIP 
it has more difficulty entering  cells  (however,  it can  still  be  internalised  by  binding to  either alpha-microglobulin 
or the  megalin  receptor).  Saporin  is stable from  protease activity (compared  with  other RIPs)  and  this  property 
has  made  it  useful.  By  conjugating  saporin  to  a  specific  substrate  it  is  possible  to  selectively  ablate  cells  that 
contain  its  receptor.  Here saporin  has been  conjugated to  substance P (SP-SAP) the  putative substrate for the 
NK1  receptor.  As such when  SP-SAP  binds  onto the  NK1  receptor the  receptor is  internalised  and  the  saporin 
is then detached and free to inhibit ribosomal activity leading to the cell death
The 30KDa protein  Saporin was first discovered  in the seeds of Saponaria officinalis (Stirpe et al, 
1983)  and  is  a  ribosome  inactivating  protein  (RIP).  RIPs  are  believed  to  have  evolved  in  part to 
protect  plants  from  viral  infections  and  insect  parasites.  Located  in  rRNA  is  an  evolutionary 
conserved  14  nucleotide  region  (Endo  et  al  1987)  (the  alpha-sarcin  loop).  RIPs  are  capable  of 
modifying the first adenosine in a GAGA sequence.  This irreversible event blocks elongation factor 
(EF) 1- and EF 2-dependant GTPase activity. This action inhibits translation and leads to cell death 
since the ribosome is unable to bind EF 2.  RIPs have been classified into 3 main groups based on 
physical characteristics these are Type  1, 2 and 3. Type  1   includes saporin,  PAP, and barley. Type 
2  RIPs are more toxic compared to type  1   and 3 and  include ricin and abrin.  The toxicity is due to 
the ease in which they enter cells. These RIPs contain two subunits that are linked to each other by 
disulphide  bonds.  One  subunit  contains  the  RIP  activity  (A  Chain)  and  the  other  (B  Chain)  has 
enzymatic  and  lectin  binding  properties.  The  B  chain  can  bind  to  galactosyl  moieties  of 
glycoproteins  or glycolipids  found  on  eukaryotic cell  membranes.  These  are  internalised  with  the 
RIP  and  retrogradely transported  to the  nucleus via  endosomes.  Type  3  RIPs  are  less  common, 
and are made from inactive precursors and are found in maize and barley.
422.5.4 Continuous infusion with mini-osmotic pumps
In order to look at the behavioural consequences of knocking down protein levels of zif268 
and the glucocorticoid receptor (GR), as well as their potential regulatory relationship with 
each other and with SGK1, this study used mini-osmotic pumps to apply a continuous supply 
of antisense, missense and vehicle for chronic knockdown studies (Fig 2.3). Osmotic pumps 
eliminated the repetitive and stressful nature of multiple bolus injections. Furthermore, they 
remove large fluctuations in drug concentrations that follow a daily cycle of bolus injections. 
This study  looked at reducing the  levels of zif268 and GR using the appropriate modified 
oligonucleotide  (for  sequences,  concentrations  and  modifications  see  table  2.1).  A  GR 
antagonist  (dexamethasone  21-mesylate,  Steraloids  Inc.  USA)  was  also  delivered  in  this 
manner in order to confirm the actions of the GR antisense treatment.
Gene Antisense sequence Missense Sequence Modification
Zif268 (42pg) 5’-GGT-AGT-TGT-CCA-
TGG-TG*G-3';
(Lee et al, 2004)
5-GTG-TTC-GGT AGG- 
GTG-TC*A-3'.
(Lee et al, 2004)
Phosphorothioate 
linkages at *
Glucocorticoid 
Receptor (200pg)
5’-TGG-AGT-CCA-TTG- 
GCA-AA*T-3’ 
(Wang etal, 2005)
5’-TGA-AGT-TCA-GTG- 
TCA-AC*T-3’ 
(Wang etal, 2005)
Phosphorothioate 
linkages at *
Table  2.1  Oligonucleotide  probes  used  for  knockdown.  The  oligonucleotides  were  made  to  order  (Eurogentec, 
Belgium)  and  were  delivered  using  mini-osmotic  pumps.  Sequences  were  ascertained  from  previous  studies  and 
were  modified  at  point  *  in  order  to  stabilise  the  oligonucleotide  from  enzymatic  degradation.  GenBank  database 
searches of the probes did  not match any other coding region of the rat.
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Figure 2.3  Principles of operation. The mini-osmotic pump utilises the  principle forces of osmosis as  its driving  force 
to deliver drug solutions to the target site. The drug  is placed  into a sealed, but fully collapsible bladder.  Surrounding 
the  bladder  is  a  layer  called  the  osmotic  layer that acts  as the  driving  agent  to  compress  the  bladder.  In  order  to 
secure the driving agent from the external environment and to allow water to enter the pump, a rigid semi-permeable 
membrane encloses the pump.  Since the semi- permeable membrane is rigid and water is highly incompressible, the 
pump, when placed  into an aqueous environment creates a net flux of water that crosses the membrane and into the 
pump.  This  entry  into  the  pump  causes an  equal  amount of drug  to  be  expelled  out of the  pump  orifice.  After 5-6h 
(37°C,  0.9%  saline)  the  amount  of  drug  being  expelled  is  fixed  at  a  constant  rate  until  the  bladder  is  empty 
(Theeuwes  and Yum,  1976),  therefore allowing for a  continuous  infusion of drug towards  its target site for extended 
periods of time.
432.5.4.1  Filling the pump
Mini-osmotic pumps (Model 2001,  Durect, CA) were filled  in a sterile environment (using a 
vertical  laminar flow hood  (VLF,  Microflow 4) one day  prior to  inserting the  pump  into the 
animal.  Each  pump  was  overfilled  beyond  its  capacity  (250pl)  using  a  specialised  filling 
needle (Durect Corp, USA) (Fig 2.3 and Fig 2.4) attached to a  1ml syringe (BDH) containing 
the drug in question (vehicle, missense or antisense). The procedure of overfilling reduces the 
chances  of air  being  trapped  inside  the  bladder  (or  reservoir)  of  the  pump,  which  could 
impede  pumping.  The  VLF  hood  prior  to  use  had  been  thoroughly  wiped  down  with  70% 
ethanol  and  any  equipment  entering  the  hood  had  been  sterilised  in  the  autoclave.  The 
procedure  itself only  required  the  partial  insertion  of the  filling  unit;  if the  filling  unit  was 
totally  inserted no air could escape and filling was hampered. Once  inserted, the bladder will 
begin to fill with the chosen solution as the syringe is compressed.  Filling was stopped when 
fluid  began  to  exit  out  of the  pump  orifice.  The  flow  moderator  was  then  inserted  into  the 
pump and a piece of silicon (‘bridging’) tubing (Sani-tech,  STHT-C-025-0F) was placed over 
the  exposed  end  and  secured  with  cyanoacrylate gel  (RS).  The  filled  pump  was  then  placed 
into saline and placed into an incubator set at 38.5°C until surgery.
On  the day  of the  surgery  each  pump was  observed  for  its  pumping efficiency.  If the  pump 
was  working  a  meniscus  was  seen  in  the  silicon  tubing,  however  if the  meniscus  was  not 
present then the pump was not surgically implanted but discarded.
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Figure 2.4.  Filling  of osmotic pump.  Pumps were filled  with chosen  solution.  The filling  unit was  attached  to  a 
syringe and filled with solution of choice. The filling  unit was then inserted  into the pump  (shaded  arrow). After 
the reservoir was overfilled the flow moderator was  inserted  (open arrow) and a  piece of silicon tubing  (~3cm) 
was attached  and glued onto the end.
442.5.4.2 Implantation of the mini-osmotic pump
The surgical procedure of pump implantation was similar to that used for intrathecal bolus 
injections.  However, modifications were made to ensure the implantation of the pump was 
successful and as comfortable for the animal as possible.
The animals were shaved and the incision site was swabbed with Betadine. An incision into 
the skin was made (Fig 2.5) similar to that used for i.t. bolus injections. However unlike the 
bolus injection, a subdermal pocket was created. The dimensions of the pocket were such that 
it was just larger than the osmotic pump and allowed the pump to slip gently into the pocket 
The  size  of the  pocket minimised  lateral  movements  that could  displace  the  cannula.  The 
pocket was located immediately dorsal to the dorsal most point of the incision and was made 
using a pair of blunt-ended Mayo scissors.  Following formation of the pocket, a  19-gauge 
needle  (the  catheter)  was  then  inserted  (as  described  in  section  2.5.3).  After  successfully 
implanting the cannula into the correct position (L5), the catheter was gently removed. Since 
the cannula is left ‘in-dwelling’ in awake animals, the cannula needed to be secured to avoid 
displacement.  The  cannula  was  held  onto  the  underlying  muscle  with  a  suture  (Ethicon 
Mersilk 3-0) at the entry point of the cannula and a loop was formed in the cannula. The loop 
was held in position by loose sutures with the underlying tissue acting as anchor points. If the 
cannula was pulled at the proximal end, the loop would absorb the force by tightening itself 
rather than displacing the cannula. The proximal end of the cannula was then inserted (5mm) 
into the  bridging tubing  (attached  to the  mini-osmotic  pump).  For added  security,  the two 
tubing  components  were  then  coated  with  2  layers  of cyanoacrylate  gel  (159-3935,  RS 
components) at the connection point and left to dry. Ensuring no kinks occurred in the tubing, 
the  pump  was  then  carefully  inserted  into  the  subcutaneous  pocket.  The  wound  was  then 
dusted with antibiotic powder (Aureomycin) and closed with 3-4 Michel clips, ensuring the 
clips did not compress the tubing.
2.5.5  Specificity of antisense treatment
In order to be certain that knocking down GR and its behavioural effects were specific  we 
also  used  the  GR  antagonist  dexamethasone  21-mesylate.  The  drug  is  stable  at  37°C  for 
extended periods of time and dissolvable in saline which allowed us to simply substitute the 
antisense for the drug while maintaining the same surgical and behavioural paradigm as the 
antisense study. Each animal received a total of 28nmol over a 7d period.
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Fig 2.5.  Implantation of osmotic pump.  Prior to  insertion  into the intrathecal space,  catheters were  pulled 
by  40%  to  ease  passage  into  the  i.t.  space  and  were  attached  to  the  cannula  (A).  The  cannula  was 
inserted  into the space between  L5-L6 following  skin incision (C). The  point of entry for the  cannula was 
lateral  of the  midline  and  at the  level  of the  iliac crest  (B,D).  The  catheter was  then  pushed  forward  by 
3cm  before  the  catheter was  removed  (E).  A  loop was  formed  in  the  middle  of the  exposed  end  of the 
cannula  and  were  held  in  position  using  3  sutures  into  the  underlying  muscle.  The  mini  osm otic  pump 
was then  attached  onto the distal  end  of the  cannula  and  secured  with  glue  (F,G).  The  pump  was  then 
placed  into  a  specially created  subdermal  pocket  Finally the  wound  was  dusted  with  anti-biotic powder 
and closed  using skin clips (H).  ^2.5.6  Post experimental pump check
Since such a small amount of substance was expelled from the pump per unit time (lpl h'1 ) it 
was essential to check that the placement of the cannula was precisely placed over the L4-L5 
region  (lumbar  enlargement)  of the  spinal  cord.  To  do  this,  animals  were  subsequently 
perfused (see 2.1.6) and the overlying muscle and spinal vertebrae were carefully removed to 
ensure that the pump and tubing were not displaced as a consequence of the dissection. Only 
animals  with  correctly  positioned  cannula  were  included  in  the  results.  After  positional 
verification, the pump and cannula were removed from the perfused  rat and the pump was 
then separated from the silicon tubing and checked. Only pumps that were fully empty or had 
minimal fluid left were included in this study. In addition, the bridging tubing and the cannula 
were  checked  for  leaks.  An  injection  of water was made  using a Hamilton  syringe.  If the 
connection was still tight, the animal data was included in the study.
2.6 Perfusion and dissection of animals
Animals were transcardially perfused after administration of a lethal intraperitoneal injection 
of pentobarbitone at a dose of 3.5 ml kg"1 . The ribcage and diaphragm were removed and a 
catheter inserted into the aortic arch via the left ventricle. The right atrium was then cut and 
the animal was flushed (40ml min'1 ) for 5 min with saline containing 0.01% heparin. To fix 
the tissue, a solution of 4% paraformaldehyde was then pumped into the rat for 15min (30 ml 
min'1 ). The spinal cord and brain were removed, post-fixed for 4h and then cryoprotected in 
30%  sucrose  solution  overnight  at  4°C.  Tissues  were  then  made  ready  for 
immunohistochemical processing (section 2.9).
2.7 Verification of knock-down
In order to verify protein knock-down efficacy, two separate techniques were run in parallel. 
The  first  was  immunohistochemistry  which  had  the  advantage  of  looking  at  protein 
concentrations per unit cell (section 2.11.3) and second western blotting (section 2.12). This 
technique is more analytically accurate and quantifiable but requires larger amount of tissue 
and lacks the spatial resolution available with immunohistochemistry.
472.8  Toxicity from oligonucleotides
On the last day of behaviour, animals were perfused, the spinal cord sections were stained for 
IB4 (a marker for non-peptidergic C-fibres) (1:500, 24h, RT, Vector Labs) to verity neuronal 
damage from the surgical procedure if any. Since concentrations of oligonucleotide probes are 
often higher in more superficial layers of the dorsal horn, sections were also immunostained 
for the NK1  receptor and NeuN using the 3  step fluorescence protocol (Fig 2.6) and stained 
using  Hoechst (1:100,000,  5min,  RT) to look for any  significant  increases  in  neuronal  cell 
death arising as a consequence of the oligonucleotide probes. The antibodies were visualised 
using Alexa 488 under a Nikon E-800 eclipse microscope and counted as described in section 
2. 11.2.
2.9  Immunohistochemistry (also see Principles of immunohistochemistry below)
2.9.1  Single immunohistochemistry
Lumbar  spinal  cord  tissue  (L4-L6)  was  transversely  sectioned  (40pm)  using  a  freezing 
microtome (Leica). Sections were then placed into 5% normal goat serum (Vector labs) (and 
2% hydrogen peroxide for serotonin immunostaining) diluted with distilled water containing 
0.2%  Triton  X-100  and  0.05M  Tris  Saline  (TTBS)  for  lh  before  being  placed  into  either 
rabbit  anti-zif268  (1:5000,  Santa  Cruz,  sc-189),  rabbit  anti-glucocorticoid  receptor  (1:500, 
Santa  Cruz,  sc-8992),  rabbit  anti-NKl  (1:5000,  Eurogentec),  mouse  anti-NeuN  (1:200, 
Chemicon,  MAB377)  or  rabbit  anti-serotonin  (1:200,  Chemicon,  AB938)  and  incubated 
overnight at room temperature (RT). The sections were then washed (3xl0min PB wash i.e. a 
standard  wash)  and  placed  into  biotinylated  anti-rabbit  or  anti-mouse  secondary  antibody 
(Vector Labs) (1:500  in TTBS  for 2h,  RT) before being washed  again and  incubated  with 
fluoroscein avidin D (1:200, Vector Labs) or Alexa Fluor 488 (1:500, Molecular Probes) in 
TTBS for 2h at RT. (Sections undergoing serotonin immunostaining were instead placed into 
Avidin-Biotin Complex (ABC, Vector Labs) solution in TTBS for lh, washed and placed into 
DAB  solution  until  positive  staining  occurred).  The  sections  were  washed,  mounted  onto 
slides  and  coverslipped  with gel  mount (Sigma).  In  the  case  of DAB  (serotonin  staining), 
sections  were  dehydrated  using  a range  of ethanol  concentrations  (70,  95,  100%,  4min  in 
each),  dipped  into  Histoclear  I  (National  Diagnostics)  and  mounted  onto  slides  and 
coverslipped with DPX (Fig 2.6).
482.9.2  Double immunohistochemistry
Serial sections (40 pm thick) were cut (with a freezing microtome, Leica) from segments of 
the lumbar enlargement (L4-L6). The sections were pre-treated for  lh with 5% normal goat 
serum (Vector labs) diluted in TTBS before being placed in rabbit anti-zif268  (1:80,000  in 
TTBS, Santa Cruz sc-189).  Sections were then left overnight at RT or 3d at 4°C. After the 
allotted time  in the primary antibody,  sections were then washed,  before being placed  into 
biotinylated anti-rabbit secondary antibody (Vector Labs) (1:400 in TTBS for 2h, RT). After 
2h the tissues were given a standard wash and placed into ABC solution (containing 4% A 
solution and 4% B solution (from Vector Labs ABC kit) in TTBS) for 30min. Tissues were 
again given a standard wash before being amplified by a tyramide based signal amplification 
(TSA) kit (NEL 700, Perkin Elmer). TSA was used at a concentration of 1:75 and left for 7 
minutes.  After  TSA  amplification,  tissues  were  washed  and  left  in  fluoroscein  avidin  D 
(1:600) for 2h. Afterwards the tissue were given a standard wash and placed into 50% ethanol 
for 30min, before being placed into 5% normal chicken serum for  lh. The tissues were then 
transferred into rabbit anti-glucocorticoid receptor (1:500 in TTBS, 24h at RT, Santa Cruz sc- 
8992). A standard wash followed and the sections were placed into chicken anti-rabbit Alexa 
Fluor  594  (1:500  in  TTBS,  2h  at  RT,  Molecular  Probes).  The  sections  were  washed  and 
mounted onto slides before being coverslipped with gel mount (Sigma) (Fig 2.6).
2.9.3  Immunohistochemical controls
Standard immunohistochemical controls were utilised and ran in parallel.  Primary antibodies 
were omitted to check for specificity and in the case of dual immunofluoresence, one of the 
primary  antibodies  was  removed  to  check  for  cross-reactivity  since  two  rabbit  primary 
antibodies were used on the same sections. With TSA, the concentration required to detect the 
first  primary  antibody  was  generally  10  times  less  than  required  for  standard 
immunofluorescence.  However  it  was  still  important  to  check  that  cross  over  between 
secondary antibodies had not occurred.  Firstly, sections were amplified with TSA giving a 
positive  signal  for  zif268  in the  FITC  range.  Following this,  and  unlike  a  normal  double 
staining,  no  second  primary  antibody  was  added:  instead  only  the  fluorophore  aimed  at 
detecting this second primary antibody was added. If no signal was detected on this channel 
then  cross-reactivity  had not occurred.  Cross-reactivity  was not  in evidence  in any  of the 
immunostaining achieved in this thesis.
49Primary Antibody Code
Glucorticoid Receptor Santa Cruz sc-8992 Rabbit N/A 1   in 5000 N/A
NeuN Chemicon MAB377 Mouse N/A 1 in 200 N/A
NK1  Receptor Eurogentec N/A Rabbit N/A 1   in 5000 N/A
Serotonin Chemicon AB-938 Rabbit 1   in 200 N/A N/A
Zif268 Santa Cruz sc-189 Rabbit N/A 1   in 5000 1   in 80,000
Secondary Antibody Company Code Raised in [DAB] [3x Fiuoroscence] [t s a ]
Biotinylated Anti-Mouse Vector Labs BA-2000 Horse 1   in 500 1  in 500 1   in 400
Biotlnylated Anti-Rabbit Vector Labs BA-1000 Goat 1   in 500 1   in 500 1   in 400
Chicken Anti-Rabbit Chemicon AP-159 Chicken N/A N/A 1   in 500
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Fluoroscein Avidin D Vector Labs A2001 1 in 200 1   in 600
Strepavidin Aiexa 488 Molecular Probes S-11223 1   in 500 1   in 600
Strepavidin Alexa 594 Molecular Probes S-11227 1   in 500 N/A
Table  2.2.  Primary  and  secondary  antibodies  used  in  this  thesis.  Concentrations  for  the  separate  immunohistochemistry 
protocols are stated here and were diluted with TTBS.
50Principles of immunohistochemistry
Immunohistochemistry  (IHC)  describes  a  process  of localising  proteins  on  biological  tissues  using 
specific antibody-antigen  interactions. The pivotal reagent in the process is the antibody.  Antibodies 
are immunoglobulins, of which there are 5 main classes. The most popular class used in IHC are the 
IgG and the  IgM classes.  Immunoglobulins contain two identical  heavy (H) chains and two identical 
light (L) chains.  Constant and variable parts make  up the  L and H  chain,  the  latter part binds to the 
antigen.
There  are  two  types  of  antibodies  used  in  IHC  each  with  different  characteristics  Polyclonal 
antibodies  can  target  and  bind  onto  a  large  array  of  different  number  of  epitopes  located  on  a 
specific antigen whereas monoclonal  antibodies only target a specific epitope on  a specific antigen 
located in the target tissue.
The primary antibody can be conjugated to a number of substances in order to visualise the antibody 
and  thus  when  bound  to  its  specific antigen  defines  areas  of tissue  where  the  protein  is  located 
Similarly,  the  second  antibody  which  targets  the  primary  antibody  can  also  be  conjugated  to 
visualisation substances. The second antibody generally targets the antigens of the species in which 
the  primary  antibody  is  made  in,  thus  the  same  secondary  antibody  can  target  any  primary 
antibodies that are made in the same species.
However in some cases the primary antibody alone is not adequate to yield a strong enough signal. 
This problem  can  be  solved  if the  signal  can  be  amplified  above  the  background  noise.  The  most 
commonly  used  method  is the  avidin-biotin  interaction.  Since  avidin  has  a  strong  affinity  for  biotin 
and has 4 binding sites for biotin, the potential to create large complexes exist (see below).  1) Here 
the  secondary  antibody  is  conjugated  with  biotin  molecules.  2) The  biotin  can  bind  free  avidin.  3) 
This in-turn allows free biotin molecules to bind onto the avidin molecules. 4) This ‘extra’ biotin then 
allows yet more avidin to bind and so on (5) to create a large avidin-biotin complex (6). An enzyme 
can  also  be  added  to  the  avidin,  in  the  case  of  DAB  it  is  horseradish  peroxidase.  As  such  when 
hydrogen peroxidase is added with DAB it catalyses a reaction whereby deposits are left around the 
immediate  area  and  can  be  visualised.  This  is  why  endogenous  peroxidase  activity  needs  to  be 
quashed  with  hydrogen  peroxide  before  the  secondary  antibody  is  added  to  prevent  unwanted 
reactions from occuring
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This  is  similar to  TSA  where  deposits  of tyramide  are  left  in  the  immediate  area  of the  primary 
antibody due to an enzymatic reaction.  An avidin based fluorophore is then added which  binds onto 
both the biotin sites on the avidin-biotin-secondary antibody complex but also the deposited tyramide 
particles.  Thus  the  tyramide  particles  amplify  the  signal.  Fluorophores  are  molecules  that  are 
‘excited’ by specific wavelengths of light in doing so they emit light at specific wavelengths.  Different 
fluorophores  have  different  excitation  and  emission  properties  as  such  one  can  use  different 
fluorophores in the same tissue as long as their characteristics do not interfere with one another.
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Figure  2.6  Immunohistochemical  protocol  framework.  There  were  4  main  protocols  that  were  used  in  this  thesis  for 
immunohistochemistry;  these  were  2-step  indirect  fluorescence,  3-step  indirect  fluorescence  and  DAB  (as  represented  by  blue, 
red,  and  brown  arrows  respectively).  TSA  was  also  used  but  not  represented  in  this  figure.  Each  arrow  represents  a  wash 
(3x10min with 0.1M PB) and  a continuation to the next step. *TTBS consisted of 0.3% Triton X-100 (for cell permeation) and 0.05M 
Tris-HCL in distilled water. ** Hydrogen peroxide was used to remove any endogenous peroxidase activity that could  have resulted 
in a non-specific DAB reaction in the sections.
522.10 Microscopy
Sections  were  examined  under  a 40X  optical  lens  using  the  Leica  DMR  microscope  with 
appropriate light filter to allow for independent viewing of fluorophores in the UV, FITC and 
CY3  range.  Images  were  taken  via  a  charge  coupled  density  (CCD)  camera  (Hamamatsu 
C5985)  attached  to  the  microscope  and  by  using  the  software  Vision  Explorer  VA1.11 
(Graftek  Imaging).  Images  were  also  taken  using  a  Nikon  E-800  Eclipse  microscope  and 
MCID software. For colocalisation studies images were merged using Photoshop 7.0 (Adobe).
2.11  Neuronal cell counts and intensity scores
2.11.1 Counts on lamina I projection neurons
Zif268  and  GR  expression  in  lamina  I  projection  neurons  was  quantified  by  manually 
counting the total number of zif268 and GR neurons on FG positive neurons in the marginal 
layer of the dorsal horn. This was then divided by the total number of FG neurons on the same 
section before  being  multiplied  by  100.  Zif268  or glucocorticoid receptor positive  neurons 
and FG neurons were counted as positive only if they were in the same focal plane
2.11.2 Neuron counts using MCID software
The  density  threshold  criteria  were  set  on  MCID  to  allow  for  target  detection  following 
immunohistochemistry.  MCID  was  given  an  upper  and  a  lower  density  threshold  (a 
segmentation  range).  Pixels  lying  within  the  segmentation  range  were  regarded  as  valid 
targets;  pixels  lying  outside  of the  range  were  ignored  by  MCID.  Owing  to  the  nature  of 
MCID, a threshold operation alone does not successfully eliminate all invalid targets. There 
are  pixels  that  have  densities  similar  to  genuine  targets.  To  prevent  artefacts  from  being 
accepted as valid targets  MCID was made to use logical target acceptance criteria.  Logical 
criteria  included  minimum  and  maximum  area  and  minimum  roundness.  As  such,  in  this 
mode MCID was fully capable of detecting individual neuronal cell bodies by taking adjacent 
pixels within the segmentation range and then evaluating the minimum and maximum pixels 
that equates to a single cell.
Positive neurons located within a 100pm boundary from the dorsal edge of lamina I (L4-L5) 
sections were counted using MCID software and a Nikon E800 Eclipse microscope (with an 
appropriate  filter).  The  sensitivity  of the  software  in  detecting  positive  (immunostained)
53neurons  had  been  calibrated  so  that  the  accuracy  was  within  95%  to  the  counts  made 
manually.  Calibrations  were  made  by  manually  counting  positive  neurons  on  6  randomly 
selected sections before finely adjusting the software so that automatic counts were accurate. 
In the actual count, a minimum of 10 sections per animal were counted and the mean taken 
before statistical analysis.
2.11.3  Neuron intensity scores
Neuron luminosity (or intensity) was measured in the ipsilateral superficial dorsal horn using 
confocal microscopy (Bio-Rad 600). L4-L5 sections were randomly chosen from each animal. 
All measurements were taken from one single session; any adjustments (to gain, intensity or 
black  level  settings)  were  not  made  during  the  session.  Using the  integrated  software,  an 
analytical marquee was generated to measure intensity scores. The marquee had an area no 
larger than the cell body being analysed. Using the marquee the mean background intensity 
for each selected section was taken at four points on the dorsal horn. The intensity score for 
each positive  cell body was then taken using the same marquee  and the mean background 
level for that section was subtracted from the luminosity score. Background luminosity had a 
value  of zero.  The  mean  was then taken from the top  20  of the most  highly  labelled  cell 
bodies  from  each  selected  section  and  statistically  compared  with  sections  from  other 
treatment group(s).
2.12  Western blots
Rats  were  implanted  as  above  (section  2.5.4.2)  with  pumps  containing  vehicle  (saline), 
missense or antisense to zif268 or the glucocorticoid receptor and were left for 4d and then 
given a unilateral injection of CFA (lOOpl.  50%). Rats where then killed under C02  before 
being quickly decapitated 2h after the CFA injection (corresponding to the peak expression of 
zif268 (Liang and Jones, 1996)). The pump and ancillary components were removed from the 
animal and the L4-L6 region of the spinal cord was dissected out of the animal and placed 
onto  an  ice-cold  surface.  The  cord  was  then  further  dissected  into  quadrants  and  each 
quadrant separately placed into a pre-chilled Eppendorf tube. The tissue was then individually 
homogenized in  1ml RIPA buffer (1% NP-40, 20mM Hepes pFI7.4,  lOOmM NaCl,  lOOmM 
NaF,  ImM Na3V04, 5mM EDTA) with lOpl of protease inhibitor (P8340, Sigma) and left on 
ice for 2h. The samples were then centrifuged (12,000rpm,  15min, 4°C) and the supernatant 
were transferred into new Eppendorf tubes. The samples were then normalised using a BCA 
kit (Pierce) and a Biotrak II plate reader (Amersham) following manufacturers instructions. 
Loading buffer (lOOmM  Tris-HCL  pH6.8,  200mM  dithiothreitol, 4%  SDS  (electrophoresis
54grade),  0.2%  bromophenol  Blue,  20%  glycerol)  was  then  added  to  each  sample  in  such  a 
manner that each sample contained the same concentration of protein (lpg pi'1 ) before being 
boiled for 5min, The samples were then individually loaded into the lanes of the SDS-PAGE 
ready gel (submerged in running buffer (3.72% glycine, 0.5% trizma base, 0.2% SDS)) with 
each lane containing  lOpg of protein (10% HCl-Tris, Bio-Rad, Hercules, CA), reserving one 
lane  for the  molecular  marker  (Amersham).  The  protein  samples  were  then  separated  into 
different molecular weights using the  Bio-Rad Power-Pac 300 (lh,  120V). After separation, 
protein  samples  were  then  transferred  from  the  gel  onto  polyvinylidene  difluoride  filter 
(PVDF) membranes (Bio-Rad,  Hercules, CA) in transfer buffer (1.16% Trizma Base, 0.58% 
glycine,  0.74%  SDS,  20% methanol).  To prepare the transfer sandwich, the membrane  was 
first primed and submerged with  100% methanol (lOmin) and then left in transfer buffer for 
5min.  The gel  was removed from  its holding shell  and submerged  in transfer buffer (5min) 
before the transfer sandwich was assembled as shown in figure 2.7 and ran for  lh at  100V. 
The  membrane  was  then  blocked  (lh)  in  PBS-Tween  (1M  PBS,  0.1%  Tween  20  (Sigma)) 
containing 5% milk
Figure  2.7  Bio-Rad  mini  transblot  system.  Following  electrophoresis  protein  samples  were  transferred  onto 
PVDF membranes using the transfer sandwich submerged with transfer buffer (1 h,  100V)
The membrane was then incubated (24h, 4°C) in PBS-Tween with 5% powdered milk with a 
primary antibody either rabbit anti-zif268 (1:200, Santa Cruz, sc-110), rabbit anti-GR (1:150, 
Santa-Cruz, sc-8892) or rabbit anti-SGKl  (1:1000, Upstate Biotechnology, 07-315) antibody 
and  then  washed  6x5min  in  PBS-Tween.  The  membrane  was  then  transferred  into  PBS- 
Tween containing anti-rabbit-HRP (1:2000, Santa Cruz, sc-2301)) and incubated for  lh (RT) 
before  being  washed  with  PBS-Tween  (6x5min).  The  blots  were  visualised  using  the  ECL 
western blotting detection system (Amersham, RPN-2106) and the Bio-Rad Chemi-Doc XRS 
system  (Bio-Rad,  Hercules,  CA)  for  l-10min.  The blots  were then  incubated  (2xl0min)  in 
stripping buffer (0.15% glycine, 0.1% SDS,  1% Tween 20) before being reprobed with mouse 
anti-GAPDH  (1:1000,  RT,  Chemicon,  MAB374),  washed  and  then  incubated  in  goat  anti- 
mouse-HRP (Santa Cruz,  sc-2302) before being visualised. The westerns were performed in
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55duplicates.  The  density  of the  specific  bands  were  measured  using  the  software  package 
Quantity One v 4.4.1 (Bio-Rad, Hercules, CA) and were normalised against the corresponding 
band of loading control (GAPDH) to attain a ratio score. By doing this a ratio score for each 
lane was attained.  The ratio  scores  for each treatment group were then compared with the 
scores from the other treatment group and statistically analysed using a unpaired t-test.
2.13  Statistical analysis
A number of different statistical tests were used to analyse experimental data presented in this 
thesis.  Fundamental  principles  underlying  the  statistics  are  described  below.  Statistical 
analysis was carried out using SPSS  12.0.1  for Windows (SPSS Inc., Chicago). All data sets 
were tested  for homogeneity  of variance  and  normal  distribution.  If the  data did  not  meet 
these  requirements,  they  were  transformed  with  the  most  appropriate  method  or  another 
statistical test was chosen. P<0.05 was the criterion for statistical significance.
2.13.1 Kolmogorov-Smirnov test
The  Kolmogorov-Smirnov  (K-S)  test  was  used  to  test  if  the  data  followed  a  normal 
distribution K-S gives the probability that the data sets are not normally distributed. Values 
above  0.05  implies that not enough  evidence  exist to  suggest that the data  set  is  normally 
distributed. Data sets with a P-value below 0.05 were analysed using non-parametric tests and 
for those above 0.05, parametric tests were used
2.13.2 T-test
The t-test is a parametric test that compares the difference in the means of two data sets to 
evaluate if the data had come from the same population or not. This test can only be applied if 
the data are normally distributed and with similar standard deviations. There are two forms of 
t-tests: paired and unpaired (Student’s t-test). Data from paired t-tests are derived from study 
subjects that have been  measured twice  at two  independent time  points.  In most  cases the 
measurements  are  taken  before  and  after  treatment.  Unpaired  t-tests  are  used  for  two 
independent  groups  and  can  be  used  in  samples  with  different  sizes.  With  2  independent 
samples  of measurements,  a non-parametric  alternative to the  independent-samples t-test  is 
the  Mann-Whitney  U test.  With two related samples, two nonparametric  equivalents  of the 
related-samples t-test are the Wilcoxon test and the Sign test. The latter two tests were not 
required to be used in this thesis.
562.13.3  Mann-Whitney U (MWU) test
The MWU test is a non-parametric statistical test that assesses if two samples are taken from 
the same distribution. The null hypothesis of the MWU test is that the two samples are taken 
from a single population which makes the probability that the distributions for the samples are 
equal  to  one  another.  The  assumption  that  the  MWU  makes  is  that  the  two  samples  are 
independent to one another and the data are ordinal or continuous in nature.
2.13.4  Analysis of Variance (ANOVA)
ANOVA  is  a parametric  statistical  test  that  is  used to  test  the  hypothesis  that  the  means 
among two or more groups are equal and makes the assumption that the data sets are normally 
distributed. ANOVA also assumes that within-subject variation is lower than among subject 
variations.  The  repeated  measure  ANOVA  is  used  when  all  members  of  a  sample  are 
measured under a number of different conditions. As the sample is exposed to each condition 
in turn, the measurement of the dependent variable is repeated. If the ANOVA test revealed a 
significant interaction Tukey’s post-hoc test was performed.
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Zif268 and Inflammatory Pain3.1 INTRODUCTION
3.1.1  Zif268: an immediate early gene
The increase  in synaptic efficacy that underlies persistent inflammatory pain (hyperalgesia 
and allodynia)  requires  macromolecular synthesis  including changes  in gene  expression  in 
order to convert extracellular signals from the periphery into long term functional changes. A 
number of studies have shown that regulation of protein synthesis is a necessary step for the 
formation of long-lasting changes in pain states, a step which normally requires transcription 
factors to  be  activated.  Transcription  factors  are  proteins that bind  onto  specific  promoter 
regions of genes and alter the expression of the gene. Immediate-early genes (IEGs) such as 
zif268 and c-fos are transcription factors that convert synaptic signals into long-term changes 
in gene expression and are thought to influence synaptic efficacy.  IEGs can be categorised 
into two general types: regulatory and effector. Regulatory IEGs encode proteins that increase 
or  decrease  downstream  gene  expression.  Effector  IEGs  (e.g.  arg3.1,  Homer  and  BDNF) 
encode  for proteins that have  a more direct role.  The  IEG  zif268  (also  known  as  EGR-1, 
Krox-24, NGF1-A and Zenk) is an inducible transcription factor and can exist in two species, 
each with different molecular weights (82 and  8 8KDa). Zif268  is pivotal to some forms of 
synaptic plasticity such as hippocampal LTP and long-term memory (Bozon et al, 2003).
The  importance  of zif268  in  signal  transduction  is  emphasised  by  numerous  regulatory 
domains presented on its promoter region (Fig 3.1). Zif268 can be regulated by a number of 
kinases.  Studies  have  shown that,  when bound,  each of the (six)  serum  response  elements 
(SREs) (which can bind Elk-1) on the promoter region can increase the expression of zif268. 
Fibroblast zif268 can be activated with just one SRE site being occupied.  In addition, since 
the zif268 gene also contains an EGR response element (ERE) binding domain it affords the 
opportunity for zif268 to autoregulate itself and the potential to amplify its own intracellular 
signal  (James  et  al,  2005;  Cao  et  al,  1993).  Zif268  also  contains  binding  domains  that 
negatively regulate the activity of the protein; animals with mutations occurring at the 5’ end 
of the  zinc  finger  R1  displayed  an  enhanced transcriptional  activity  (Gashler  et  al,  1993; 
Russo et al,  1995). Certain proteins such as NAB1  and NAB2 can negatively regulate zif268 
by binding onto the R1  domain. NAB1  operates as an active repressor and directly inhibits 
zif268  activity. NAB2  unlike NAB1  can be activated by the same stimuli  as zif268  which 
enables NAB2 to control the transcription of zif268 in circumstances where both genes are 
simultaneously  activated  (Svaren  et  al,  1996;  Swimoff et  al,  1998).  Other  motifs  on  the 
promoter region  of zif268  include two  cAMP  response  element-binding  (CREB)  response
59element (CRE) sites (binds with CREB), a Sp 1  -like motif, CCAATT sequences, an AP-1  like 
motif (binds c-jun-fos dimer), and an AP-2-like binding sequence.
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Figure  3.1  Promoter  region  of zif268.  The  promoter  region  of zif268  contains  a  large  number  of 
binding  motifs  including  AP-1,  zif268  (ERE)  and  the  putative  binding  sites  for  the  transcription 
factors AP-1,  serum  response element (SRE);  cyclic AMP-responsive element (CRE);  TATA, TATA 
box. (Adapted from Hirabayashi and Saffen, 2000).
Zif268 belongs to the early growth response factor (EGR) family and is located to the nucleus 
when activated. Its residency in the nucleus is due to a bipartite signal in the DNA binding 
domain of the second and third zinc finger (Gashler et al,  1993). The zinc fingers are also 
important for physical interactions with target DNA molecules. The binding domain of zif268 
consist  of three  zinc  fingers  (Fig  3.2)  which  recognises  and  bind  onto  DNA  targets  that 
contain  a  sequence  of  9  base  pairs  (bp).  The  zif268  binding  consensus  sequence  is 
GCG(G/T)GGGCG.  With  each  zinc  finger  recognising  a  sequence  of  3bp  (Christy  and 
Nathans, 1989; Cao et al, 1990).
Figure  3.2  Three  dimensional  representation  of  zif268.  Zif268  is  an  82  or  88KDa  protein  and 
consists of three zinc fingers (blue, green, purple) which are responsible for binding on specific DNA 
sequences  to  cause  the  transcription  of  a  number  genes.  (Adapted  from 
http://www.biochem.ucl.ac.uk/bsm/nucplot/1zaa_molscript.html)
3.1.2  Zif268 expression
Zif268  mRNA  is  constitutively  expressed  at  low  levels  in  a  number  of  brain  regions, 
including the amygdala, cerebellum, entorhinal cortex, neocortex, nucleus accumbens and the 
striatum, (Christy et al,  1988;  Mack et al,  1990; Schlingensiepen et al,  1991;  Worley et al,
601991;  Herms et al,  1994).  Zif268  expression also occurs in the hippocampus (Saffen et al, 
1988;  Hughes  et  al,  1992)  where  it  has  been  implicated  as  a  key  protein  involved  with 
synaptic plasticity including long term potentiation (LTP) and learning and memory (Jones et 
al, 2001; Tischmeyer and Grimm,  1999). Hippocampal zif268 was found to be expressed in 
the CA1  region with less in the CA2  region and minimally expressed  in the dentate gyrus. 
Induction  of LTP  by  stimulation  of the  perforant  path  results  in  massive  upregulation  of 
zif268  in  the  dentate  gyrus.  Zif268  is  also  expressed  in  the  spinal  cord. 
Immunohistochemistry has shown that zif268 is lightly expressed, constitutive, and restricted 
primarily to lamina I at post natal day 6 (P6). However, by PI 1, the expression of zif268 was 
found to have extended ventrally into lamina III, before disappearing at P26 (Liang and Jones, 
1996). In adult rats, the expression of zif268 in the dorsal horn requires noxious stimulation to 
the periphery. Innocuous stimulation such as light brushing does not increase the expression 
of zif268  in  the  dorsal  horn.  Induction  of spinal  zif268  expression  (including  superficial 
layers)  requires  a  more  severe  input  into  the  spinal  cord  (Liang  and  Jones,  1996)  and 
expression has  been  seen  after high threshold  stimulations  (HFS)  on C-fibres  (Rygh  et al, 
2006); HFS can also induce LTP in this region.
3.1.3  Zif268 and LTP
The  induction  of  LTP  in  the  dentate  gyrus  is  accompanied  by  a  rapid  increase  in  the 
expression of zif268. The mRNA increase can occur within lOmin (Wisden et al,  1990) and is 
dependant on the activation of the NMDA receptor. This suggests that calcium entry through 
the NMDA  receptors elicited by  LTP  inducing stimuli  may  serve  as the  initial  step  in the 
signalling  pathway  leading to  enhanced  expression  of the  zif268  protein.  Furthermore,  the 
expression  of zif268  is  directly  correlated  with  the  persistence  of LTP  and  not  with  the 
induction  protocol  used  to  induce  LTP  in  awake  animals  (Richardson  et  al,  1992).  In 
comparison with other IEGs, zif268 has been shown to be related to LTP. In comparison c-fos 
is not expressed in the dentate gyrus following LTP (Dragunow et al,  1989) whereas Jun-B 
and  C-Jun  are  less  reliable  markers  of  LTP  and  are  not  always  expressed  during  LTP. 
However, Schreiber et al (1991) reported a reduction in the expression of zif268 following the 
induction of LTP, while stimulation that failed to generate LTP increased zif268 expression. 
Suggestions  to  explain  this  discrepancy  include  the  use  of  different  anaesthetics  and  a 
difference in the LTP induction protocol used (Knapska and Kaczmarek, 2004).  In addition, 
more recent research has demonstrated that the expression of zif268 did not change in certain 
regions  (subfields)  of the  hippocampus  following  LTP  induction  (French  et  al,  2001).  In 
addition, in-vivo LTP induction in the dentate gyrus was shown to increase the expression of
61zif268 mRNA whereas LTP induction with high frequency stimulation on the commissural 
projection neurons did not change zif268 expression in CA1 pyramidal cells.
The expression of hippocampal  zif268  can be  increased by  a number of behavioural  tests 
including the water maze test, the elevated plus maze and open field tests (Poliak et al, 2005). 
The  requirement  of  zif268  in  synaptic  plasticity  and  for  the  consolidation  of  object 
recognition  memory  was  seen  in  zif268  knockout  mice  (Jones  et  al,  2001). 
Electrophysiological analysis of the dentate gyrus in the hippocampus in awake mutant mice 
showed  that  the  induction  of  LTP  was  unaffected  by  the  mutation.  However  synaptic 
plasticity could not be maintained to the same extent as in wildtype mice.  In correlation to 
electrophysiological data, behavioural tests showed that these mice, although retaining short­
term memory, did not perform well in memory tests that required memories that lasted longer 
than a few hours. Mutant mice were less effective at spatial memory tasks, recognition tasks, 
olfactory and gustatory memory.
Zif268 antisense oligonucleotides that targeted the zif268 gene in the hippocampus suggested 
that  zif268  is  important  for  reconsolidation  of  long  term  fear  conditioned  contextual 
memories  (Lee  et  al,  2004).  Hall  et  al  (2001)  revealed  that  zif268  may  be  important  for 
temporal consolidation of contextual fear memories due to an increase expression of zif268 in 
CA1  neurons  of the  hippocampus  after  the  retrieval  of recently  formed  contextual  fear 
memories, but not for the retrieval of older memories, suggesting a temporal limit for zif268. 
In addition, the retrieval of both cued and contextual fear memories were also associated with 
an increase in the expression of zif268 in the amygdala. This would suggest the amygdala is 
an  important  locus  for  supporting  retrieval  and  acquisition  of fear-related  memories  and 
suggests a role for zif268 in neuronal plasticity associated with reconsolidation of memories 
accompanying the retrieval process.
3.1.4  Zif268: pain and synaptic plasticity
Noxious stimulation and injury leads to central sensitisation of dorsal horn neurons and the 
development of allodynia and hyperalgesia.  Wind-up has often been included as a form of 
central sensitisation and describes spinal cord amplification of nociceptive information from 
repetitive  stimulation  of C-flbre  nociceptors.  The  physiological  importance  of wind-up  is 
unclear; due to its short lasting nature wind-up has been suggested to be either  1) a correlate 
of central sensitisation or 2) part of normal acute pain processing (reviewed by Herrero et al, 
2000).
62Central sensitisation shares many features with hippocampal LTP (Miyamoto, 2006; Ji et al,
2003) including the phosphorylation of glutamate receptors  (including AMPA  and NMDA 
receptors) and the insertion of AMPA receptors into the post-synaptic density (Galan et al,
2004). The activation of the same intracellular pathways and protein kinases are also seen, 
including mitogen-activated protein kinase (MAPK) (Ji  et al,  1999;  Ji et al,  2002),  protein 
kinase  A  (PKA),  protein  kinase  C  (PKC)  and  calcium/calmodulin-dependent  kinase  II 
(CaMKII) (Yang et al, 2004).  Spinal LTP has also been reported and may be an important 
process that allows acute pain to shift into a more persistent pain state (Klein et al, 2004). 
Lamina  I  neurons  that  project  to  the  brain  from  the  spinal  dorsal  horn  are  critical  for 
maintaining persistent inflammatory pain states and the formation of neuropathic pain states 
following  spinal  nerve  ligation  (SNL)  or  chronic  constriction  injury  (CCI)  (Mantyh  et  al, 
1997; Nichols et al,  1999). These neurons have been shown to support LTP in deep dorsal 
horn neurons although synapse specificity has not been shown. A recent study by Ikeda et al 
(2006) has shown that low frequency, high threshold stimulation can induce LTP in spinal- 
PAG lamina I projection neurons.
Nociceptive  neurons  can  express  zif268  following  most  types  of  peripheral  noxious 
stimulation.  Herdegen  et  al  (1991)  showed  that  electrophysiological  stimulations  on  the 
sciatic nerve at C-fibre intensity increased the expression of zif268 (reaching peak at lh post 
stimulation).  While noxious thermal stimulation using hot water (52 °C) induced a NMDA 
receptor dependent rise in the expression of zif268, little induction was seen with non-noxious 
warm  water  (Wisden  et  al,  1990;  Rahman  et  al  2001).  Mechanical  stimulation  that  was 
capable of inducing the expression of c-fos in the dorsal horn can also induce spinal zif268 
(Rahman et al, 2001), with a similar response in the trigeminal nucleus caudalis following the 
injection of formalin into the rat whisker pad (Otahara et al, 2003).
Although increases of zif268 in post-synaptic neurons are seen following hippocampal LTP 
and  noxious  stimulation,  the  importance  of the  molecule  in  pain  behaviours  (mechanical 
hyperalgesia and allodynia) is not entirely certain. Studies using mice that lacked the zif268 
gene  showed that  while  normal  pain processing remained  unaffected  by  the  mutation,  the 
generation  of  chronic  pain  states  and  central  sensitisation  were  attenuated.  Hindpaw 
inflammation with subcutaneous formalin in the mutant mice did not alter the first phase but 
reduced the behavioural response (paw licking and biting) to the second phase.  Mechanical 
allodynia  following  CFA  induced  inflammation  was  also  attenuated  in  comparison  with 
wildtype  controls.  Furthermore,  inflammation  of the  hindpaw  in  wildtype  mice  increased 
zif268 expression in the anterior cingulate cortex (ACC) (Ko et al, 2005). Previously, tetanic 
stimulation in the ACC was shown to enhance C-fibre evoked field potentials and nociception
63in the  spinal  cord via a  descending modulatory  pathway  that included the  dorsal  reticular 
nucleus (Zhang et al, 2005).  Similar to other studies using mutant mice (Jones et al 2001) 
synaptic plasticity was altered in the study by Ko et al (2005).  Theta burst stimulations on 
layer V neurons of the ACC that usually generates LTP in layers II and III of the ACC failed 
to  do  so  in  animals  that  lacked the  zif268  gene.  This  led the  authors  (Ko  et  al,  2005)  to 
suggest that zif268 in the ACC played a prominent role in long-term inflammatory pain but 
did not clarify the role of zif268 induced in the dorsal horn neurons.
3.1.5  SGK1: regulation and synaptic plasticity
The IEG serum and glucocorticoid inducible kinase (SGK) consists of three isoforms (SGK1- 
3) (Kobayashi et al,  1999) and is expressed in a number of tissues including the spinal dorsal 
horn.  Its  activation  can  be  modulated  by  serum  and  glucocorticoids.  Neuronal  SGK1  can 
regulate  both  AMPA  and  kainate  receptors  as  well  as  glutamate  transporters,  which  are 
important  for the  removal  of excess  glutamate  from  the  synaptic  extracellular  space.  The 
balance  of  glutamate  transporters  in  the  synapse  is  important,  the  lack  of  glutamate 
transporters  can  lead to both  neurotoxicity  and altered  synaptic  efficacy.  Although  studies 
using zif268 knockout animals and microarray studies have shown that SGK1  expression can 
be negatively  regulated by  zif268  in the brain (James et al,  2005,  2006),  it was  unclear if 
spinal  SGK1  had a part in persistent inflammatory pain.  SGK1  can be phosphoiylated at a 
number of locations and can itself phosphorylate a large number of other proteins regulating 
transcription.  In order to become fully active, SGK1  needs to be phosphorylated at several 
residues. Phosphorylation of SGK 1  is partly achieved by PDK1 (PI3-dependent kinase 1) and 
PDK2.  PDK2  is  responsible  for  the  phosphorylation  of  serine422  which  facilitates  the 
phosphorylation of threonine256 by PDK1. SGK1  can also be activated and phosphorylated 
by ERK5 at serine78 (Lang and Cohen, 2001) and by ERK1/2 pathway (Lee et al, 2006).
SGK1  in  the  hippocampus  may  be  involved  with  spatial  memory  consolidation  and 
reconsolidation.  SGK1  expression  in  the  hippocampus  increased  during  both  the 
consolidation  and  reconsolidation  phase  following  contextual  fear  conditioning.  Levels  of 
SGK1  also  increased  after  lh  and  returned  to  baseline  by  24h.  During  reactivation  of 
consolidated memories the  expression  of SGK1  increased to  a similar  level  to  those  seen 
during consolidation (von Hertzen and Giese, 2005), although the expression of SGK1  was 
not  specifically  regulated  after  contextual  fear  conditioning,  SGK1  is  important  for 
hippocampal memories (Tsai et al, 2002) and requires the activation of the ERK1/2 pathway 
(Lee et al, 2006). Animals that were initially classified as fast or slow learners were found to 
express SGK1  (mRNA) at different levels  in the dorsal hippocampus.  Fast learners are by
64definition animals that can find the hidden platform in the water maze test within 30 seconds 
before  the  third  session.  In  comparison,  slow  learners  only  find  the  platform  during  the 
seventh or eighth session and not before. The levels of SGK1 were found to be higher in fast 
learners in areas such as the CA1, CA2 and the dentate gyrus. Furthermore, DNA transfection 
of SGK1  into the hippocampus facilitated water maze spatial learning, while transfection of 
mutant SGK1  DNA hindered learning; an effect that can be reversed by enrichment training. 
SGK 1   is also critical for novel object recognition and enrichment training and is upregulated 
in  hippocampal  neurons during  these  events (Lee  et al,  2003).  The transfection  of mutant 
DNA  (a  dominant-negative  mutant  of  SGK1)  that  inhibits  the  actions  of  SGK1  in  the 
hippocampus blunted the ability of the animal to perform well in these tasks (relative to the 
control group). Antagonists targeting the AMPA receptor in the hippocampus prevented both 
spatial  learning and  SGK1  upregulation,  suggesting  SGK1  expression  is  dependent  on the 
activation of AMPA  receptors.  Using a dominant-negative  mutant of SGK1  (DNA)  it was 
found  that  SGK1  also  can  impede  the  expression  of LTP,  while  the  constitutively  active 
SGK1,  SGKS422D,  up-regulated  postsynaptic  density-95  (PSD-95)  expression  in  the 
hippocampus. (Ma et al, 2006)
Using oligonucleotides with the same sequence that successfully reduced the levels of zif268 
in other studies (Lee  et al,  2004;  Malkani  et al,  2006),  I  have  assessed  the  importance  of 
spinally  expressed  zif268  on  the  induction  and  maintenance  of inflammatory  pain  states. 
Furthermore since SGK1  expression is regulated by zif268 in the brain, I also investigated if 
spinal  SGK1  is  affected  by  changes  in the expression of zif268  during  inflammatory  pain 
states.
653.2  METHODS (see chapter 2 for details)
3.2.1 Temporal expression of zif268 expression after inflammation
To determine the time-line of zif268 expression following peripheral inflammation, adult rats 
(280g) were either perfused without peripheral stimulation (naive) or at  lh, 2h,  6h and 24h 
after CFA injection into the intraplantar region of hindpaw. Animals were perfused and 40pm 
sections were then taken from the spinal lumbar region L4-L5 and immunostained for zif268. 
Sections  were  counted  automatically  using  MCID  software  specifically  calibrated  for 
counting zif268  positive  cells.  Cell  counts  were  made to the  ipsilateral  medial  half of the 
superficial layer of the dorsal horn.
In order to make lamina specific cell counts lamina boundaries were defined by using bright- 
field  microscopy  and  MCID  software.  Under  bright-field  microscopy  it  was  possible  to 
distinguish lamina II (owing to the lack of myelination). Two boundary markers were drawn 
using MCID across the dorsal horn. The first separated lamina I and lamina II and the second 
was drawn at the point between lamina II and lamina III. Thus, it was possible to distinguish 
lamina I  and  lamina  II.  Deeper  lamina were  more  difficult to  differentiate  but  cells  lying 
within 150pm from the second boundary marker of lamina II (the most ventral marker) were 
regarded as lamina III-V.
In order to  determine  if zif268  expression  occurred  in  lamina  1   projection  neurons to  the 
parabrachial nucleus,  adult rats received bilateral  injections of 5% fluorogold (FG) into the 
parabrachial nucleus under halothane anaesthesia. Animals were then injected intraplantarly 
into the  hindpaw  4d  afterwards  with  complete  Freund’s  adjuvant  (CFA,  50%,  lOOpl)  and 
perfused  2h  later with  4% paraformaldehyde.  The time point  at which  rats  were  perfused 
coincided with peak expression of zif268 protein in the dorsal horn. 40pm sections were then 
taken from the spinal lumbar region L4-L5 and immunostained for zif268. Sections were then 
analysed for colocalisation with FG in the marginal layer of the dorsal horn.
3.2.2 Intrathecal catheterization and drug delivery.
Osmotic pumps were implanted sub-dermally. Pumps were connected to a PE 10 catheter that 
was  inserted  at  the  level  of  the  lumbar  enlargement  under  halothane  anaesthesia.  For 
experiments using zif268 oligonucleotides, the antisense sequence was 5’-GGT-AGT-TGT- 
CCA-TGG-TG*G-3’  and the missense was  5’-GTG-TTC-GGT-AGG-GTG-TC*A-3’.  Each 
pump administered 0.16pg/pl/h of oligonucleotide dissolved in 0.9% saline for 7d. A vehicle
66control (saline) group and a no pump group (nai've) was also included into this study to ensure 
that saline or the pump itself did not have any untoward effects on pain behaviours. Following 
behavioural tests, animals were perfused and examined for catheter placement and damage to 
spinal  cord.  Animals  with damaged  cords  and displaced  cannula were  discarded  from  the 
study  (also  see  Methods  and  Materials).  Oligonucleotides  were  thio-capped  (*)  to  reduce 
oligonucleotide  degradation  following  intrathecal  injection.  Phosphothioate  modification 
replaces an oxygen atom with a sulphur atom in the intemucleotide linkage of DNA.  This 
enables the oligonucleotide to be more resistant to nuclease degradation than natural  DNA, 
while maintaining the ability to bind onto complementary nucleic acid sequences.
3.2.3 Behavioural tests and statistical analysis
Animals  belonging  to  each  treatment  group  (naive,  saline,  missense,  antisense)  were 
habituated to the test environment before surgery. 3d following surgery, the baseline score to 
ramped  mechanical  stimulation  was  taken  (mean  of 4  scores  taken,  each  separated  by  a 
minimum of 5 min). On the third day, rats received a unilateral intraplantar injection of CFA 
(lOOpl,  50%) into the hindpaw. Over the following 4d, animals were tested for mechanical 
allodynia.  The change in paw withdrawal thresholds from the baseline score was used as a 
measure  of mechanical  allodynia  and  hyperalgesia.  Comparisons  were  made  between  the 
baseline  score  for  each  group  with  the  respective  group  behaviour  scores  for  each  day 
following CFA treatment. Tests were statistically analyzed using two-way ANOVA (repeated 
measure) and Tukey’s post hoc test.
3.2.4 Immunocytochemical staining for oligonucleotide toxicity
Following  oligonucleotide  administration  and  behavioural  analysis,  rats  were  deeply 
anaesthetized  with  pentobarbital  and  transcardially  fixed  with  400-500ml  of  4% 
paraformaldehyde.  The  lumbar  spinal  cords  were  dissected,  and  postfixed  for  4h,  left 
overnight  in  30%  sucrose  and  40pm  transverse  sections  cut  on  the  microtome. 
Immunocytochemical  staining  was  used to  detect  zif268,  neuronal-specific nuclear  protein 
(NeuN), and NK1  (see table 2.2 for concentrations). Sections were also stained for Hoescht 
and IB4 to check for toxicity.
3.2.5 Immunocytochemical staining for zif268
Osmotic pumps containing zif268 antisense or missense were implanted into adult rats sub- 
dermally.  4d  later,  rats  received  a  unilateral  injection  of  CFA  (50%,  lOOpl)  into  the 
intraplantar hindpaw and were perfused 2h later. Luminosity scores were made on an MRC
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luminosity then the more  protein  is being expressed  by the cell.  Sections  from  the  L4-L5 
region of the spinal dorsal horn were taken from animals treated with either zif268 antisense 
or  missense.  Sections  were  immunostained  for  zif268  and  the  luminosity  scores  were 
ascertained  from  10  sections  per  animal.  Since  the  background  for  each  section  varied 
slightly, sections were normalised by subtracting the background value taken from adjacent 
neuropil of that section.  The mean from the twenty highest scores from each  section were 
taken and statistical comparisons were made to the other treatment group.
3.2.6  Western blotting for zi£268 and SGK1
Following 4d of zif268 antisense and missense treatment (delivered via osmotic pumps), the 
dorsal horn of animals stimulated by 2h intraplantar CFA  were analysed using western blot 
techniques  to  examine  the  effectiveness  of the  antisense  knockdown  and  to  look  for any 
changes to the expression levels of SGK1  protein (also see Methods and Materials).  Signal 
intensity (density) was quantified using the software package Quantity One 4.4.1  (Bio-Rad). 
Densitometric  values  were  expressed as the  ratio  of zif268  or SGK1  to  GAPDH  (loading 
control). Statistical comparisons between the ratio scores of missense and antisense treatment 
were then assessed using an unpaired t-test.
683.3 RESULTS
3.3.1 Zif268 expression following CFA
Zif268 positive cells were counted (using MCID software) in the superficial layers and deeper 
regions of the dorsal horn. Counts were restricted to the medial half of the dorsal horn that 
represented the region of hindpaw innervation. Unstimulated (naive) dorsal horn neurons, in 
general, were void of zif268 expression (10 +/- 1   cells per 40pm section in the marginal layer 
per section).  However,  in comparison with naive animals the intraplantar injection of CFA 
was associated with a transient rise in zif268 expression in the dorsal horn. Significant (Mann 
Whitney  U test,  P<0.05)  increases were seen at  lh (69 +/-  7 cells per 40pm  section in the 
marginal layer per section) and at 2h where zif268 expression peaked (84 +/- 9 cells per 40pm 
section in the marginal layer) (Mann Whitney U test, P<0.05) before gradually returning to 
basal levels after 6h (Fig 3.3) where no significant differences were seen compared to naive 
animals (P=0.10). No zif268 expression was seen in the ventral horn either in the naive or 
CFA injected animals at any of the time points analysed above. Zif268 expression was present 
from  L4-L6.  Analyses  beyond  these  lumbar  segments  were  not  made.  Zif268  expression 
followed a similar time course across L4-L6.
3.3.2 Expression pattern of zif268 in the dorsal horn
Zif268  expression was  induced by  an  injection of CFA  into the  intraplantar region  of the 
hindpaw  and  analysed  using  immunohistochemistry  at  peak  expression  (2h).  Substantial 
increases of zif268 expression were seen in the ipsilateral dorsal horn and the majority was in 
the  medial  half of the  dorsal  horn.  This  is  not  surprising  as  this  region  more  accurately 
represents  the  region  of  innervation  of the  intraplantar  region  of the  hindpaw  that  was 
stimulated.  In  addition,  zif268  expression  in terms  of individual  laminae  was  strongest  in 
lamina I,  II  (outer)  and  lamina  II  (inner).  Lamina I  expressed  19 +/- 4  cells  and  lamina  II 
(combined (inner and outer)) expressed 65  +/-  8  cells.  In comparison,  zif268  expression  in 
deeper  layers  of the  dorsal  horn  (lamina  III,  IV  and  V)  were  less  intense  and  offered  a 
scattered distribution with no expression in the ventral horn (Fig 3.3). Combined, these deeper 
layers of the dorsal horn expressed 34 +/-  10 cells following 2h of CFA injection. Statistical 
analysis (Mann Whitney U test) comparing the expression of zif268 in the superficial layers 
(lamina I and II) of the dorsal horn with deeper regions of (lamina III-V) showed a significant 
difference (P<0.05).
693.3.3 Zif268 expression in lamina I projection neurons
Bilateral injections of fluorogold into the parabrachial nucleus labelled a subset of neurons in 
the  marginal  layer  of  the  spinal  dorsal  horn  (lamina  I  projection  neurons). 
Immunohistochemistry revealed that 47 +/-  8 % of these neurons expressed zif268 following 
CFA induced peripheral inflammation (Fig 3.4 and see chapter 5).
3.3.4  Zif268 antisense blunts the maintenance of inflammatory pain states
To examine the importance of spinal zif268  in persistent inflammatory pain states,  animals 
were implanted with mini-osmotic pumps that either contained oligonucleotides that targeted 
zif268 mRNA, missense or saline. Treatment baseline scores were similar (one way ANOVA) 
with  each  other  prior  to  CFA  injection  (F  3 >   40  =  0.7,  P  =  0.5)  Animals  then  received  a 
unilateral  injection of CFA  into the intraplantar surface of the hindpaw.  Statistical  analysis 
(paired  t-tests)  indicated  that  on  the  first  day  after  CFA  all  treatment  groups  displayed 
allodynia to mechanical stimuli (P<0.005). Percent change in paw withdrawal thresholds on 
the first day after CFA were 36 +/- 8% for nai've, 37 +/- 4% for saline, 50 +/- 5% for missense, 
and 30 +/- 6% for antisense treatment. Further statistical analysis (two way ANOVA repeated 
measures) revealed that paw withdrawal thresholds  remained stable for the  duration  of the 
study (days  1-4 after CFA) (F  2,74 = 2.6, P = 0.08) with no interactions occurring between 
time and treatment (F 6, 74 = 1.9; P = 0.10). In addition, an overall effect of treatment was seen 
(F  3,37  =  13.2;  P0.001) that affected paw withdrawal thresholds.  Tukey’s post-hoc testing 
(HSD)  revealed that  overall  zif268  antisense treatment  significantly  attenuated  mechanical 
allodynia following peripheral inflammation (antisense in comparison to nai've,  P<0.005; to 
saline, P<0.05; to missense, P<0.005). Analyses of individual days, revealed that mechanical 
sensitivity  on  day  1   were  similar  across  all  treatment  groups.  Two  days  following  CFA 
injection,  mechanical  allodynia  and  hyperalgesia  was  significantly  reduced  in  antisense 
treated  animals  when  compared  with  saline  (21%  reduction,  P<0.03),  missense  (35% 
reduction,  P<0.05)  and  CFA  only  treated  animals  (40%  reduction,  P<0.005)  (Fig  3.5).  A 
similar result was seen on day 4 post CFA where mechanical allodynia and hyperalgesia were 
fully  attenuated  in the antisense treated group.  Importantly, throughout the duration  of the 
behavioural  experiment,  no  difference  was  seen  between  the  nai've  (no  pump)  group,  the 
saline treated group and the missense treated group  indicating that the  implantation  of the 
pump did not affect the paw withdrawal thresholds to mechanical  stimuli.  Paw withdrawal 
thresholds of the nai've group were not significantly different to missense (P = 0.98) or the 
saline group (P = 0.28) and the missense group was not different to saline group (P = 0.12).
703.3.5 Zif268 antisense reduces zif268 protein expression in the dorsal horn
The  effectiveness  of  zif268  knockdown  was  assessed  using  immunohistochemistry  and 
western blotting. Animals were treated with zif268 oligonucleotides in the same manner as 
for behaviour and were followed by a unilateral injection of CFA for 2h. Analysis of zif268 
inmmunoreactivity  in the superficial  layers  of the dorsal horn revealed that  in comparison 
with missense  (70  +/-  14  cells per 40pm  section) antisense treatment  significantly  reduced 
(unpaired t-test, P<0.05) the number of zif268 positive cells (48 +/- 9 cells per 40pm section). 
In addition, cell luminosity was also significantly reduced (unpaired t-test, P<0.05) following 
zif268 antisense treatment in comparison with missense treatment (relative luminosity, 85 +/- 
9 compared with 53 +/- 9) (Fig 3.6). In agreement with cell counts western blot analysis (Fig 
3.7) also revealed a significant reduction (38%, unpaired t-tests P<0.05) in zif268 expression 
in animals treated with antisense in comparison with missense
3.3.6 Lack of toxicity and cell death using antisense
To  examine  if oligonucleotide  treatment  resulted  in  unwanted  tissue  toxicity  or  damage, 
spinal cord tissue was stained for IB4, NeuN and NK1. In the majority of cases, no gaps in the 
IB4 staining were present. Under normal circumstances IB4 staining is observed as a distinct 
band that spans across the entire lamina II region of the dorsal horn (Fig 3.5). Any gaps or 
disruptions  in  the  IB4  staining  represented  neuronal  cell  loss  caused  by  primary  afferent 
damage.  Animals  with  damaged  spinal  cords  were  removed  from  the  experiment  and 
behavioural data collected discounted (n = 3). Cell counts made in the superficial layers of the 
dorsal horn using NeuN revealed no oligonucleotide toxicity. The number of NeuN cells was 
similar across all treatment groups (naive 730 +/- 46; missense 640 +/- 58; antisense 710 +/- 51 
per 40pm section). Furthermore, Hoescht labelling did not detect any pyknotic nuclei in any 
of the groups. NK1  expressing cells are important for persistent inflammatory pain. Owing to 
their proximity to the catheter, NK1 cells would be most susceptible to any toxic effects. This 
would have dramatic  effects on nociceptive behaviours.  We found that NK1  positive cells 
were healthy in all groups and no toxic effects were in evidence (Fig 3.8).
3.3.7 Zif268 regulates the expression of SGK1
The significant reduction (29%,  P<0.05)  of zif268  expression in the  spinal  cord following 
zif268  antisense  treatment  also  had  a  profound  effect  on  the  levels  on  serum  and 
glucocorticoid  inducible  kinase  1   (SGK1)  in  the  dorsal  horn.  SGK1  expression  was
71significantly (P<0.05) increased in the zi£268 antisense treated group in comparison with the 
missense  group  indicating  a  negative  regulatory  role  of zif268  on  SGK1  expression  2h 
following injection of CFA into the intraplantar hindpaw (Fig 3.9).
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Figure  3.3.  Time  course  of  zif268  following  peripheral  inflammation.  Animals  were  perfused  and 
immunostained for zif268 at different time  points following  a CFA injection into the  intraplantar region  of the 
hindpaw.  A)  Representative  images  of animals  immunostained  at  different time  points.  2h* shows  nuclear 
staining  of zif268  at  2h  following  CFA  treatment.  B)  Cell  counts  of zif268  positive  neurons  in  the  medial 
portion  of  the  dorsal  horn  (superficial  layer).  Naive  rats  expressed  little  zif268.  However  following  CFA 
induced  inflammation,  zif268 expression  increased dramatically within  1 h,  peaked  at 2h  before  dropping  to 
baseline levels at 6h.  B,  inset table) indicates that 2h following CFA treatment more zif268  positive cells are 
expressed  in  the  marginal  layers  (lamina  I  and  II)  in  comparison  to  deeper  regions  of  the  dorsal  horn 
(lamina  lll-V)  (Confidence  levels  in  comparison  with  naive  group.  Mann  W hitney  U  test  *  P<0.05,  10 
sections counted  per animal).
73A
Parabrachial
nucleus
B
FG +ve cell 
/
Dorsal Horn
C
FG +ve cell
Zif268
Figure  3.4.  Lamina  I  projection  neurons  to  the  parabrachial  nucleus  (Ll-Pb)  express  zif268  during 
inflammation.  A)  Image  taken  from  a  rat  brain  section  showing  site  of  Fluorogold  (FG)  injection  into  the 
parabrachial  nucleus  (Pb).  B)  FG  injection  successfully  labelled  Ll-Pb  projection  neurons  in  the  dorsal 
horn.  C)  Image  showing  zif268  expression  (green) in the dorsal  horn following  intraplantar CFA  injection. 
Zif268  expression was  also found  to  be  expressed  in  Ll-Pb  projection  neurons  (red)  (with  zif268  seen  as 
yellow).  Cell counts revealed that 47% of Ll-Pb projection neurons expressed zif268 (n = 5).
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Figure  3.5.  Zif268  contributes to the  maintenance  but  not the  induction  of mechanical  allodynia  in  the  CFA  model. 
A)  IB4 was chosen to assess primary afferent damage following  surgery and  the intrathecal  implantation  of osmotic 
pumps.  Representative  images  showing  IB4  staining  in  the  dorsal  horn.  Only  animals  without  primary  afferent 
damage were included  into the  behavioural studies.  B) Comparison  of the  mechanical sensitivity (allodynia) of CFA 
injected  animals  receiving  pumps  containing  saline  (blue  bar,  n  =  10),  mismatch  ODN  (orange  bar,  n  =  12), 
antisense  ODN  (purple  bar,  n  =  12)  or  no  pump  (open  bar  n  =  7).  Animals  receiving  zif268  antisense  treatment 
displayed  markedly  reduced  mechanical  allodynia  and  hyperalgesia.  Data  are  plotted  as  percentage  of  baseline 
response  compared  with  antisense  treated  group  (Two  way  ANOVA  repeated  measure  *  P<0.05,  **  P<0.01,  *** 
P 0 .0 0 1 ).
75Figure  3.6.  Analysis  of sections  treated  with  zif268  antisense  or missense  after intraplantar CFA  injection  into  the 
hindpaw  (2h,  lOOpI,  50%).  (A)  Immunohistochemical  techniques  indicated  a  significant  difference  between  the 
mean  num ber of cells  positive  for zif268  per 40pm  section  following  treatment with  either zif268  antisense  (black 
bar)  or  missense  (red  bar).  (B)  The  difference  in  relative  luminosity  of  cells  treated  with  either  zif268  antisense 
(black  bar)  or missense  (red  bar)  relative  to  background.  (C,D)  Representative  example  sections  treated  with  (C) 
antisense or with (D) missense (Unpaired t-test * P<0.05,  n = 8).
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Figure  3.7.  Verification  of zif268  knockdown.  Rats  were  implanted  with  mini-osmotic  pumps  containing 
oligonucleotides that targeted zif268 mRNA in the spinal dorsal horn. Nominal infusion rate was 0.5pg/pl/h. 
Animals  were  infused  for  4d  before  receiving  an  intraplantar  injection  of  CFA  (2h,  100(jl,  50%)  into 
hindpaw.  Ipsilateral  dorsal  horn  quadrants  were  freshly  dissected  and  analysed  using  western  blotting 
techniques.  Zif268  protein  levels were  significantly  lower in  animals treated  with  the  zif268  antisense  in 
comparison  with  missense treatment (Confidence levels in comparison with missense. Unpaired t-test * P 
<0.05, AS:n = 4, MS: n = 4).
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Figure  3.8.  No  toxic  effect  of zif268  antisense  or  missense  on  dorsal  horn  neurons.  Animals  received 
chronic  intrathecal  infusion  of  zif268  antisense  or  missense  oligonucleotides  via  mini-osmotic  pumps 
followed by an intraplantar injection of CFA for 4d. Sections of spinal cord were immunostained for NeuN, 
and  NK1  and  stained  for Hoescht.  A)  NeuN  positive  cells  located  in  lamina  I  and  II  were  automatically 
counted using MCID software. No significant differences were found between naive, antisense or missense 
treated animals. B) Representative images showing (a) NeuN staining, (c) Hoescht staining and (e) NK1-R 
immunostaining for zif268  antisense treated  animals and  (b)  NeuN  staining,  (d)  Hoescht staining  and  (f) 
NK1-R immunostaining for missense treated animals. Hoescht staining did not pick up any pyknotic cells in 
either the  antisense  or the  missense  group.  NK1  staining  was  similar  in  both  antisense  and  missense 
treated rats. Cells appeared healthy and intact (Mann Whitney U test n = 5, 10 sections per animal).
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Figure  3.9.  Zif268  negatively  regulates the expression  of SGK1.  Rats  were  implanted  intrathecally with  mini- 
osmotic pumps  containing  oligonucleotides that targeted zif268  mRNA.  Nominal  infusion  rate  was  0.5|jg/|jl/h. 
Animals were  infused for 4d  before  receiving  an  intraplantar injection  of CFA (2h,  100pl,  50%)  into  hindpaw. 
Ipsilateral  dorsal  horn  quadrants were  freshly dissected  out and  analysed  using  western  blotting  techniques. 
SGK  protein was  significantly  higher in  animals  treated  with zif268  antisense  in  comparison  with  missense 
treatment (Confidence levels in comparison with missense. Unpaired t-test * P<0.05, AS: n = 6. MS: n = 6).
793.4 DISCUSSION
3.4.1 Zif268 expression: dorsal horn and lamina I projection neurons
This study has shown that an injection of CFA into the hindpaw can transiently increase the 
expression  of zif268  in  selective  neurons  throughout  the  dorsal  horn.  Antisense  treatment 
targeting zif268  suggests a functional  role for this protein  in the maintenance of persistent 
inflammatory pain states and the repression of SGK1 expression. The pre-treatment of zif268 
antisense did not alter the normal acute pain processing.
The  expression of the  IEGs  c-fos  and  zif268  can  be  induced  in the  dorsal  horn  following 
noxious peripheral stimuli or HFS on C-fibres. The expression of zif268 is strongly linked to 
the  successful  establishment  of LTP  in  both  the  hippocampus  and  the  dorsal  horn.  The 
ablation of lamina I/NK1  projection neurons reduces both spinal LTP and zif268 expression 
(Rygh et al, 2006). This strongly suggests that zif268 expression is involved with long-term 
changes in pain sensitivity.  In support of this, inflammatory hyperalgesia was attenuated  in 
studies  using zif268  knockout mice  (Ko et al,  2005).  In the hippocampus zif268  knockout 
mice were unable to maintain LTP (after 24h) and learning and memory type behaviours were 
severely inhibited in comparison to wildtype mice (Davis et al., 2003). Therefore, it is likely 
that  zif268  drives  a chain  of molecular events  that  lead to  long-term  changes  in  synaptic 
efficacy. Since protein expression is vital for maintaining LTP, the data strongly suggest that 
gene  expression  leading  to  physiological  changes  in  neurons  belonging  to  the  superficial 
layers  of dorsal  horn  is  crucial  for maintaining  long-term  changes  in  sensitivity.  This  is  a 
hypothesis that is taken up in a later chapter.
3.4.2 Antisense treatment reveals a role for zi£268 in inflammatory pain
Zif268  is expressed in a number of regions in the nervous system. Although previous work 
using a global knockout (Ko et al, 2005) have shown the importance of zif268  in persistent 
inflammatory pain, our work using intrathecal zif268 antisense has helped pin-point the spinal 
cord  as  an  anatomical  loci  where  zif268  modulates  the  transition  from  acute  pain  to  a 
persistent pain state.  Under normal conditions the adult spinal dorsal horn does not express 
zif268  except  following  noxious  stimulation  or  HFS.  Zif268  expression  was  also  seen  in 
lamina I projection neurons following peripheral inflammation. Previous studies (Mantyh et 
al,  1997; Nichols et al, 1999; Ikeda et al, 2006) have shown that these neurons are vital for the 
maintenance of persistent inflammatory pain. The expression of zif268 here could modulate
80transcriptional events that are crucial  for setting-up long term changes  in synaptic efficacy 
and pain behaviours.
Synaptic plasticity  such as LTP in hippocampal neurons requires the expression of zif268. 
Recent  studies  have  shown  that  synaptic  plasticity  may  be  dependent  on  the  levels  of 
proteosomic  activity  in the  synapse  and that  proteosome  expression  itself is  dependent  on 
zif268. The inhibition of proteosomes can prevent long term facilitation in Aplysia (Hegde et 
al,  1997) and can have negative effects on long-term memory in the hippocampus (Lopez- 
Salon et al, 2002). Through protein degradation, proteosomes are responsible for regulating 
protein  composition  in  the  post-synaptic  density  and  therefore  vital  for  the  efficacy  of 
synaptic transmission. Microarray studies (James et al, 2005) have shown that the activation 
of zif268 can modulate the expression of 26S (a proteosome protein).  It has been proposed 
that post-synaptic proteosome activity suppresses some forms of synaptic plasticity (Zhao et 
al, 2003). The repressive nature of zif268 was further highlighted with the use of the zif268 
knockout mice. Proteosomes are heteromeric complexes that are made up from a number of 
subunits.  Using  the  zif268  knockout  mice  it  has  been  noted  that  the  expression  of some 
proteosome  subunits were  increased  in the zif268  knockout mouse  in comparison with the 
wildtype  (James  et  al,  2006).  This  report  would  indicate  that  by  decreasing  proteosomic 
activity, zif268 could aid in synaptic plasticity and the generation of persistent pain states. In 
support of this,  a  study  has  also  shown that protein kinase A  (PKA) was  subject to  rapid 
degradation  by  proteosomes  (James  et  al,  2005).  PKA  may  be  involved  with  persistent 
inflammatory pain since increased phosphorylation of PKA occurs ipsilaterally in the dorsal 
horn during  long term  CFA  treatment and the  use  of selective  PKA  inhibitors  (KT-5720) 
applied  intrathecally  can  attenuate  thermal  hyperalgesia  (Yajima  et  al,  2003).  Therefore 
zif268  by  preventing  the  degradation of certain key  synaptic  proteins  at  specific  synapses 
could help facilitate persistent pain.
3.4.3  Regulation of SGK1 by zif268
Data from this study has shown that SGK1  in the dorsal horn can be negatively regulated by 
spinal zif268. SGK1  can enhance the expression of EAAT4 in cerebellar climbing fibres by 
protecting the  glutamate  transporters  from  degradation  (Bohmer et  al,  2004).  EAAT4  can 
offer a neuroprotective  role  by  preventing  glutamate  neurotoxicity  by  regulating  levels  of 
glutamate in the synaptic cleft. Therefore it is possible that zif268 by decreasing the levels of 
SGK1  can also reduce the expression of EAAT4. Although this would increase the risk of 
neurotoxicity it can also enhance synaptic efficacy by activating mGlu receptors lying in the 
perisynaptic region (Wadiche and Jahr,  2006).  SGK1  also positively regulates the EAAC1
81(EAAT3) glutamate transporter in retinal tissue (Schniepp et al, 2004). EAAC1  like EAAT4 
prevents  excess  glutamate  accumulation  from  occurring,  importantly  dorsal  horn  neurons, 
glial cells and the DRG express EAAC1  (Shashidharan et al,  1997).  Furthermore,  EAAC1 
expression has been shown to be downregulated in the dorsal horn following rhizotomy (Tao 
et al, 2004) and CC1  (Wang et al, 2006) and may well play a role in other long lasting pain 
states.
Another mechanism  by which SGK1  could  affect  synaptic  plasticity  is  by  modulating the 
expression of stargazin. Recently, stargazin has been implicated in the expression of formalin 
induced  inflammatory  pain  (Tao  et  al,  2006).  Stargazin  is  an  AMP  A  receptor  interacting 
protein that regulates the targeting  and clustering of AMPA  receptors  in the  post-synaptic 
membrane. Stargazin can also directly alter the biophysical properties of AMPA receptors by 
reducing the desensitization and deactivation of the receptor (Tomita et al, 2005, Priel et al,
2005).  Stargazin  contains  a  consensus  sequence  that  can  bind  SGK1.  However,  it  would 
appear that SGK3 at least in xenopus oocytes and in hippocampal neurons is more effective at 
binding this motif in comparison with SGK1  (Strutz-Seebohm et al, 2005; Strutz-Seebohm et 
al, 2006).
During CFA induced inflammation, GluR6 (mRNA) is upregulated (2 to 5h post stimulation) 
in the dorsal horn. The attenuation of thermal hyperalgesia can be seen with the intrathecal 
use of antagonists aimed at GluR6 (Guo et al, 2002). Since SGK1  can modify the expression 
of GluR6 (a kainate receptor subunit) in hippocampal neurons (Strutz-Seebohm et al, 2005), 
spinal SGK1 may also enhance GluR6 expression in the dorsal horn.
The expression levels of hippocampal glucocorticoid receptors (GR) have been shown to be 
modulated by epigenetic factors. Offspring that receive maternal attention such as licking and 
grooming have a higher expression of GR in comparison to littermates that do not (Weaver et 
al, 2004). Since zif268 can bind onto the GR promoter the authors have suggested that GR 
expression  may  be  modulated  by  zif268.  In  a  similar  manner  it  would  be  interesting  to 
investigate if GR modulation in the dorsal horn can be achieved by spinally expressed zif268 
and whether GR has a role in persistent inflammatory pain states (see chapter 5).
Although  changes  in  synaptic  sensitivity  of  central  neurons  are  important  for  the  full 
expression of long term inflammatory pain, continuous peripheral input to these neurons may 
be needed for the maintenance of this pain.  Indeed protein expression in the DRG changes 
with  time.  A  recent  study  (Inglis  et  al,  2005)  has  revealed  that  during  CFA  induced 
inflammation of the knee, the TNF receptors, TNFR1  and TNRF2, are chronically increased
82(mRNA)  but  at  different  anatomical  locations  in  the  DRG.  TNFR1  expression  increased 
bilaterally in DRG neuronal cells for 7d while TNFR2 increased ipsilaterally on macrophages 
(but not in neuronal cells). Etanercept, a TNF antagonist, administered before and (7 days) 
after knee inflammation reduced long term mechanical hyperalgesia. Suggesting TNF and the 
TNF receptors may be involved with both the induction and the maintenance phase of this 
pain state.
3.5  CONCLUSION
Zif268 is rapidly and transiently expressed in the dorsal horn (inclusive of lamina I projection 
neurons)  during  peripheral  inflammation.  The  expression  of  zif268  in  the  dorsal  horn 
maintains mechanical allodynia and hyperalgesia and is important for the repression of SGK1 
in the dorsal horn
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Descending Serotonergic Modulation of Persistent Inflammatory Pain
844.1 INTRODUCTION
4.1.1 Lamina I and the spino-bulbo-spinal loop
Noxious stimulation can engage spino-bulbo-spinal circuits. From lamina I, projections to the 
brainstem and forebrain are thought to activate a series of pathways that converge onto the 
rostral ventromedial  medulla (RVM).  Descending pathways from  RVM  impinge  upon the 
dorsal  horn and regulate nociceptive traffic.  Incoming nociceptive  information can thus  be 
either facilitated or inhibited depending on environmental contingencies recorded by higher 
brain centres.
4.1.2 Primary and secondary hyperalgesia
In  1950,  Hardy  et  al  investigated  two  types  of  experimentally  produced  cutaneous 
hyperalgesia; primary and secondary. Primary hyperalgesia occurs at the site of injury, while 
secondary hyperalgesia remains associated with the injury but occured in “undamaged tissues 
adjacent to and at some distance from the site of an injury.”  It is now widely accepted that 
mechanisms of primary and secondary hyperalgesia are, respectively, peripheral and central. 
The activation of capsaicin sensitive C-fibres are essential  for the development of primary 
hyperalgesia at the  site  of damage  and secondary  hyperalgesia  in areas  around the  site  of 
damage. (Magerl et al,  1998; Magerl et al, 2001). Activation of capsaicin sensitive C-fibres 
leads  to  the  sensitisation  of dorsal  horn  neurons  which  leads,  heterosynaptically,  to  the 
generation of secondary  hyperalgesia and allodynia (Zeigler et al,  1999).  The activation of 
mechanical  low  threshold  A-fibre type  (such  as  light touch)  corresponds  with  mechanical 
allodynia and the activation of nociceptive A-fibres (e.g with pin-prick)  is  associated  with 
mechanical hyperalgesia. This increase in excitability of spinal neurons (central sensitization) 
after peripheral injury has been extensively studied (Woolf,  1995; Woolf, 2004). It has been 
shown that the enhanced reflex excitability after peripheral tissue damage did not necessarily 
require ongoing peripheral input and that spinal dorsal horn neuron receptive fields expanded, 
responsiveness  to  suprathreshold  stimuli  increased,  response  thresholds  decreased,  and 
sensitivity to novel stimuli was acquired after peripheral injury.
Urban  and  Gebhart  (1999)  hypothesized  that  facilitatory  influences  from  the  brainstem 
significantly contribute to secondary, but not primary hyperalgesia.  Intra-RVM injection of 
lidocaine reverses established secondary hyperalgesia, suggesting a clear role for the RVM in 
maintenance of secondary hyperalgesia. Other studies revealed that spinal cord transection or
85cell specific lesions of the RVM prevented the development of secondary, but not primary, 
hyperalgesia. They argue that the evidence suggests that the RVM  is important to both the 
development  and  maintenance  of  secondary  hyperalgesia  but  perhaps  not  primary 
hyperalgesia.
But  is  RVM  input necessary  for central  sensitization?  Schaible  et al  (2002)  examined the 
effect of acute inflammation of the knee joint on spinal dorsal horn neurons and reported that 
spontaneous activity and responses to both  innocuous and noxious stimulation  of the joint 
increased as inflammation progressed but was increased further by cold block of the spinal 
cord.  They  concluded  that  spinal  neuron  hyperexcitability  associated  with  a  peripheral 
inflammation  was  counteracted  by  an  enhancement  of  descending  inhibitory  influences. 
Lidocaine injected into the midline RVM (Ren and Dubner. 1996) increased the spinal neuron 
response to mechanical  and thermal  stimulation applied to an inflamed hindpaw (complete 
Freund’s  adjuvant  induced).  This  result  was  interpreted  to  indicate  that  peripheral 
inflammation leads to an enhanced descending inhibition. Both of these studies used models 
of primary  hyperalgesia  because  stimuli  were  applied  to  injured  tissue  and  suggest  that 
activation  by  peripheral  noxious  inputs  of descending  excitation  and  inhibition  that  can 
modulate spinal nociceptive transmission.
4.1.3  The rostral ventromedial medulla (RVM)
Neurons  in the  RVM  have  been broadly  classified  into three  cells types  based  upon their 
reflexive  (tail  flick  or  paw  withdrawal)  response  to  noxious  heat.  Electrophysiological 
characterisation of neurons in the RVM suggests that two cell classes could account for the 
inhibitory  and  the  facilitatory  drive  from  the  RVM.  ‘On’  cells  are  believed  to  facilitate 
nociception  and  respond  by  increasing  their  firing  rate  to  noxious  heat  (just  before  a 
nociceptive reflex response).  ‘Off  cells are tonically active and just prior to a nociceptive 
reflexive response they reduce or cease firing. ‘Off cells are inhibitory and their cessation in 
firing allows for the successful transmission of nociceptive input into dorsal horn (Fields et al, 
1983; Heinricher et al,  1989). The third group respond to mechanical stimulation (Schnell et 
al,  2002) and are  called  ‘neutral’  cells. Neutral  cells do not initially  respond to  peripheral 
thermal noxious stimulation, but with time, are activated by stimulations made at other areas 
of the body.  However, stimuli such as noxious colonic distension can activate ‘neutral’ cells 
but do not activate ‘on’ cells nor inhibit ‘off cells (Brink and Mason, 2003). During normal 
circumstances numbers of ‘on’ and ‘off cells are relatively stable. However during long term 
persistent pain, there may be a shift in response towards the ‘on’ cell category.
864.1.4 Descending inhibition from RVM
Descending  inhibition  from  the  RVM  can  be  mediated  by  GABAergic,  serotonergic  and 
noradrenergic receptors in the spinal cord (Millan, 2002). Classically, the descending RVM 
projections  (especially  from  the  NRM)  were  believed  to  be  mainly  serotonergic  fibres 
(Bowker et al,  1981). However, recent studies have shown that this is not that case and those 
projections to the spinal cord from the RVM are heterogeneous in nature and only about 20% 
of RVM neurons are serotonergic and are generally thought to be ‘neutral’ cells. Retrograde 
labelling  from  the  cervical  and  the  lumbar  spinal  cord  using  horseradish  peroxidase  and 
fluorogold respectively have shown that a large number of RVM projection neurons to the 
dorsal  horn  do  not  co-localise  with  serotonin  (5-HT)  (Jones  et  al,  1991;  Wang  and 
Wessendorf,  1999;  Marinelli  et  al,  2002)  indicating  the  presence  of  a  non-serotonergic 
descending system.  Indeed  studies have shown that the majority of descending projections 
from the RVM are not serotonergic but GABA-ergic, indeed the vast majority of ‘off  cells 
are GABA-ergic (Winkler et al, 2006).
5-HT  is  released  in  the  spinal  cord  following  electrical  activation  of NRM  but  an  added 
complexity is that descending neurons do not express a single neurotransmitter.  For instance, 
a  subset  of  serotonergic  neurons  from  the  RVM  co-exists  with  a  number  of  other 
neurotransmitters including substance P, GABA, dynorphin, glycine, galanin and/or CCK. It 
has  been  found  that  25%  of serotonergic  neurons  innervating  the  superficial  dorsal  horn 
contain GABA,  while those projecting to deeper layers (lamina V) do not contain GABA. 
Therefore,  in a subset of descending neurons their activation could co-release both GABA 
and 5-HT to inhibit the post-synaptic response of dorsal horn neurons (Millhom et al,  1987, 
1988; Bowker and Abbott, 1988; Reddy et al, 1990; Millan, 2002).
4.1.5  Descending facilitation from RVM
Following  spinal  nerve  ligation,  Burgess  et  al  (2002)  discovered  that  the  RVM  cells 
expressing the  mu-opioid  receptor  and  their projections  through  the  dorsolateral  funiculus 
(DLF) are vital for the maintenance of neuropathic pain. The ablation of mu-opioid receptor 
expressing neurons with dermorphin-saporin conjugates or the transection of the DLF reduced 
both long term mechanical and thermal hyperalgesia (Burgess et al, 2002).
Numerous  studies  (reviewed  by  Urban  and  Gebhart,  1999)  have  shown  that  peripheral 
inflammation  or  spinal  nerve  ligation  with  either the  spinal  cord  transected  or  the  RVM
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the  RVM.  Reviewing  the  extensive  literature,  Urban and  Gebhart  (1999)  suggest  that the 
principal  effect  of  descending  controls  is  on  secondary  (and  therefore)  mechanical 
hyperalgesia. In addition, studies have also revealed that the descending facilitation can also 
affect pain behaviour and spinal physiology of deeper layers of the dorsal horn (lamina V). 
The response is driven, in part, by NK1-positive projection neurons from lamina I (Suzuki et 
al, 2002; 2003).  In fact the selective ablation of lamina I  cells with SP-SAP  shows  strong 
similarities to that following selective ablation of descending serotonergic axons. The effects 
on  lamina  V  cells  include  the  reduction  of the  second  phase  of the  biphasic  response  to 
formalin, as well as the reduction in the coding response to both thermal (noxious range) and 
mechanical (mid-noxious range) stimuli.
Descending  serotonergic  pathways  originating  from  the  RVM  are  fundamental  to  the 
maintenance of persistent pain and are believed to be part of the spinal-bulbo-spinal loop. For 
example, the removal of serotonergic axons with 5, 7-dihydroxytryptamine (5, 7 DHT) can 
attenuate  cooling  and  mechanical  hyperalgesia  following  spinal  nerve  ligation  (SNL) 
(Rahman et al, 2006). Release of 5-HT from serotonergic axons can activate a number of 5- 
HT receptors. The 5-HT3 receptor is ligand gated and gates calcium poorly, however it can 
indirectly activate calcium channels (Jones and Yakel,  1998) and facilitates the maintenance 
of neuropathic  pain  (Suzuki  et  al,  2002).  The  administration  of ondansetron  (a  selective 
inhibitor  of  the  5-HT3  receptor)  intrathecally  can  attenuate  SNL  induced  mechanical 
allodynia.
RVM  serotonergic  activity  is essential  for the maintenance of neuropathic  mechanical  and 
cold allodynia (Rahman et al, 2004).  I have investigated if serotonergic drive is required for 
persistent inflammatory pain by locally ablating 5-HT axons within the lumbar dorsal horn. In 
addition, levels of zif268 and c-fos expression (after CFA induced inflammation) were also 
examined using immunohistochemistry.
884.2  METHODS (see Chapter 2 for details)
4.2.1 Bolus injections of 5, 7 DHT and behaviour
Adult  rats  were  anaesthetised  using  halothane  and  injected  i.p.  with  1ml  desipramine 
hydrochloride (25mg kg'1 ) before being given an (i.t.) injection of 5, 7 DHT (60pg) or saline 
(lOpl). Following 5, 7 DHT injections the animals were left for 3-4d and separated into two 
groups; behaviour or immunohistochemistry, before being given a unilateral injection of CFA 
into either the hindpaw (50%,  lOOpl, intraplantar) or into the ankle joint (50%,  lOpl) under 
halothane anaesthesia.
The immunohistochemical group were perfused 2h after the CFA injection and processed for 
immunohistochemistry using antibodies that target 5-HT, c-fos and zif268. Cells located  in 
the superficial  layer of the dorsal horn that were positive for c-fos or zif268 were counted 
using a calibrated computer software programme (MCID). While the behavioural group were 
tested for mechanical allodynia and hyperalgesia (change in paw withdrawal thresholds) for 
7d after the CFA injection
4.2.2 SP-SAP and SAP injections
To  ablate  superficial  NK1  neurons  in  the  lumbar  segments  L4-L6,  adult  rats  were 
intrathecally cannulated under halothane anaesthesia and injected (in a bolus manner) with 
SP-SAP  (1pm  lOpl)  followed  by  a  intrathecal  saline  flush  (lOpl)  or  SAP  (control)  (1pm, 
lOpl)  followed by  a intrathecal  saline  flush (lOpl)  using a Hamilton  syringe.  The  animals 
were left for 28d in their home cage, injected with CFA (50%  lOOpl, hindpaw, intraplantar) 
and perfused 2h later (section 2.1.6). Spinal cord sections were then immunostained for NK1 
and  zif268.  Positive  cells  located  within  lamina  I  and  II  were  counted  using  the  MCID 
software.
894.3 RESULTS
4.3.1 Descending serotonergic axons facilitates persistent inflammatory pain
An overall significant decrease in mechanical withdrawal thresholds was found following the 
intraplantar  injection  of CFA  into the  hindpaw  in  animals  receiving  intrathecal  5,  7  DHT 
animals and intrathecal saline (F 2, n = 61.49; P<0.001). This effect was persistent in nature 
and lasted for the remainder of the study (day  1-7 post CFA) (F 5, i35 = 0.412; P<0.77) (Fig 
4.IB). In addition post hoc analysis (Tukey’s HSD) revealed that each treatment group were 
significantly different from each other (P<0.005) with regards to paw withdrawal thresholds. 
Unsurprisingly, animals receiving only 5, 7 DHT but without paw inflammation did not show 
any significant (P=0.50) reductions in paw withdrawal thresholds, suggesting that intrathecal 
5, 7 DHT alone did not affect paw sensitivity in this study. Importantly, although sensitivity 
in animals receiving 5, 7 DHT and CFA were allodynic the paw withdrawal thresholds were 
significantly higher (P<0.005) than animals receiving  intrathecal  saline (vehicle) and CFA. 
This difference became apparent by  6 hours post CFA. Animals that received 5, 7 DHT and 
CFA had a drop in threshold of 11 +/- 3g, in comparison the vehicle group experienced a drop 
in threshold of 20 +/-  lg (Fig 4.1 A). However, the induction of the inflammatory pain state 
were  unaffected  by  either  treatments  with  both  showing  a  significant  decrease  in  paw 
withdrawal thresholds early on (0-6h) after CFA injections (F 4>32 = 13.2; PO.OOl).
In  a  similar  manner  to  peripheral  inflammation,  CFA  injection  into  the  ankle  joint 
(monoarthritic  model)  resulted  in  a  persistent  mechanical  allodynia  and  hyperalgesia  (Fig 
4.1C). This pain state was partially alleviated with the pre-treatment of intrathecal 5, 7 DHT. 
On an overall basis, treatment had a significant effect on paw withdrawal thresholds (F i, 15 = 
5.06  p<0.04).  However  further  analysis  (post  hoc  testing)  that  took  individual  days  into 
account, found that the pre-treatment of 5, 7 DHT only significantly reduced paw withdrawal 
thresholds on day  1   (PO.Ol) and day 4 (P<0.05) Paw withdrawal thresholds on day  1   were 
reduced by  19 +/- lg in the vehicle and CFA group and 8.9 +/- 3g in the 5, 7 DHT and CFA 
group. On day 4 the thresholds were reduced by  17 +/- 3g in the 5, 7 DHT and CFA group 
and 11.9+/-2g in the vehicle and CFA group.
4.3.2 Zif268 and c-fos expression are regulated by the spino-bulbo-spinal loop
The expression of immediate early gene zif268 and c-fos in the dorsal horn are markers of 
CFA induced peripheral inflammation. Cell counts made in the superficial layer of the dorsal 
horn (using MCID software) revealed that serotonergic axons innervating the dorsal horn are
90not  required  for  the  expression  of  spinal  zif268  following  peripheral  inflammation.  No 
significant  differences  were  seen  in  zif268  expression  levels  in  animals  pre-treated  with 
intrathecal 5, 7 DHT or intrathecal saline. Cell counts were  157 +/-1 and  162 +/- 9 per 40pm 
section respectively (Fig 4.2A and Fig 4.3A,  B).  In comparison,  intrathecal  5,  7 DHT pre­
treatment did have an affect upon c-fos expression in the dorsal horn. C-fos expression was 
significantly higher (unpaired t-test, P<0.05) in animals pre-treated with intrathecal 5, 7 DHT 
in comparison to vehicle control (Fig 4.2B and Fig 4.3C, D). Mean number of c-fos positive 
cells (per 40pm section) were 77 +/- 8 after intrathecal 5, 7 DHT and 46 +/- 5  for intrathecal 
saline.
In comparison with the SAP control, the ablation of NK1  expressing cells in lamina I  with 
intrathecal  SP-SAP significantly  reduced (unpaired t-test,  P<0.05) zif268  expression  in the 
dorsal horn (Fig 4.2C). Mean cell counts for zif268 per 40pm section were 55 +/- 3  for SP- 
SAP and 84 +/-13 for SAP treated animals. However c-fos levels were not analysed after CFA 
injection  into the  hindpaw  in  SP-SAP  treated  animals.  Previously  it  has  been  shown  that 
induction of c-fos following high frequency stimulation was the same in sham and SP-SAP 
treated animals (Rygh et al, 2006).
4.3.3  Successful depletion of local serotonin using i.t. 5, 7 DHT
To verify that 5, 7 DHT successfully depleted 5-HT in the lumbar regions of the spinal cord, 
immunohistochemistry  was  carried  out  on  all  animals  used  in  the  experiment.  Following 
intrathecal 5, 7 DHT treatment a marked reduction in 5-HT immunoreactivity was seen in the 
entire lumbar enlargement in comparison with vehicle (saline) treated animals (Fig 4.4). Clear 
5-HT depletion was seen from  L4-L6.  It was, however, not clear if the depletion exceeded 
this  point  since  visual  inspection  was  not  made  beyond  these  lumbar  regions.  5-HT 
expression in the whole dorsal horn was extremely low following 5, 7 DHT. Lamina I was 
visibly reduced following 5, 7  DHT treatment.  The level of immunostaining  for 5-HT was 
similar  in  animals  perfused  3-4d to  those  after  10-1 Id  post  5,  7  DHT,  suggesting  the  re­
growth of serotonergic axons does not occur within this time frame. Animals treated with 5, 7 
DHT that did not show any serotonergic depletion (especially in the superficial layers of the 
dorsal  horn)  were  discarded  from  the  experiment.  Although  5,  7  DHT  can  also  affect 
noradrenergic neurons,  other studies have shown that the use of desipramine  (at similar to 
concentrations to ours) prevented 5, 7 DHT induced loss of noradrenergic neurons (Sawynok 
and Reid, 1996; Choi et al, 2004).
914.3.4 SP-SAP successfully ablated NK1 receptor expressing neurons in lamina I
Immunohistochemistry and cell counts revealed that SP-SAP treatment successfully reduced 
the expression of the NK1  receptor in lamina I of the spinal dorsal horn in comparison with 
SAP treated animals (Fig 4.5) (unpaired t-test,  P<0.05).  The number of NK1  positive cells 
after SP-SAP was 15 +/- 3 per 40pm section and 30+/-2 for SAP.
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Figure  4.1.  Descending  serotonergic  axons  facilitate  persistent inflammatory  pain.  A)  The  local  depletion  of 
serotonin  in  descending  axons  with  5,7  DHT  did  not  affect  paw  withdrawal  thresholds  (PWTs)  in  the  early 
stages  of peripheral  inflammation  until  6h  after CFA treatment  (n  =  5  for each  group).  B)  Depletion  of local 
(L4-L6) serotonergic axons alone  (without inflammation) did  not change  PWTs  (green  line,  n  = 6).  Peripheral 
inflammation  with  CFA caused  persistent  mechanical  allodynia  and  hyperalgesia  (blue  line,  n  =  12) that can 
be  attenuated  by  5,  7  DHT  (red  line,  n  =  12).  C)  Monoarthritis  (injection  of  CFA  into  the  ankle)  caused 
persistent  mechanical  allodynia  (blue  line,  n  =  8)  which  was  partially  reversed  by  intrathecal  5,  7  DHT  (red 
line,  n = 9). Confidence levels are comparisons between 5,7 DHT + CFA or 5,  7 DHT only with  Saline + CFA. 
(Two way ANOVA repeated  measure and Tukey’s post hoc testing  *** P<0.005,  ** P<0.01, * P<0.05).
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Figure  4.2.  Descending  serotonergic  axons  and  NK1  positive  projection  neurons  in  the  dorsal  horn 
differentially  modulates  the  expression  of  zif268  and  c-fos  in  the  spinal  dorsal  horn.  Adult  rats  were 
administered  with  i.t  5,  7  DHT  (n  = 4),  saline  (n  =  4).  SP-SAP  (n = 4)  or SAP  (n=4)  before  receiving  a 
unilateral intraplantar injection  of CFA (50%,  100pl). Animals were then  perfused  2h  later to allow for the 
peak expression of both zif268 and  c-fos. A) The local depletion  of descending serotonergic axons in the 
dorsal horn did  not modulate the expression of zif268 in the dorsal horn during  peripheral  inflammation  in 
comparison to saline control.  B) The local depletion  of descending  serotonergic axons  in the dorsal  horn 
increased  the  expression  of c-fos  in  the  dorsal  hom  during  peripheral  inflammation.  C)  The  ablation  of 
lamina I NK1  expressing cells in the dorsal horn reduced the expression of spinal zif268. (Unpaired t-test in 
comparison with controls * P<0.05,10 sections per animal).
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Figure 4.3.  Spinal cord  sections (lumbar) from  animals during peripheral  inflammation (50% CFA, 2h,  100pl) 
Animals were pre-treated with i.t. injections of SP-SAP, SAP, 5, 7 DHT or saline. A) Spinal zif268 expression 
was unaffected by the ablation of descending serotonergic axons (using 5, 7 DHT). Cell counts revealed that 
zif268  expression  was  similar  to  (B)  saline  treated  animals.  C)  In  comparison,  spinal  c-fos  expression 
increased  following  5,  7  DHT  pre-treatment  in  comparison  with  (D)  animals  receiving  saline.  Spinal  zif268 
expression  can  be  modulated  by  spinal  NK1-R  expressing  projection  neurons.  E)  The  ablation  of these 
neurons with  SP-SAP  reduced  zif268 expression  in the dorsal  horn  in  comparison with  F)  SAP  pre-treated 
animals.
c-fos  5 , 7DHT
*  •  > *  *  W  »
V *  Wo<V.
95Vehicle
B i, 7 DHT
ii
Figure 4.4.  Intrathecal  administration  of 5,  7  DHT  depleted  serotonin  axons  in  the  lumbar region  of the 
dorsal  horn.  Representative  sections  of  adult  rat  spinal  cord  (L5)  immunostained  for  serotonin.  Ai)  In 
animals treated with vehicle (saline), serotonergic axons were still  present in the superficial  layers  of the 
dorsal  horn.  Aii)  Magnification  of the  marquee  area  from  image  Ai.  Bi)  Treatment  with  intrathecal  5,  7 
DHT  depleted  serotonin  expression  in the  superficial  layers  of the dorsal  hom.  Bii)  Magnification  of the 
marquee area from  image Bi.
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Figure  4.5.  Intrathecal  SP-SAP  successfully  ablated  neurons  that  expressed  the  NK1  receptor  in 
lamina  1.  A)  A  representative  image  of  a  lumbar  dorsal  horn  section  immunostained  for  the  NK1 
receptor following  an  intrathecal  injection  of SP-SAP  30  days  earlier.  B)  A  representative  image  of a 
lumbar  dorsal  horn  section  immunostained  for  the  NK1  receptor  following  an  intrathecal  injection  of 
SAP 30 days earlier.  C) Cell  counts for NK1-R expressing  neurons in  lamina I  of the spinal dorsal  horn 
revealed  that  SP-SAP  (red  bar)  significantly  reduced  the  number  of  NK1-R  expressing  neurons  in 
lamina  I  in  comparison  with  SAP  (black  bar).  (Confidence  levels  in  comparison  with  SAP.  Unpaired  t- 
test * P<0.05,  n = 4,  10 sections per animal).
974.4 DISCUSSION
4.4.1 Descending serotonergic axons facilitate inflammatory pain states
This study has shown that 1) the early development of inflammatory pain sensitivity does not 
require  local  serotonergic  activity  2)  maintenance  of  inflammation  induced  mechanical 
hyperalgesia can be attenuated by depleting 5-HT in the spinal cord (L4-L6). 3) Depletion of 
5-HT axons alone did not influence acute pain response and 4) zif268 and c-fos expression in 
dorsal horn neurons are differentially modulated by different components of the spino-bulbo- 
spinal  loop.  These  data  supports  the  hypothesis  that  descending  serotonergic  axons  are 
involved in the maintenance of mechanical hyperalgesia but not with its induction.
Our behavioural  data has  shown a decrease  in paw withdrawal  thresholds  following  5-HT 
depletion in the lumbar spinal cord. Results from this experiment compliments a number of 
other  studies  that  show  descending  projections  originating  from  the  RVM  facilitate  and 
maintain chronic neuropathic pain states (Pertovaara et al,  1996; Ossipov et al, 2000; Porreca 
et al,  2001;  Burgess et al,  2002;  Suzuki  et al,  2004  and  Rahman et al,  2006).  This  would 
suggest that chronic neuropathic pain and persistent inflammatory pain may share a similar 
mechanism in the maintenance of their respective pain states.
4.4.2 Descending serotonin axons do not regulate spinal zif268 expression
The activation of the ERK1/2 pathway in dorsal horn neurons is vital for the full expression 
of hyperalgesia and allodynia (Ji  et al,  1999).  Recently  it has been suggested that ERK1/2 
expression  is  under the  influence  of descending  serotonergic  axons.  The  ablation  of 5-HT 
neurons  with  intrathecal  5,  7  DHT  before  peripheral  inflammation  with  CFA  decreases 
ERK1/2  expression  in  the  spinal  dorsal  horn  (Svensson  et  al,  2006).  In  addition  pain 
behaviours (paw lifting, biting and licking) to formalin was reduced following a similar pre­
treatment with 5, 6 DHT (Tjolsen et al,  1991). Given that zif268 lies downstream of ERK1/2 
in the hippocampal neurons, the local depletion of 5-HT in the dorsal horn surprisingly did 
not affect the expression of zif268 in the dorsal horn. However, the ablation of the ascending 
portion  of  spino-bulbo-spinal  loop  with  SP-SAP  significantly  reduced  zif268  expression 
following peripheral inflammation. Previously it has been seen that induction of zif268 after 
C-fibre high frequency stimuli can also be reduced in animals previous treated with SP-SAP 
with no change  in levels of c-fos expression (Rygh et al, 2005).  This result would  suggest 
that,  depletion of 5-HT alone is not sufficient to reduce zif268  expression but nevertheless
98attenuates the maintenance but not induction of the inflammatory pain state.  Given that 5-HT 
depletion  attenuates  the  maintenance  phase  of inflammatory  pain  but  only  lamina  I/NK1 
projection  neuron  ablation  attenuates  the  maintenance  and  induction  phase,  it  might  be 
concluded that modulation of zif268 expression is more closely related to  induction of the 
pain state.  However, the previous experiments (chapter 3) suggest that this may not be the 
case.  Antisense  knockdown  of zif268  expression  attenuates  the  maintenance,  but  not  the 
inductive phase of inflammatory pain. An alternative explanation is that NK1   positive lamina 
I projection neurons may activate a number of different descending pathways in a coordinated 
fashion.  Thus  SP-SAP  lesions  of lamina I  neurons  would be  expected  to  produce  a more 
profound  effect  on  spinal  processing  than  simple  isolation  and  ablation  of  one  small 
component of the descending pathways (the serotonergic component).  We were recently able 
to  show  that  LTP  in  deep  dorsal  horn  neurons  was  lost  following  ablation  of lamina  I 
projection neurons and this was accompanied by an attenuated rise in zif268  expression in 
superficial  dorsal  horn neurons but did  not  influence  c-fos  expression  (Rygh et  al,  2006). 
Depletion of spinal 5-HT had a much more limited influence on the development of LTP in 
deep dorsal horn neurons. Increased c-fos expression suggests that inhibitory components of 
serotonergic control were revealed by 5, 7 DHT treatment which are not seen following SP- 
SAP  treatment.  Interestingly,  this  may  mean  that the  integrated  activation  of descending 
pathways  can  be  modulated to  produce  either inhibition or facilitation as  indeed  has  been 
suggested experimentally (Urban and Gebhart, 1999).
4.4.3  Spinal c-fos expression is modulated by descending serotonergic axons
Along with a number of other studies, the data has revealed that c-fos expression in the dorsal 
horn  can  be  modulated  by  descending  serotonergic  axons.  C-fos  expression  is  widely 
accepted  as  a  marker  of neuronal  activity  that  can  lead  to  long  term  changes  in  cellular 
activity. C-fos is an immediately early gene that is expressed in the dorsal horn following a 
number of different types  of noxious  peripheral  stimulation  (Doyle  and  Hunt,  1999).  The 
protein itself forms heterodimers with members of the jun family in order to form an active 
transcription factor. In this state c-fos is able to regulate the expression of a number of second 
response  genes.  The  expression  of  spinal  c-fos  has  been  correlated  with  behavioural 
hyperalgesia following  peripheral  inflammation (Dubner and Ruda,  1992)  with  both being 
simultaneously attenuated with the intrathecal administration of NMDA receptor antagonists 
(Kehl et al,  1991). More recently, the importance of c-fos in nociception processing has been 
highlighted with the use of oligonucleotides that targeted the c-fos gene in the spinal cord.
99Peripheral  injection  of  formalin  into  the  hindpaw  normally  produces  gross  nocifensive 
behaviours  including  paw  licking  and  paw  lifting.  There  are  two  distinct  phases  to  the 
formalin  response  that  are  separated  by  quiescence  in  the  nocifensive  behaviours.  Pre­
treatment  with  c-fos  antisense  significantly  reduced  the  second  phase  formalin  in  a  dose 
dependent manner (Hou et al,  1997) but did not affect the first phase.  The reduction of c-fos 
also  reduced  the  transcription  of preprodynorphin  (Hunter  et  al,  1995)  which  has  been 
suggested to be pro-nociceptive (Zhang et al, 2003) stressing the importance of c-fos in the 
regulating pain-related genes in inflammatory pain states. However the transcriptional role of 
c-fos in CFA induced behaviours is still unknown.
Interestingly, our data showed that the depletion of 5-HT in the dorsal horn increased local c- 
fos  expression.  The  results  we  obtained  would  suggest,  in  part,  an  inhibitory  role  for 
descending  serotonergic  axons.  In  support,  previous  experiments  using  spinally  transected 
animals have yielded similar results. Ren and Ruda (1996) discovered that c-fos expression 
following peripheral inflammation was higher in animals with transected cords in comparison 
with whole animals. Since c-fos expression is related to neuronal activity in the spinal cord 
the  authors  believed  that  the  descending  pathways  net  role  is  to  dampen  down  central 
hyperexcitablity  in the  spinal  cord  during  peripheral  inflammation.  A  possible  solution  to 
account for both the excitatory and inhibitory activity of descending serotonergic pathways is 
that during the early phases (hours) of persistent inflammatory pain, the dorsal horn is under 
increased descending inhibition (Cervero et al, 1991; Schaible et al, 1991). This event may be 
dependent on a serotonergic drive from the RVM onto inhibitory spinal 5-HT receptors. This 
is then followed by a gradual  switch from  inhibition to descending facilitation after a few 
hours (Danziger et al, 2001), possibly because of changing patterns of gene expression in the 
RVM (Imbe et al, 2005; Imbe et al, 2007) and 5-HT acting at the excitatory 5-HT3 receptor 
playing  a prominent role.  This would explain both the behavioural  response  and the  c-fos 
response seen in this study and that c-fos expression may be modulated by different 5-HT 
receptors.
4.4.4  5-HT3 receptors mediate descending facilitation
The results gathered from this study have shown that descending serotonergic axons play a 
facilitatory role in mediating CFA induced hyperalgesia. The removal of 5-HT axons with 5, 
7 DHT significantly increased paw withdrawal latencies at later time points. It still remains 
uncertain  as to  which  particular  5-HT receptor subtype  or subtypes  are  involved  with the
100maintenance of CFA induced inflammatory pain state, but other inflammatory models have 
shown the 5-HT receptors are intimately involved with nociception.
While a strong  case  for the  5-HT3  receptor in  mediating descending  facilitation  has  been 
made,  a growing number of studies  using  electrophysiological  and  behavioural  techniques 
have shown that other 5-HT receptor subtypes and the release of 5-HT plays a vital role in 
inhibiting (Eide et al, 1988; Eide et al, 1990; Xu et al, 1994; Gjerstad et al, 1996; Millan et al, 
1996; Oyama et al,  1996), or facilitating (Murphy and Zemlan,  1990; Crisp et al, 1991; Ali et 
al, 1994) the nociceptive response. The inhibitory or excitatory response of the neuron can be 
partly determined by the 5-HT receptor subtype that is being activated, making it conceivable 
that other spinally expressed 5-HT receptor subtypes could play a role in the maintenance of 
CFA induced inflammatory pain (reviewed by Millan, 2002). For instance the activation of 5- 
HT2  receptor can  evoke  long-lasting  synaptic  facilitation  (Hori  et  al,  1996),  and  produce 
nocifensive-like  behaviours  that  are  reversible  by  substance  P  antagonist  (Eide  and  Hole, 
1991;  Eide  and  Hole,  1993).  Peripheral  inflammation  with  carrageenan  increases  the 
expression of 5-HT 1A and 5-HT2A receptors in the dorsal horn, including lamina I and II but 
also in GABAergic neurons (Zhang et al, 2002; Zhang et al, 2001). Activation of 5-HT1A and 
5-HT IB enhances the behavioural response to noxious stimulation (Zhang et al, 2001).
However, although a compelling case has been made for a role of the 5-HT3 receptor in the 
maintenance  of  persistent  inflammatory  pain,  studies  on  animals  that  lacked  the  5-HT3 
receptor gene (Zeitz et al, 2002) have concluded that this receptor does not alter the noxious 
behaviours  associated  with  intraplantar  CFA  injections  (measured  at  day  1   and  2).  No 
difference  was  seen  between  mutant and  wildtype animals  in the  response to thermal  and 
mechanical stimulation.  However, it still remains unclear if this was specifically due to a lack 
of 5-HT3  receptor at the  level  of the  spinal  cord  or due  an effect  of 5-HT3  receptor  loss 
throughout  the  CNS.  In  comparison,  other  inflammatory  models  have  shown  that  the 
activation of the 5-HT3 receptor is vital for facilitating noxious heat (Ali et al, 1996).
Oyama et al (1996) examined the role of the descending serotonergic system in the regulation 
of nociceptive processing.  Intrathecal 5-HT showed a dual effect on second phase formalin 
response in 5, 7 DHT treated animals. 5-HT at low dose inhibited aversive effects of formalin 
while  high  dose  5-HT  facilitated  the  pain  response.  The  effectiveness  of both  doses  was 
affected  by  antagonising  the  5-HT1A  and  the  5-HT3  receptor  respectively.  The  results 
suggest that spinal 5-HT 1A receptor suppresses the formalin response and that spinal 5-HT3 
receptors facilitates the formalin response.
1014.4.5 Spino-bulbo-spinal loops are essential for the induction and maintenance of 
persistent pain states
Spino-bulbo-spinal loops are crucial for the maintenance of chronic and persistent pain states. 
The interruption of the loops with either the ablation of ascending projection neurons from 
lamina I (Nichols et al,  1999; Suzuki et al 2002), the use of NK1  mutant mice (Kidd et al, 
2003), transection of the dorsolateral funiculus (DLF) (Ossipov et al, 2000) or disruption of 
the  RVM  can  alleviate  long  term  pain.  Neuronal  protein  expression  in  the  RVM  can  be 
modulated  by  ascending  projections  from  lamina I.  For example,  CFA  induced  peripheral 
inflammation can increase the expression of proteins associated with plasticity within hours in 
the  RVM,  including  the  NMDA  receptor  subunits  (NR1,  NR2A  and  NR2B)  (Miki  et  al, 
2002), GluRl  (Guan et al,  2003) as well  as increasing ERK1/2  expression  in the majority 
(60%) of serotonergic neurons in the RVM (Imbe et al, 2005). Moreover, persistent peripheral 
inflammation can also induce unresponsive cells to start firing in a subpopulation of RVM 
cells  (Miki  et  al,  2002).  Gene  transcription  in  the  RVM  may  enhance  the  drive  onto 
descending  serotonergic  axons.  Consistent  with the  idea that  descending  facilitatory  drive 
originating from the  RVM  is a component of the  spino-bulbo-loop,  the  depletion  of 5-HT 
from the spinal cord, in this experiment, can attenuate persistent mechanical allodynia in the 
same manner as SP-SAP treatment on NK1  neurons in lamina I.  In addition the attenuation 
occurred within hours after CFA administration and may reflect the time needed for protein 
modification and expression to occur in the RVM.
4.5 CONCLUSION
In conclusion, these studies have shown that the induction of inflammatory pain states may be 
independent of descending serotonergic axons. This behavioural response would seem to be 
dissociated with dorsal horn c-fos expression since local depletion of 5-HT increased c-fos 
expression. Moreover, in contrast to the early stages of inflammation, persistent mechanical 
allodynia  caused  by  peripheral  inflammation  to  the  hindpaw  and  ankle  is  dependent  on 
descending 5-HT released from descending axons of the RVM.  However,  it must be noted 
that since we did not fully examine the effects of 5, 7 DHT on other neuronal populations in 
the dorsal horn we cannot fully exclude the possibility that our results are also influenced by 
other non-serotonergic activity.
102CHAPTER 5
The Glucocorticoid Receptor: A Role in Persistent Inflammatory Pain
1035.1 INTRODUCTION
5.1.1  The HP  A axis
Stress  can  be  defined  as  any  stimulus  that  can  perturb  normal  homeostasis  and  therefore 
activate  the  hypothalamus-pituitary-adrenal  (HPA)  axis.  The  HPA  axis  regulates  the 
production and release of glucocorticoids, including the steroid hormone cortisol (in humans) 
and corticosterone (in rodents).  The responses of the HPA axis to stressful  and/or harmful 
stimuli  are  controlled  by  a  subset  of  hypophysiotrophic  neurons  located  in  the  medial 
parvocellular division of the paraventricular nucleus (PVN) within the hypothalamus. These 
neurons produce and secrete the corticotrophin releasing hormone (CRH) and vasopressin that 
act in a synergistic manner with arginine vasopressin to stimulate corticotrophs in the adrenal 
gland to release adrenocorticotropic hormone (ACTH) (Aguilera et al,  1994;  Romero et al, 
1996). ACTH  is synthesised from the precursor pro-opiomelanocorticortin (POMC),  which 
when  cleaved  produces  both  ACTH  and  beta-endorphin.  In  the  presence  of ACTH,  the 
adrenal gland is  responsible  for converting cholesterol  into androgens,  glucocorticoids  and 
mineralcorticoids. The major glucocorticoid produced by the adrenal gland is corticosterone.
Glucocorticoids are steroids that are released in times of stress and require strict regulation to 
avoid excess production. Glucocorticoids released by the activation of the HPA axis can form 
part of a negative feedback system to inhibit any further release (Herman and Cullinan,  1997; 
Sapolsky et al, 2000). The inhibitory feedback effect of glucocorticoids on the hypothalamus 
can occur rapidly and dissipate within minutes, but also in a much slower manner that can 
take minutes to hours for an effect to take place (Keller-Wood and Dallman,  1984).  While 
slow  glucocorticoid  effects  are  believed  to  involve  gene  regulation,  the  rapid  feedback 
mechanism is too fast for transcriptional  activity to occur and involve non-genomic events 
(Falkenstein et al, 2000). In support, in-vivo electrophysiology studies using ionophoretically 
applied  corticosterone  produced  a  rapid  excitatory  effect  in  a  number  of brainstem  loci 
(Avanzino et al, 1987). The reticular formation, the locus coeruleus and the RVM (Rong et al, 
1999) were all  found to be affected by corticosterones  in a non-genomic  manner,  with the 
RVM seeing an increase in firing frequency in 75% of neurons that project to the spinal cord. 
In addition electrophysiological  recordings have shown that PVN  neurons can also rapidly 
respond to corticosteroid application (Kasai et al,  1988; Kasai and. Yamashita,  1988; Saphier 
and Feldman, 1988). It is believed that both forms of feedback are achieved by using different 
corticosterone  binding  receptors,  although  this  has  yet  to  be  fully  resolved  (Tasker  et  al,
2005).  There  are two  receptors  that  can bind  corticosterones;  these  are  the  glucocorticoid
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ten-fold lower affinity for corticosterones in comparison with MR. As a consequence, higher 
levels  of  circulating  corticosterone  are  needed  for  GRs  to  cause  any  cellular  changes. 
Glucocorticoids  when  released  can  target  several  anatomical  regions  of the  HPA  axis  to 
initiate the negative feedback loop. There is a large population of GR and MR located within 
the hippocampus, hypothalamus, and pituitary. Targeting any one or all of these regions can 
reduce the release of the steroid (Fig 5.1).
Figure  5.1.  Stressors  can  stimulate  the  HPA  axis  by  activating  the  paraventricular  nucleus  (PVN) 
(parvocellular  division).  The  PVN  contains  both  CRH  and  arginine  vasopressin  (AVP).  These  are 
released  into the  hypophyseal  portal system  and  transported  to the anterior pituitary gland.  CRH  acts 
at  anterior  pituitary  corticotropes  as  a  secretagogue  in  synergy  with  the  weaker  secretagogue 
vasopressin to release adrenocorticotrophic hormone (ACTH) into the systemic circulation.  ACTH acts 
upon the  adrenal  cortex (zona fasciculate) and  causes  both the  production  and  the  release  of cortisol 
or  corticosterone  (glucocorticoids)  into  the  blood.  Excess  glucocorticoid  release  can  be  prevented 
using  a  negative  feedback  loop  where  glucocorticoids  can  prevent  the  release  of  ACTH  from  the 
pituitary,  CRH  and  vasopressin  from  the  PVN  and  finally  glucocorticoids  from  the  adrenal  cortex.  In 
additional  glucocorticoids  may  act  on  GR  and  MR  in  the  hippocampus  by  increasing  the  activity  of 
NMDA receptors that stimulate the activity of inhibitory neurones (GABA) located in the bed  nucleus of 
the  stria  terminalis.  Noradrenergic  and  serotonergic  input  from  the  brainstem  may  also  negatively 
modulate  the  activity  of the  HPA  axis.  Further  negative  feedback  may  be  supplied  by  the  amygdala 
and by the cytokine IL-1 b.  (Adapted from Blackburn-Munro and Blackburn-Munro, 2001)
Stimuli from internal or external sources can reach the PVN via a number of pathways from 
the spinal cord. These pathways include the spino-hypothalamic tract that relays to the lateral 
hypothalamic neurons as well as the spino-recticular-thalamic tract which includes fibres that
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105terminate in the ventrolateral and dorsomedial medulla where catecholaminergic neurons of 
the Al and A2 cell group project to the PVN. Moreover, spinal lamina I projections terminate 
on the Al and A2 group of the medulla, as well as in a number of other regions including the 
parabrachial nucleus, the periaqueductal gray (PAG), the solitary nucleus, the locus coeruleus, 
and the subcoerulear region (Westlund and Craig,  1996; Gauriau and Bernard, 2002; Spike et 
al, 2003). The HPA axis can also be activated indirectly via the amygdala (both the medial 
and central nuclei). The amygdala is known to receive direct and indirect projections from the 
spinal  cord.  The  parabrachial  nucleus  is  located  in the  hindbrain  and  receives  nociceptive 
information direct from spinal  lamina I neurons (Hermanson and  Blomqvist,  1996) and has 
been  shown  to  send  collaterals  to  specific  amygdaloid  nuclei.  Anatomical  studies  using 
retrograde tracers injected into the amygdala have identified projections from the parabrachial 
to the amygdala.  Small subsets of these neurons are activated by formalin injected  into the 
hindpaw. Therefore it remains possible that peripheral noxious stimulation may also be able 
to activate the HPA axis by activating neurons in the amygdala (Richard et al, 2005).
5.1.2 Glucocorticoid release and pain
Glucocorticoids are secreted in situations where homeostasis has been perturbed. Studies have 
shown that pain can cause the HPA axis to respond. Glucocorticoid release can be initiated by 
direct PVN activation via nociceptive pathways. Injection of dilute formalin into the hindpaw 
of  rats  can  lead  to  the  bilateral  c-fos  expression  within  catecholominergic  cells  in  the 
brainstem including the cell groups Al  and A2 of the medulla which send projections to the 
hypothalamus. Peripheral injection of formalin (after 30min) can increase both noradrenaline 
release into the PVN (4 fold) and ACTH and glucocorticoid release (Palkovits et al,  1999).
5.1.3 The HPA axis and persistent pain states
Formalin and adjuvant induced arthritis (AA) has been shown to affect the HPA axis. The AA 
model of polyarthritis is a T cell dependent inflammatory model and is a model of rheumatic 
diseases.  This  model  generates  both  persistent hyperalgesia  and  allodynia  and  is  on-going 
(Bomholt  et  al,  2004).  AA  rats  show  a  number  of physiological  disturbances  including 
perturbations in their circadian rhythm (increase wakefulness) (Shanks et al,  1998; Harbuz et 
al, 1998) as well as increased EEG amplitudes (Andersen and Tufik, 2000). These phenomena 
can be reduced by the administration of analgesic compounds (Calvino et al,  1996). The AA 
model is also associated with abnormally high levels of plasma corticosterones and ACTH. 
Increases of propiomelanocortin (POMC, a precursor to ACTH) mRNA was also seen in the
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found  to  be  significantly  altered.  In  healthy  animals,  corticosterone  release  occurs  in  a 
rhythmical manner, but this did not occur in animals that suffered from polyarthritis; the usual 
peaks  and  troughs  of  corticosterone  release  were  flattened.  In  addition,  high  levels  of 
corticosterone  and ACTH  that  are  usually  seen  in the active  evening  period  (in  nocturnal 
rodents)  were  significantly  reduced.  Instead,  high  levels  of corticosterone  were  released 
during daylight hours including the non-active dawn period (Persellin et al, 1972; Sarlis et al, 
1992; Selgas 1997).
Under normal  circumstances corticosterones are released in a pulsatile manner, however in 
arthritic  animals  the  interpulse  phase  is  reduced.  The  outcome  is  an  increased  release  of 
corticosterone  release  per unit time  (Windle  et  al,  2001).  Other effects  of AA  include  an 
alteration in the level of CRH and AVP release. CRH was found to be decreased, while AVP 
was found to have increased with time. It is believed that the upregulation of AVP arises in 
order to compensate for the loss of CRH drive in the HPA axis. Using adrenolectomised rats 
it  was  noted  that  formalin  induced  peripheral  inflammation  increases  the  release  of 
corticosterone  which  does  not  feedback  and  modulate  the  HPA  axis  (Taylor et  al,  1998). 
There are two possible mechanisms whereby peripheral inflammation can increase the levels 
of  ACTH  or  corticosterone.  Subcutaneous  formalin  injection  can  lead  to  an  increase 
production of interleukin-6 (IL-6) and ACTH in the plasma (Aloisi et al,  1995). Interleukin 6 
has been shown to directly  activate the PVN portion of the HPA  axis  (Rivier,  1995).  The 
second possible mechanism is achieved by activating the ascending pathways that directly or 
indirectly  influence the HPA  axis.  Destruction of C-fibres has been  shown to  decrease the 
effectiveness  of formalin  and  CFA  to  cause  the  secretion  of ACTH  from  the  HPA  axis 
(Amann and Lembeck,  1987). The efficacy of formalin to increase circulating corticosterone 
in the plasma can be inhibited by lesions to the PVN, although lesioning of this structure does 
not affect the pain state of the animal. Furthermore, the expression of substance P and CGRP 
in the  DRG  are  increased  in adrenolectomised  rats  (which  have  reduced  plasma  levels  of 
corticosterones)  whereas  the  levels  of  somatostatin  are  decreased.  The  effects  of 
adrenolectomy can be successfully reversed with the GR agonist dexamethasone (Smith et al, 
1991).
Several studies using the CCI (chronic constriction injury) model have shown the HPA axis 
was perturbed, but to a lesser degree than in the AA model. For instance, the glucocorticoid 
negative feedback loop remained intact. No significant increases were seen in corticosterone 
or ACTH release  (Vissers et al,  2003;  Bomholt et al, 2005) and the rhythmical  release of 
corticosterone, which is perturbed in the AA model, remained normal (Bomholt et al, 2005).
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function of the HPA axis remained unaffected. The basal expression of CRF (mRNA) also 
remained  unaltered.  However the release of CRF  during the restraint test was  reduced  (in 
comparison to their controls). The levels of AVP secretion also remained the same (unlike in 
inflammation). Overall it would seem that the CCI model does not perturb the HPA axis to 
the same extent as some inflammatory pain models.
5.1.4  The glucocorticoid receptor and its role in pain
The  GR  is  a member  of the  nuclear receptor  superfamily,  and  like  other members  of the 
superfamily the GR functions as a ligand-dependant transcription factor.  The GR can bind 
steroids such as cortisol and corticosterone and can affect the transcriptional activity of the 
cell. The GR when unbound to corticosterones are unable to dimerise and are restricted to the 
cytoplasm.  However following corticosterone binding,  GR changes conformation  state  and 
dissociates itself from chaperone molecules allowing the GR to dimerise and translocate to 
the nucleus. GRs can bind directly to specific DNA sequences that recognise activated GR; 
these regions are termed glucocorticoid response elements (GRE). There are 2 types of GRE, 
each with opposing effects. Positive GREs, as the name suggests, are responsible for allowing 
the  process  of  transcription  to  occur,  conversely,  negative  GREs  direct  transcription 
repression.  Furthermore,  GRs can interact with other transcription factors such as activator 
protein-1  (AP-1) and nuclear factor kappa beta (reviewed by Slater et al,  1986; Schoneveld et 
al, 2004).
Even though the corticosterone levels remained unaltered in neuropathic pain models, in the 
spinal cord, the  GR has  been  shown to be  a key  molecule  in modifying  neuropathic  pain 
states. Several studies by Wang et al (2004, 2005) have helped to elucidate the role of the GR 
in neuropathic pain states. GR expression in the dorsal horn is predominantly neuronal and 
increases during neuropathic injuries (CCI), the use of either GR antagonists (dexamethasone 
21-mesylate) or adrenolectomy prior to CCI reduced both mechanical and thermal allodynia 
that normally accompanies CCI (Wang et al, 2004; Takasaki et al, 2005). In addition, Mao’s 
group (2004) further investigated the regulatory role of the GR in the CCI  model.  The GR 
was found to regulate a number of proteins  and receptors in the dorsal  horn.  The  increase 
expression in the dorsal horn of the NMDA receptor subunit NR1  and NR2 caused by CCI 
can be successfully attenuated with the use of a GR antagonist or GR antisense when applied 
chronically and intrathecally, indicating a regulatory role of spinal GR on NMDA receptors in 
the dorsal horn (Wang et al, 2005). Furthermore, the contribution to pain does not lie solely 
with GRs ability to regulate the expression of NMDA receptors. Studies have also shown that
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normal  circumstances  EAAC1  prevents  the  over-stimulation  of  glutamate  receptors  by 
regulating  the  amount  of  extracellular  glutamate  that  is  present  in  the  synaptic  cleft 
(Brustovetsky et al, 2004). However, during neuropathic injuries EAAC1   is down-regulated 
in the dorsal horn (Sung et al,  2003) a process that can be prevented with the use of GR 
antagonists and antisense aimed at disrupting GR expression in the dorsal horn (Wang et al,
2006). GR can also modulate the expression of cannabinoid receptor in the dorsal horn (Lim 
et al, 2005) as well as being a key molecule in the development of morphine tolerance. The 
mechanism by which the expression of GR is regulated in the CCI model remains unknown. 
However, owing to the existence of a zif268 binding site on exon 1   of the GR promoter (Fig 
5.2) it remains possible that GR expression in the dorsal horn is dependent on the activity of 
zif268 (Weaver et al, 2004).
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Figure 5.2.  The  promoter region  of GR (exon  17) contains a  binding  site for zif268.  This  binding site  may 
provide a site where zif268 can regulate the expression of GR. (Adapted from Weaver et al, 2004)
Since CCI does not increase corticosterone plasma levels, it is possible that in the absence of 
increased corticosterone levels, local changes in the GR signalling in the dorsal horn may be 
restricted to regions of the CNS that have received substantial activation such as after nerve 
injury or peripheral inflammation. Thus activation leading to central sensitisation would be 
accompanied by  increased  expression of GR  in the dorsal  horn  neurons.  The  experiments 
presented here attempted to determine the role of the GR in the expression of mechanical 
allodynia  and  hyperalgesia  and  whether  spinal  GR  expression  changes  during  persistent 
peripheral inflammation. In addition, focus was also placed on the potential regulatory role of 
zif268 in determining the expression levels of the GR in the dorsal horn following peripheral 
inflammation.
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5.2.1 General GR immunostaining
Adult Sprague-Dawley rats were rapidly anesthetised using halothane, half the animals were 
injected with CFA into the intraplantar region of the hindpaw, the remaining animals did not 
receive CFA and remained non-inflamed. Animals were then perfused 2h later with 4% PFA. 
Dorsal horn sections (lumbar 4-6) were cut into 40pm sections and immunostained for GR 
with  rabbit  anti-GR  (1:500,  4°C,  overnight).  Biotinylated  anti-rabbit  secondary  antibody 
(1:200, 2h, RT) was used to enhance the signal and visualised using Alexa Fluor 488 (1:500, 
2h, RT). Sections were mounted onto glass slides and coverslipped with Gel Mount (Sigma).
5.2.2 Intrathecal catheterization and drug delivery
Mini-osmotic pumps were implanted sub-dermally. Pumps were connected to a PE 10 catheter 
that was inserted at the level of the lumbar enlargement (L4-L5) under halothane anaesthesia. 
For experiments using GR oligonucleotides, the antisense sequence was 5’-TGG AGT CCA 
TT GCA AA*T-3’ and the missense was 5’-TGA AGTTCA GTG TCA AC*T-3’). The GR 
antagonist dexamethasone 21-mesylate (dex-mes) was also used in this study. For zif268, the 
antisense  sequence  was  5’-GGT-AGT-TGT-CCATGG-TG*G-3  and  for  the  missense,  5’- 
GTG-TTC-GGT-AGG-GTG-TC*A-3\  Each mini-osmotic pump administered 0.5pg/pl/h of 
oligonucleotide for the GR study, 0.16pg/pl/h for the zif268 study and 28nmol (in total) of 
dex-mes  (dissolved  in  0.9%  saline)  for  7d.  Following  behavioural  tests,  animals  were 
perfused and examined for correct catheter placement and damage to spinal  cord.  Animals 
with damaged cords and displaced cannula were discarded from the study (see Methods and 
Materials 2.2).
5.2.3 Behavioural tests and statistical analysis
Animals were habituated to the testing environment before surgery. 3d following surgery, the 
baseline  score to  ramped mechanical  stimulation was taken (mean of 4  scores taken,  each 
separated by  a minimum  of 5min).  On the third day, rats received a unilateral  intraplantar 
injection  of CFA  (lOOpl,  50%).  Over the next 4  days animals were tested  for mechanical 
allodynia  and  hyperalgesia.  Comparisons  were  made  between  antisense  and  missense 
animals. Results were statistically analyzed using a two-way ANOVA repeated measure.
5.2.4 Retrograde labelling with FG
noRats were anaesthetised continuously with halothane throughout the surgical procedure and 
mounted onto a stereotaxic frame. Co-ordinates for the parabrachial nucleus were ascertained 
using an appropriate brain  atlas (Paxinos and  Watson,  1998).  An  injection (4%,  300nl)  of 
fluorogold  (FG)  was  made  into  the  parabrachial  nucleus  (see  Methods  and  Materials). 
Animals were left to recover for 3-4d before being given a unilateral injection of CFA (lOOpl, 
50%)  into  the  intraplantar  surface  of  the  hindpaw.  Rats  were  then  perfused  and 
immunostained for zif268 and GR (see below)
5.2.5 Immunocytochemical staining for oligonucleotide toxicity
Following  oligonucleotide  administration  and  behavioural  analysis  Rats  were  deeply 
anaesthetized  with  pentobarbital  and  transcardially  fixed  with  400-500  ml  of  4% 
paraformaldehyde.  The  lumbar  spinal  cords  were  dissected,  and  postfixed  for  4h,  left 
overnight  in  30%  sucrose  and  40pm  transverse  sections  cut  on  the  microtome. 
Immunocytochemical staining was used to detect Neuronal-specific nuclear protein (NeuN), 
NK1  (see table 2.2  for concentrations).  Sections were also stained for Hoescht and  IB4 to 
check for toxicity.
5.2.6 Immunocytochemical staining for GR after oligonucleotide treatment
Osmotic pumps containing zif268 or GR antisense or missense were implanted into adult rats 
sub-dermally.  4d  later,  rats  received  a  unilateral  injection  of CFA  (50%,  lOOpl)  into  the 
intraplantar hindpaw and were perfused 2h later. The immunocytochemistry then followed the 
same  protocol  as  described  in  the  Chapter  2  and  Section  5.2.1  (above).  Individual  GR 
expressing neurons were then analysed for pixel luminosity using the BioRad 600 confocal 
microscope.  Luminosity  scores  are  a  measurement  of  the  brightness  emitted  from  the 
fluorophore during the excitation.  The technique makes the assumption that the greater the 
luminosity score the more of the detected protein that is present in the cell. Sections from the 
L4-L5 region of the spinal dorsal horn were taken from animals treated with either zif268 or 
GR antisense or missense.  Sections were immunostained for GR and the luminosity scores 
were ascertained from  10 sections per animal. Since the background for each section varied 
slightly,  sections  were  normalised  by  subtracting  the  background  value  from  adjacent 
neuropil.  The  mean  from  the  twenty  highest  score  from  each  section  were  taken  and 
comparisons were made with the other treatment group.
ill5.2.7 Western blotting
Following  zif268  and  GR  antisense  and  missense  treatment  for  4d,  and  2h  following 
intraplantar CFA  injection to the hindpaw,  protein  levels of GR residing  in the  ipsilateral 
dorsal  horn  of  the  spinal  cord  were  analysed  using  western  blotting  techniques.  This 
technique was also used to analyse the effectiveness of the antisense knockdown as well as to 
study  the  potential  role  of zif268  in  regulating  GR  in  the  dorsal  horn  (see  Methods  and 
Materials).  Quantification  of individual  protein  bands  of GR  and  GAPDH  were  analysed 
using the software Bio-Rad Quantity One 4.4.1. To analyse if the GR protein levels changed 
following  GR or zif268  antisense  or missense treatment,  the  GR quantification value  was 
divided with the appropriate GAPDH (loading control) quantification value for each lane. By 
doing this a ratio score for each lane was made.  The ratio scores for each treatment group 
were then compared with each other.
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5.3.1 Increased expression of GR after peripheral inflammation
Immunohistochemistry  revealed  that  dorsal  horn  neurons  constitutively  express  GR.  The 
majority of GR positive cells were present in both the inner and outer regions of lamina II, 
with some positive cells also being located in lamina I, although the levels were lower than in 
lamina II (Fig 5.8) (LI  12 +/- 3  and LII 48 +/- 5).  In order to examine the role of GRs in 
persistent inflammatory  pain,  a unilateral  injection of CFA  (50%,  lOOpl) was made to the 
intraplantar region of the hindpaw of adult rats. CFA injections did not increase the number of 
cells in either the ipsilateral (90 +/- 7 cells per 40pm section) or the contralateral (98 +/- 3 per 
40pm  section)  dorsal  horn  in  comparison  with  naive  animals  (105  +/-  16  cells  per  40pm 
section) (Fig 5.3). However, confocal microscopy detected a significant increase in GR cell 
body luminosity following CFA in the ipsilateral dorsal horn (relative luminosity 112+/- 6) in 
comparison  with  naive  animals  (relative  luminosity  83  +/-  3)  (P<0.05).  However,  no 
significant  differences  were  found  in  GR  cell  luminosity  between  naive  animals  and  the 
contralateral side of CFA treated animals (relative luminosity 83 +/- 2).
5.3.2 GR antisense blunts the maintenance of inflammatory pain states
To examine if GR expression affected the paw withdrawal thresholds to mechanical stimuli 
during inflammatory pain, adult rats received a continuous intrathecal infusion of missense or 
antisense targeting GR mRNA. The administration of GR antisense or the missense alone did 
not cause any significant changes in the respective baseline scores to mechanical stimulation 
(Fig 5.4). Paw withdrawal thresholds were 26 +/- 5g for antisense and 36 +/-  4g for missense 
treated animals before surgery and 32 +/- 2g and 33 +/- 6g respectively after surgery (before 
CFA). Following a unilateral injection of CFA into the intraplantar region of the hindpaw all 
animals developed mechanical allodynia and hyperalgesia  Id after the injection (Fig 5.5). A 
significant reduction in paw withdrawal thresholds was seen in both the missense (P<0.04) 
and the antisense group (P<0.05) compared with baseline scores one day after CFA injections. 
Overall,  there  was  a  significant  affect  of  oligonucleotide  treatment  on  paw  withdrawal 
thresholds  following  peripheral  inflammation  (F  i, j5   =  10.6;  P<0.005).  This  response  was 
stable and remained unaffected with time (day 1  to day 4 post CFA) (F 3 >  45 = 2.12; P = 0.14). 
Analysis  on  individual  days  showed  that the two  treatment  groups  were  not  significantly 
different  from  each  other  on  the  first  day,  where  the  mean  paw  withdrawal  threshold 
decreased by  18 +/- 2g following antisense treatment and 24 +/- 4g after missense treatment in 
comparison  with their respective  baselines.  However,  on the  second  day,  paw  withdrawal
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missense group, so that paw withdrawal thresholds decreased by 20 +/- 2g with antisense and 
29 +/- 2g with missense from baseline. The paw withdrawal threshold of the antisense group 
remained significantly higher than the missense group from day 2 onwards until day 4 post 
CFA (day 3 P<0.01; day 4 P<0.01).
5.3.3 Examination of glucocorticoid receptor knockdown
In order to verify GR knockdown was successful, western blots and immunohistochemistry 
were performed on a further two groups treated with GR antisense or missense at the same 
concentration as that used in the behavioural study. Relative luminosity scores for antisense 
(96  +/-  8)  were  significantly  lower  (P<0.05)  in  comparison  with  missense  (126  +/-  3).  In 
addition, cell counts revealed that GR antisense treatment significantly (P<0.05) reduced the 
number of GR positive cells in the dorsal horn in comparison with the missense group (61 +/- 
13 compared with 112 -t-/- 21  cells per 40pm section). Western blots also showed a tendency 
towards a reduction in the levels of GR, however, the difference between the antisense and 
missense was not significant (Fig 5.6). An increase in the number of animals used for this 
analysis  may  have  helped  to  reveal  a  significant  drop  in  protein  levels.  Signal  intensity 
(density)  was  quantified  using  the  software  package  Quantity  One  4.4.1  (Bio-Rad). 
Densitometric  values  were  expressed  as  the  ratio  of  GR  to  GAPDH  (loading  control). 
Statistical  comparisons  between the  ratio  scores  of missense and antisense treatment  were 
assessed using an unpaired t-test.
5.3.4 Lack of toxicity and cell death using antisense
To  examine  if oligonucleotide  treatment  resulted  in  unwanted  tissue  toxicity  or  damage, 
spinal cord tissue was stained for IB4, NeuN and NK1. In the majority of cases, no gaps in the 
IB4 staining were present. Under normal circumstances IB4 staining is observed as a distinct 
band that spans across the entire lamina II region of the dorsal horn (Fig 5.5). Any gaps or 
disruptions  in the  IB4  staining  represent primary  afferent damage.  Animals  with damaged 
spinal cords were removed from the experiment and behavioural data collected discounted (n 
= 5). Cell counts made in the superficial layers of the dorsal horn using NeuN revealed no 
oligonucleotide toxicity. The number of NeuN cells was similar across all treatment groups 
(naive 703 +/- 16; missense 737 +/-  17; antisense 722 +/- 21  per 40pm section), Furthermore, 
Hoescht labelling did not detect any pyknotic nuclei  in any of the groups. NK1  expressing 
cells  are  important  for  persistent  inflammatory  pain.  Owing  to  their  proximity  with  the 
catheter, NK1 cells would be most susceptible to any toxic effects. This would have dramatic
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groups and no toxic effects were in evidence (Fig 5.7).
5.3.5 Behavioural effects of glucocorticoid receptor antagonist
In order to provide further evidence of the importance of the GR in persistent inflammatory 
pain it was decided to use dex-mes (a GR antagonist). The chronic intrathecal administration 
of dex-mes (28nmol) alone did not affect paw withdrawal thresholds (36 +/- 3g before surgery 
compared with 38 +/- 2g after surgery) (Fig 5.4).  However, the antagonist did  significantly 
inhibit mechanical allodynia and hyperalgesia following peripheral  inflammation with CFA 
(F i, 12 =  11.8; P<0.005). Overall paw withdrawal latencies in dex-mes treated animals were 
significantly different from those treated with saline. This effect was stable for the entirety of 
the experiment (day  1-4 post CFA injection) (F 3 t 36 = 0.54; P = 0.70). In addition, analysis of 
individual  days  revealed  that  unlike  the  antisense  treatment,  dex-mes  treatment  partially 
attenuated  mechanical  sensitivity  on  all  days  following  CFA  induced  peripheral 
inflammation.  Paw  withdrawal  thresholds  on  day  1   after  CFA  decreased  by  10  +/-  3g  in 
animals treated with dex-mes and 17 +/-2g for saline treated animals.
5.3.6 Zif268 and GR colocalisation in the dorsal horn and projection neurons
One  of our  hypotheses  was  that  spinal  GR  may  be  regulated  by  zif268  during  chronic 
inflammatory pain.  In order for zif268 to regulate GR the two proteins  must reside  in the 
same cell. Immunohistochemistry targeting both GR and zif268 was applied to 40pm sections 
from  animals  that  had  previously  been  injected  with  CFA  (2h)  before  perfusion.  Results 
indicate that both zif268 and GR colocalise in a subpopulation of cells in the dorsal horn (Fig 
5.8). Cell counts on the medial half of the dorsal horn revealed that the population of zif268 
positive cells (99 +/-  11  per 40pm section) outnumbered the population of the GR positive 
cells (62 +/- 6 per 40pm section).  19 +/- 3% of cells containing zif268 colocalised with GR, 
while 31  +/- 5%  of GR  cells  colocalised with zif268  (Fig 5.9).  The  level  of colocalisation 
between  GR  and  zif268  in  Ll-Pb  projection  neurons  was  34  +/-  2  %.  Using  retrograde 
labelling it was noted that 61% of projection neurons to the parabrachial nucleus were GR 
positive of which half colocalised with zif268 (Fig 5.9).
5.3.7 Regulation of GR expression by zi£268
Having  established  that  zif268  colocalised  with  a  small  number  of dorsal  horn  neurons 
(including projection neurons to the parabrachial nucleus), it was still unclear as to whether or
115not zif268 had any regulatory role over GR during persistent inflammatory pain states. Using 
osmotic pumps to continuously deliver the oligonucleotides for a week, it was noted that the 
application  of  zif268  antisense  not  only  attenuated  the  mechanical  allodynia  seen  with 
peripheral CFA inflammation (see chapter 3) but also significantly reduced the expression of 
GR  during  peripheral  inflammation.  Comparisons  of  luminosity  scores  between  zif268 
antisense and missense treated animals revealed that immunostaining of GR positive cells in 
the missense group (with a relative luminosity score of 109 +/- 8) was 34% more intense in 
comparison  with  antisense  treated  animals  (with  a  relative  luminosity  score  of 69  +/-  5). 
Baseline  values  for  both  groups  were  normalised  to  zero.  Western  blots  also  showed  a 
reduction of GR protein in the dorsal horn following zif268 antisense treatment. Levels were 
reduced  by  ~21  %  in  comparison  with  the  missense  group  although  this  did  not  reach 
significance (Fig 5.10).
116Naive
Naive  CFA ipsi  CFA cont
C
Figure  5.3.  Peripheral  inflammation  with  CFA  increased  GR  expression  in  the  superficial  dorsal  horn. 
Immunohistochemistry for GR  provided  evidence that GR  levels  increased  following  a  unilateral  injection 
of  CFA  (100|jI,  50%,  2h)  into  the  hindpaw.  A)  Luminosity  scores  (normalised  to  background  scores) 
revealed  that  CFA  caused  a  significant  increase  in  the  levels  of GR  in  the  dorsal  horn.  There  were  no 
difference  between  the  levels  of  GR  in  the  contralateral  side  compared  to  naive  animals.  B)  The  total 
number  of  cells  expressing  GR  in  the  medial  portion  of the  dorsal  horn  remained  unchanged  following 
peripheral  inflammation.  C)  Representative  images  of  GR  expression  in  the  medial  portion  of  the 
ipsilateral  dorsal  horn  without CFA  (naive)  or 2h  after intraplantar injection  of CFA.  (Confidence  levels  in 
comparison with naive group.  Unpaired t-test * p<0.05,  n = 5,  10 sections per animal).
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Figure  5.4.  GR  antisense,  missense  and  dexamethasone  21-mesylate  (dex-mes)  did  not  affect  paw 
withdrawal  thresholds  to  mechanical  stimuli  without  inflammation.  Paw  withdrawal  thresholds  before 
surgery (BS) were compared to those 2d  after the implantation of the osmotic pumps (PS) containing  either 
GR  antisense,  missense  or  dex-mes  but  before  CFA  injection.  A)  Intrathecal  administration  of  dex-mes 
alone  did  not  significantly  affect  the  baseline  paw  withdrawal  thresholds  in  non-inflamed  animals.  B)  The 
intrathecal  administration  of  either  GR  antisense  (red  bars)  or  missense  (black  bar)  did  not  affect  paw 
withdrawal  responses  in  non-inflamed  animals.  (Unpaired  t-test,  AS:  n  =  9,  MS:  n  =  8,  dex-mes:  n  =  7, 
vehicle:  n = 7).
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Figure  5.5.  Glucocorticoid  receptors  (GRs)  are  important  for the  maintenance  of  persistent  inflammatory 
pain  states.  A)  IB4 was  chosen to  assess  primary  afferent damage following  implantation  of mini-osmotic 
pumps.  Representative  images  showing  IB4  staining  in  the  dorsal  horn.  Only  animals  without  primary 
afferent  damage  were  included  into  the  behavioural  studies  B)  Mechanical  allodynia  and  hyperalgesia 
associated  with  peripheral  inflammation  was  significantly  reduced  with  the  chronic  i.t.  infusion  of  GR 
antisense  using  mini-osmotic pumps  (red  bar,  n  =  9)  in  comparison with  missense treatment  (black  bar,  n 
=  8) on  days  2  to  4 following  intraplantar CFA  injection  (100pl,  50%).  C)  Mean  paw withdrawals following 
chronic  i.t.  administration  using  mini-osmotic  pumps  containing  dexamethasone  21-mesylate  (a  GR 
antagonist,  red  bar,  n=  7) was significantly  reduced  in  comparison with vehicle  (saline)  control  (black bar, 
n  =  7).  (Two  way ANOVA  repeated  measure  and  Tukey’s  post  hoc testing  *P  <  0.05,  **P  <  0.01,  ***P  < 
0.001).
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Figure  5.6.  Verification  of  GR  knockdown  following  antisense  treatment.  Adult  rats  were  implanted  with  mini- 
osmotic  pumps  delivering  GR  antisense  or  missense  oligonucleotides  onto  the  dorsal  horn.  Animals  were 
infused  for 4d  before  receiving  an  intraplantar  injection  of CFA  (2h,  lOOpI,  50%)  into  hindpaw.  A)  Luminosity 
scores  (normalised  to  background) were  analysed  following  immunostaining.  Scores  were  significantly  lower  in 
animals treated with  antisense  in  comparison  to the  missense  group.  B) Cell  counts for GR  positive  cells  in  the 
dorsal  horn  revealed that GR  antisense treatment significantly reduced the  mean  number of GR positive cells  in 
comparison  with  missense  group.  C)  Animals  were  also  analysed  for  changes  in  GR  protein  levels  using 
western  blotting  techniques.  GR  protein  levels  were  somewhat  lower  in  animals  treated  with  GR  antisense  in 
comparison  with  the  missense.  However  the  reduction  did  not  reach  significance  D)  Representative  images 
taken  from the  medial  ipsilateral  dorsal  horn  in  antisense  and  missense treated  animals  2h  after CFA  injection. 
(Unpaired  t-test,  *p <0.05).  12oAntisense
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Figure  5.7.  No toxic effect of GR  antisense  or missense  on  dorsal  horn  neurons.  Animals  received  chronic 
intrathecal  infusion  of  GR  antisense  or  missense  via  mini-osmotic  pumps  followed  by  an  intraplantar 
injection  of CFA  for 4d.  Sections  of spinal  cord  were  immunostained  for  NeuN,  and  NK1  and  stained  for 
Hoescht. A) NeuN  positive cells located  in  lamina  I  and  II were automatically counted  using  MCID software. 
No  significant  difference  was  found  between  naive,  antisense  or  missense  treated  animals  in  the  spinal 
dorsal  horn.  B)  Representative  images  showing  (a)  NeuN  staining,  (c)  Hoescht  staining  and  (e)  NK1-R 
immunostaining for GR  antisense treated  animals  and  (b) NeuN  staining,  (d)  Hoescht staining  and  (f)  NK1- 
R  immunostaining  for  missense  treated  animals.  Hoescht  staining  did  not  pick  up  any  pyknotic  nuclei  in 
either  the  antisense  or  the  missense  groups.  NK1  receptor  staining  was  similar  in  both  antisense  and 
missense treated  rats; with cells appearing  healthy in both groups  (Unpaired t-test,  n = 7).
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Figure  5.8.  Zif268  and  GR  colocalise  in  spinal  dorsal  horn  neurons.  A)  GR  expression  and  B)  zif268 
expression  in  the  dorsal  horn  2h  after  an  intraplantar  injection  of  CFA.  C)  Merged  image  (of A  and  B) 
showing colocalisation  of zif268 and  GR.  D) High  magnification image of zif268  (green) and  GR (red)  in the 
medial  portion  of the  dorsal  horn.  *  cells  that  express  both  zif268  and  GR.  Inset  images  were  taken  from 
different animals to the main pictures.  ^ 2A B
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Figure  5.9.  Zif268  and  GR  colocalise  in  spinal  dorsal  horn  neurons  and  in  lamina  I  -  projection  neurons 
following  peripheral  inflammation  (intraplantar  CFA,  2h,  50%,  100pl).  A)  Mean  number  of  neurons 
expressing  zif268  (red  bar)  and  GR  (black  bar)  in  the  superficial  layers  of the  lumbar dorsal  horn  (per 40 
pm section,  medial  portion).  B)  19 +/- 3% of zif268 positive cells colocalised with  GR positive cells (red  bar) 
and  31  +/-  5%  GR  positive  cells  colocalised  with  zif268  positive  cells  (black  bar)  in  the  superficial  layers 
(medial  portion)  of  the  dorsal  horn.  C)  (i)  Fluorogold  (FG)  injection  into  the  parabrachial  nucleus 
successfully labelled  lamina  I - projection  neurons  (Ll-Pb) (ii). A number of Ll-Pb  neurons co-expressed  (iii) 
GR  with  (iv)  zif268  and  can  be  seen  in  figure  Cv.  D)  Pie  chart  indicating  percentage  of zif268  and  GR 
expression  in  Ll-Pb  projection  neurons.  Retrograde  labelling  from the  parabrachial  nucleus  with  fluorogold 
showed  that  in  total  61%  of Ll-Pb  neurons  expressed  GR  (red  and  hashed  slice).  A  total  of 47%  of Ll-Pb 
neurons expressed zif268 (green + hashed slice), while 34%  of Ll-Pb neurons co-expressed zif268 and GR 
(hashed  slice) (n=5, ten sections per animal).
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Fig  5.10.  Zif268  regulates  the  expression  of  GR  during  peripheral  inflammation.  A)  Chronic  intrathecal 
administration  of  zif268  antisense  using  mini-osmotic  pumps  significantly  reduced  GR  expression  in  the 
medial  half of the dorsal  horn  by 34%.  in animals with peripheral inflammation (CFA,  100|jl,  50%,  2h)  in the 
hindpaw.  B)  W estern  blot  confirmed  a  reduction  in  GR  expression  in  zif268  antisense  treated  animals. 
However this did  not reach significance (p<0.12).  C) Representative  images of GR expression  in the medial 
dorsal  horn following  chronic intrathecal infusion  of zif268 antisense  and  missense with  2h  CFA treatment. 
(Confidence levels  in comparison with missense) (Unpaired t-test *p<0.05).
1245.4 DISCUSSION
5.4.1 Peripheral inflammation induces the upregulation of spinal GR
Using  immunohistochemical  approaches  we  found  that  spinal  GR  expression  was 
predominantly located in lamina I and II of the dorsal horn. Deeper lamina of the dorsal horn 
expressed a much lower level of GR. The spinal ventral horn (motomeurons) also expressed 
GR. As such our immunohistochemical analysis is in agreement with other studies that have 
localised GR to the same spinal cord regions (Clarck et al,  1981; Duncan and Stumpf,  1984; 
Fuxe et al, 1985; Wang et al, 2004).
This  study  has  shown  that  peripheral  inflammation  induced  by  CFA  can  increase  the 
expression of GR in a subset of dorsal horn neurons. There were no significant changes to the 
number of GR positive cells in the dorsal horn indicating that the increase in GR expression 
was within neurons that already expressed the protein. This increase expression in a restricted 
population  of  neurons  suggests  that  these  GR  positive  neurons  play  a  certain  role  in 
nociception  possibly  by  increasing  signalling  to  corticosterone.  The  use  of  intrathecally 
applied antisense that targeted GR expression in the dorsal horn during CFA  inflammation 
reduced GR expression and subsequently  reduced mechanical hyperalgesia.  Using antisense 
that targeted zif268 mRNA, GR expression was found to decrease in the dorsal horn
During CCI the expression of both NR1 and EAAC1 are regulated by GR activation (Wang et 
al, 2006). Studies have shown that the NMDA receptor is important in the establishment of 
inflammatory  pain  both  for  visceral  pain  (Zhou  et  al,  2006)  and  peripherally  derived 
inflammatory  pain  states  (Guo  et  al,  2005).  Indeed  in  the  dorsal  horn  the  NR1  subunit 
undergoes  rapid  phosphorylation  at  Ser897  following  CFA  injection  into  the  hindpaw. 
Moreover,  a rise in the NR1  protein in the dorsal horn was seen in the  first day  following 
CFA injection (Guo et al, 2005). A similar response with the NR1  subunit can also be seen in 
rats with chronic colonic inflammation (Zhou et al 2006). The evidence for the importance of 
EAAC1  during inflammatory pain is less clear due to the fact that no specific inhibitor exists 
for this  protein.  However,  studies  using a combination of inhibitors aimed  at a number of 
glutamate  transporters  have  given  clues  that  EAAC1  may  be  important  for  the  full 
behavioural  expression  of pain  following  formalin  and  CFA  (Tao  et  al,  2005a,  Tao  et  al, 
2005b). Therefore, it remains possible that these proteins seen to be regulated by the GR in 
neuropathic pain, may also be regulated by the GR in models of inflammatory pain.
1255.4.2  Spinal GR: a role in inflammatory pain behaviour
The use of antisense that targeted the mRNA of the GR has shown that chronic inflammatory 
pain requires the activation of the GR in the dorsal horn. This result was further verified with 
the use of a GR antagonist (dexamethasone 21-mesylate). The effect of dex-mes was more 
potent  in  comparison  with  the  antisense treatment  being  effective  at  reducing  mechanical 
allodynia and hyperalgesia a day earlier. A possible explanation could reside in the method 
and  rates  in  which  they  disrupt  the  actions  of the  GR.  The  antagonist  forms  permanent 
covalent  bonds  with  GR  (Stoney-Simons  and  Thompson,  1981;  Miller  et  al,  1984)  and 
inhibits the actions of both constitutive GR and de-novo GR. GR antisense, unlike dex-mes, 
does  not  interact  with  GR  at  the  protein  level.  Instead,  the  antisense  interferes  with  GR 
translation and therefore does not immediately interfere with constitutive GR.
The  activation  of constitutively  expressed  GR  may  lead  to  non-genomic  changes.  Non- 
genomic effects of GR have been seen in other parts of the nervous system: GR have been 
shown to modulate synaptic plasticity  and drive  intracellular changes. GR can increase the 
levels  of  intracellular  calcium  in  hippocampal  neurons  by  activating  voltage  dependent 
calcium channels (VDCC) (Coussens et al, 1997). GR can also facilitate synaptic potentiation 
by  affecting  VDCC.  Furthermore,  GR  has  also  been  implicated  in  the  inhibition  of the 
NMDA  receptor  activation  (Krugers  et  al,  2005).  In  the  dorsal  horn,  mice  with  mutated 
VDCCs respond in a different manner to wildtype mice to the intrathecal application of a GR 
antagonists, indicating a potential interaction in the dorsal horn between the N-type calcium 
channel  aijd  GR  (Takasaki  et  al  2005).  There  is  also  the  possibility  that  constitutively 
expressed GR can lead to the production of more GR and other proteins by either a direct or 
indirect signalling pathway  (Meaney  et al  2000,  Revest et al  2005) which may  lead to an 
amplification of GR mediated signalling in the dorsal horn.
The effectiveness of the GR antisense treatment became apparent two days after the injection 
of  CFA.  This  may  reflect  the  time  needed  for  GR  to  be  transcribed  and  cause  other 
transcriptional  events  in  the  dorsal  horn  following  initial  inflammatory  stimulation.  It  is 
possible that the time point represents a switch from non-genomic effects to a more genomic 
effect.  Therefore GR may  have a dual  role:  constitutively expressed GR is responsible for 
signalling events that lead to persistent pain states, while transcribed GR maybe important for 
the  maintenance  of  chronic  pain  states  i.e.  increasing  the  transcription  of  key  proteins 
involved with maintenance of chronic pain. However this will need to be investigated further.
126In contrast to our results, GR activation in the dorsal horn has been suggested to have anti­
nociceptive qualities.  The GR agonist dexamethasone can reduce spinal  cyclo-oxygenase-2 
(COX-2) expression in the dorsal horn (Hay and de Belleroche,  1999). COX-2 activation in 
dorsal horn has been linked to the facilitation of mechanical allodynia and hyperalgesia in 
inflammatory  pain  models  (Hay  et  al,  1997;  Seybold  et  al,  2002)  and  in  neuropathic 
conditions (partial sciatic nerve ligation) (Ma et al, 2002). There are no clear explanations for 
the discrepancy  with  our work and that of Hay  and de  Belleroche  (1999).  However, they 
administered  dexamethasone  subcutaneously,  with  the  first  dose  beginning  30min  before 
CFA, Avhile we applied oligonucleotides intrathecally, continuously and 3d before CFA. The 
chronic infusion of oligonucleotides itself into the spinal cord or the down-regulation of the 
GR receptors with chronic dex-mes in the dorsal horn could have led to neuronal and non­
neuronal adaptations in the dorsal horn that may have compromised the activation of spinal 
COX-2  during  inflammation.  To  resolve  this  issue,  changes  in  COX-2  activity  could  be 
analysed following our GR regime.
5.4.3  Zif268 regulates the expression GR
Results from chapter 3 have made suggestions that spinal zif268 expression during peripheral 
inflammation  was  vital  for  the  maintenance  of the  pain  state.  The  knockdown  of zif268 
attenuated mechanical allodynia and hyperalgesia. Immunohistochemistry revealed that both 
zif268 and GR colocalised in the dorsal horn neurons including lamina I projection neurons. 
Lamina I projection neurons to the brain provide important pathways for chronic pain states 
and undergo long-term changes in their synaptic sensitivity (Ikeda et al, 2003;  Ikeda et al, 
2006). The vast majority of lamina I projection neurons express the NK1  receptor (Bester et 
al, 2001; Todd et al, 2002).  The response to chronic but not acute pain can be significantly 
attenuated  following  the  ablation  of NK1  positive  cells  in  lamina  I  (Mantyh  et  al,  1996; 
Nicholls et al, 1999). Using high frequency stimulation of C-fibres it was shown that lamina I 
projection neurons that also expressed the NK1 receptor were capable of supporting long term 
potentiation (LTP) with an enhancement in the excitatory post synaptic current (EPSC) (Ikeda 
et al, 2003).
It is currently unclear which signalling pathways are involved with the increase expression of 
GR in the dorsal horn. This study suggests that the immediate early gene zif268 is involved. 
During peripheral inflammation and HFS the protein expression of zif268 in the dorsal horn 
dramatically  increases  within  the  first  2  hours.  By  binding  to  the  GR  promoter,  zif268 
expression could dramatically  increase transcription of GR on lamina I  projection neurons, 
and in general, in dorsal horn neurons. Previous studies on the hippocampus have shown that
127LTP in the dentate gyrus was dependent on the transient activation of the ERK1/2 pathway 
(Davis et al, 2000). The inhibition of this pathway with MEK inhibitors not only prevented 
the induction of LTP but also prevented Elk-1 and CREB phosphorylation and reduced zif268 
expression.  Zif268  is  vital  for  persistence  hippocampal  LTP  and  is  essential  for  the 
maintenance  of  persistent  inflammatory  pain.  Peripheral  inflammation  induces 
phosphorylation  of ERK1/2  within  lOmin  in the  dorsal  horn (Ji  et  al,  2002).  In  a  similar 
manner to hippocampal ERK1/2 activation, spinal ERK1/2 expression is dependent upon the 
activation of protein kinase C (PKC) and the subsequent phosphorylation on raf-1  which lies 
upstream  of  ERK1/2.  The  activation  of  PKC  requires  high  intracellular  calcium 
concentrations  through  the  NMDA  receptors  in  the  dorsal  horn.  Noxious  stimulation  can 
activate  and  phosphorylate  the NMDA  receptor.  We  propose that  peripheral  inflammation 
activates and phosphorylates the NMDA  receptor,  which facilitates calcium  influx and the 
phosphorylation of ERK1/2 via PKC and Raf. The activation of the ERK1/2 pathway would 
lead  to  the  phosphorylation  of CREB  and  Elk-1  in  the  dorsal  horn  and  the  subsequent 
transcription of zif268. Zif268 would then bind onto the GR promoter leading to an increase 
in GR expression.
At present the temporal  profile of corticosterone release  following intraplantar injection of 
CFA  is  currently  unclear,  however  a  number  of  other  inflammatory  pain  models  have 
suggested that circulating corticosterones can be increased rapidly and possibly for extended 
periods of time. The intraplantar injection of formalin can lead to the activation of the HPA 
axis and the rapid secretion of both ACTH and corticosterones. Plasma analysis suggests that 
ACTH  and  corticosterones  are  secreted  within  5min  and  peaks  at  30min  after  formalin 
stimulation  (Taylor  et  al,  1998).  The  injection  of CFA  into the  temporo-mandibular joint 
(TMJ)  can  also  increase  the  levels  of corticosterone  for 2  days  (Harper  et  al,  2000).  It  is 
therefore possible that, in a similar manner to hippocampal neurons (Revest et al, 2005), the 
increase concentrations of corticosterones caused by peripheral inflammation with CFA can 
lead to the activation of the MAPK pathway through constitutively expressed GRs leading to 
changes in gene transcription.
5.5  CONCLUSION
Long term changes in synaptic sensitivity in the superficial dorsal horn are dependent on gene 
expression.  These  essential  molecular changes may be crucial  in the  maintenance  of long­
term  pain  states  that  are  mediated  by  lamina  I  projection  neurons.  Dorsal  horn  neurons 
increase  GR synthesis when  stimulated and are vital  for the full  expression  of mechanical 
allodynia and hyperalgesia following CFA induced peripheral inflammation. Reducing zif268
128expression in dorsal horn neurons can also reduce the expression of GR, suggesting that GR 
expression in the dorsal horn is subject to zif268 regulation. This work has provided a new 
insight into the molecular complexities surrounding inflammatory pain states.
129CHAPTER 6 
General Discussion6. GENERAL DISCUSSION
Molecular changes in the dorsal horn are essential to support the modifications in synaptic 
efficacy  that  underlie  persistent  inflammatory  pain  states.  In  this  thesis  the  role  of the 
immediate early gene zif268, has been shown to play an important role in the maintenance of 
inflammatory  pain  in  part  through  the  regulation  of two  downstream  genes,  serum  and 
glucocorticoid inducible kinase 1  (SGK1) and the glucocorticoid receptor (GR).
6.1  Zif268 expression and regulation of pain states
Spinal zif268 expression has been shown to be induced in dorsal horn neurons following a 
number of different stimuli including formalin and high frequency, high threshold stimulation 
of primary  afferents  (Rygh,  et  al,  2006).  In this  study,  we have  shown that  CFA  injected 
peripherally into the intraplantar region of the hindpaw can likewise increase the expression 
of spinal zif268. Time course studies have shown the expression of spinal zif268 occurred by 
lh and disappeared by 6 hours following peripheral inflammation with CFA. Expression of 
zif268 was predominantly found in the superficial layers of the dorsal horn and ipsilateral to 
the CFA injection, closely matching the innervation pattern from the hindpaw.  Retrograde 
labelling  from  the  parabrachial  nucleus  indicated  that  zif268  expression  following  CFA 
injection into the periphery occurred in lamina I projection neurons. The expression of zif268 
in these neurons would  suggest that alterations  in gene transcription  are obligatory  for the 
development of persistent inflammatory pain regulating the synaptic plasticity of these key 
neurons (Nichols et al., 1999; Ikeda et al., 2006).
CFA injection into the intraplantar region of the hindpaw resulted in mechanical allodynia. 
Mechanical pressure that were previous insufficient to generate a withdrawal response did so 
following  inflammation.  This  affect  was  attenuated  with  zif268  antisense  treatment; 
suggesting an intimate relationship between mechanical allodynia and zif268. At present it is 
not clear if zif268  has a function in mechanical  hyperalgesia.  To resolve this issue,  future 
work  should  focus  on  paw  withdrawal  thresholds  in  inflamed  animals  using  von  Frey 
filaments in the noxious range during intrathecal zif268 antisense (and missense) treatment.
Perhaps  surprisingly  ablation  of  5-HT  axons  in  the  lumbar  cord  reduced  inflammatory 
allodynia and hyperalgesia but did not reduce zif268 expression.  We have previously shown 
that CFA induced zif268 expression is however reduced by lesioning lamina I/NK1   positive 
projection  neurons  that  form  the  ascending  component  of a  spinal-brainstem-spinal  loop 
(Suzuki et al 2002; Rygh et al., 2006).  The reduction in zif268 positive neurons was seen
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sensitivity.  Given that zif268 seems to be essential for the full development of inflammatory 
pain  states  the  result  of the  5-HT  ablation  study  is  puzzling  given  a  similar  behavioural 
change. I have suggested above that destruction of 5-HT axons may disrupt both descending 
inhibition and excitation and changes  in zif268  levels may not therefore be  evident.  This 
might also explain why c-fos levels are increased in 5-HT ablated rats even though this should 
have  predicted  increased  sensitivity  to  mechanical  stimulation  in  sensitized  rats.  It  also 
suggests that an increase in c-fos expression is not directly correlated to increased mechanical 
sensitivity despite earlier claims to the contrary (Dubner and Ruda,  1992; Hunter et al,  1995; 
Hou et al, 1997).
6.2  Zif268 regulation of SGK1
Zif268 differentially regulates the transcription of two other genes in the dorsal horn; SGK1 
and  the  GR  following  peripheral  inflammation.  The  SGK1  promoter  region  has  been 
characterised and contains several motifs  including GRE (glucocorticoid response element) 
(Webster et al,  1993) and several ERE (EGR response elements) motifs (James et al, 2006). 
The presence of these  motifs,  allow for the direct regulation of SGK1  expression by  both 
glucocorticoids and zif268 respectively. The SGK1 promoter also contains a TATA box and 
Sp-1 elements as well as putative binding sites for a variety of other transcriptional regulators 
including  the  AP-1  complex  and  NF-kB  (Firestone  et  al,  2003).  Analysis  from  both 
immunohistochemistry and western blots revealed that SGK1  expression was repressed and 
GR transcription was induced as a consequence of spinal zif268 expression (Fig 6.1).
However, previous studies have demonstrated that, at later time points, increased expression 
of SGK1  occurred in models of joint inflammation. The expression of SGK1  in the dorsal 
horn of monoarthritic rats peaked at 6h, corresponding with a decline of zif268 expression in 
both  the  monoarthritic  model  and  the  peripheral  inflammatory  model.  Moreover,  the 
expression  of SGK1  also  occurred  in  approximately  half of all  projection  neurons  to  the 
parabrachial  nucleus  from  lamina  I.  A  large  proportion  of these  neurons  also  expressed 
zif268. The intrathecal application of antisense targeting SGK1  also delayed the induction of 
mechanical allodynia and hyperalgesia (Geranton et al, 2007).  However, it seems likely that 
this later increase in SGK1  mRNA and protein follows phosphorylation of the MeCP2 gene 
repressor complex resulting in de-repression of SGK1 gene expression (Geranton et al, 2007). 
This would suggest that  1) the expression of zif268 represses constitutive levels of SGK1, 2) 
that by 6h post inflammation, zif268 expression has returned to baseline levels and 3) at 6h 
levels of SGK1  rise following de-repression by MeCP2. However, Geranton et al (2007) did
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the 2h time point. This discrepancy may reside in the fact that the models used were different. 
First, the amount of CFA used was higher in our study. Second, the innervation pattern from 
the ankle joint to the dorsal horn is different from that of the hindpaw. Several studies using 
c-fos as a marker of neuronal activity have shown that c-fos expression in the arthritic model 
(ankle) was  predominantly  expressed  in  lamina  I  and  V  of the  dorsal  horn  (Honore  et  al, 
1995; Leah et al,  1996). In comparison hindpaw inflammation in our studies resulted in c-fos 
expression  in lamina I,  II  and V.  In addition, while Geranton et al  (1997) analysed  SGK1 
expression at the mRNA level with RT-qPCR, we analysed SGK1  protein using western blot 
techniques. Moreover, the time course of allodynia and hyperalgesia of the two models are 
slightly different and may reflect different use-dependent transcription of SGK1.
6.3  Zif268 regulation of GR
In contrast to SGK1, the expression of GR was positively regulated by zif268. The expression 
of GR during peripheral inflammation has been shown to be integral to the development of 
the  full  pain  state.  The  knockdown  of this  gene  with  GR  antisense  or  antagonism  of the 
receptor significantly attenuated pain states associated with CFA induced inflammation.
The pro-nociceptive role of GR has also been implicated in other pain states.  Studies have 
shown  that  the  glucocorticoid  receptor  in  the  dorsal  horn  during  the  chronic  constriction 
model  is upregulated and  is essential  for the full expression of this pain state (Wang et al, 
2004).  In  addition,  GR  expression  in  this  pain  state  is  dependent  on  the  activities  of 
interleukin-6  (IL-6)  and  protein  kinase  C  (PKCgamma).  Spinal  PKCgamma  facilitates 
inflammatory pain (Guo and Huang, 2001; Sweitzer et al, 2004), and I have shown that spinal 
GR plays a functional role in regulating hyperalgesia and allodynia during inflammation. Our 
results suggest that neuropathic pain and inflammatory pain may share a common mechanism.
The enhancement of GR expression in a subset of neurons (including lamina I parabrachial 
projection  neurons)  in  the  dorsal  horn  during  peripheral  inflammation  would  allow  for 
specific neuronal populations to become more responsive to circulating corticosteroids (i.e. 
only neurons that are involved with peripheral inflammation). The increase in GR expression 
in specific neuronal populations would increase transcriptional activity driven by circulating 
corticosterones and activate downstream  genes that regulate synaptic plasticity.  It has been 
shown  for  example  that  expression  of the  NMDA  receptor  in  the  dorsal  horn  can  be 
modulated by GR in the dorsal horn following CCI (Wang et al 2005)  as well as EAAC1 
(Wang et al, 2006) and voltage gated calcium channels (Takasaki et al, 2005).
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neuronal  plasticity.  ERK1/2  expression  following  stress  can  be  prevented  with  the  GR 
antagonist  (RU38486)  and  the  induction  of LTP  can  also  be  altered  (Yang  et  al,  2004). 
Furthermore, the activation of GR greatly increased the expression and the enzymatic activity 
of a number of proteins in the mitogen-activated protein kinase (MAPK) signalling pathway. 
Kinases that were seen to be affected include Ras and Raf-1, both of which can be directly 
activated  via  their  GRE  motifs.  The  inhibition  of this  pathway  abolished  the  increase  in 
contextual fear conditioning induced by glucocorticoids (Revest et al, 2005).
The ERK1/2 pathway has been implicated in the transcriptional activity that is necessary for 
the  maintenance  of both  neuropathic  and  inflammatory  pain  states.  As  such,  this  would 
suggest that the GR  can  affect transcription by  activating the  ERK1/2  pathway.  However, 
ERK1/2 expression in the superficial layers of the dorsal horn occurs rapidly (within  lOmin) 
in the peripheral inflammatory model and remains above baseline for over 24h (Ji et al, 2002). 
Since  GR expression  is  in  part  dependent on zif268  expression  in the  dorsal  horn  (which 
increases  at  lh)  it  seems  unlikely  that  the  early  ERK1/2  expression  is  GR  dependent. 
However this does  not exclude the possibility  that the maintenance  of ERK1/2  expression 
following the 1  h-2h time-point is GR dependent.
6.4  Technical limitations
This thesis used a number of techniques in order to analyse the role of zif268  in persistent 
inflammatory pain. However, these techniques have their limitations and inherent problems. 
These are briefly discussed below.
6.4.1  Chronic oligonucleotide treatment
The use of phosphorothioate modified oligonucleotides in this thesis successfully reduced the 
spinal  expression  of zif268  and  GR  in the  dorsal  horn.  Oligonucleotides,  in  general  have 
inherent limitations including cell toxicity and lack of specificity. While our studies checked 
for toxicity  (and found no evidence of this), the observation for oligonucleotide specificity 
was  more  problematic.  Phosphorothioate  oligonucleotides  were  chosen  for their  ability  to 
withstand  nuclease  digestion.  However,  studies  have  shown  that  this  type  of  modified 
oligonucleotide may have non-specific effects, including binding to membrane proteins, DNA 
polymerases  and  the  induction  of transcription  factors.  For  example,  studies  using  c-myc 
antisense  have  shown  that  cell  growth  could  be  affected  in  a number  of ways  including,
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inhibition, and non-sequence-specific inhibition (Chavany et al,  1995). Moreover, sequence- 
specific effects  of control  oligonucleotides were also observed (Sun et al,  1996).  As  such, 
non-specific down-regulation of other genes may have occurred in our studies that may have 
played an influential role on our results.  The use of microarray technology  may provide a 
possible solution to help identify oligonucleotide specificity by monitoring other changes in 
gene  expression  (Delihas,  2001).  However,  given  the  fact  that  our  oligonucleotides  are 
designed to target transcription  factors  (GR  and  zif268),  it may  prove  difficult  even  with 
microarray technology to determine specificity, as the expression of downstream genes will 
be modulated.  In addition,  chronic  infusion of oligonucleotide could  lead to compensatory 
effects in the spinal cord, adding to the problem, although vehicle controls were always used.
6.4.2 Immunohistochemistry
Immunohistochemistry  was widely  used in this thesis.  Although we used negative controls 
(omission of the primary antibody) to test for specificity, ideally the antibodies should have 
been controlled further. The antibodies could have been used after adsorption of the primary 
antibody  with  the  purified  antigens  and/or  using  dorsal  horn  sections  from  GR  or  zif268 
knockout  animals.  This  would  have  reduced  the  likelihood  of false  positives.  However, 
knockout  animals  were  not  available  but  zif268  and  GR  antibodies  run  on  western  blots 
provided  a second method for testing specificity  and revealed distinct bands at the correct 
molecular weight for the proteins.
6.4.3 Cell counts
A potential problem with automatic cell counting is an over-estimation of the number of cells 
present  on  the  tissue  due  to  non-specific  staining.  In  addition,  the  possibility  of under­
estimating the number of positive cells can also occur if the cell is not bisected through the 
maximum  diameter.  However, these problems would affect sections from both control  and 
treated animals alike. In addition, the MCID cell count criteria was set at a rigorous enough 
setting to reduce the likelihood of false negatives. Cells were only counted if they fell within a 
certain size and fluorescence limit.
6.4.4 Luminosity scores
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following  oligonucleotide  treatment.  The  major  problem  with  analysing  protein 
concentrations using this method is the assumption that the greater the signal from the cell, 
the greater the proportion of protein that is present in the cell. This assumption does have its 
problems; increases in protein would be rendered undetectable if the signal was saturated. To 
avoid this complication the protein was never immunohistochemically amplified with TSA. In 
addition, the settings of the confocal microscope and software had an upper limit of detection 
that  was  well  above  the  maximum  emission  of  the  immunoreactive  cells.  Despite  the 
limitations of this  method, the approach  has helped  identify  changes  in protein content of 
individual cells in the dorsal horn undetectable by western blots.
6.4.5 Fluorogold tracing
The  parabrachial  nucleus  forms  part  of the  spino-bulbo-spinal  loop  and  is  involved  with 
modulating spinal cord activity (through descending projections from the RVM). Fluorogold 
injections  into  the  parabrachial  nucleus  successfully  labelled  lamina  I  projection  neurons. 
However, necrosis was present at the injection site possibly as a consequence of the physical 
trauma of the FG injection and/or the FG itself. Damage to parabrachial region would affect 
descending modulation of the spinal cord and thus may play a role in the changes in gene 
expression  seen in the dorsal horn (Svensson et al,  2006), affecting cell  count analysis.  In 
addition, the presence of FG in viable cells may have directly led to unwanted transcriptional 
changes in labelled lamina I projection neurons, leading to an increase (and over-estimation) 
of GR and/or zif268 expression in these neurons. However, this is unlikely due to rapid and 
transient nature of zif268 expression. Nevertheless, since we did not analyse the dorsal horn 
for gene expression immediately (l-6h) after FG injection we cannot exclude the possibility 
that zif268 (or indeed any other transcription factors) may have  ‘primed’  the ascending FG 
positive neurons to react to inflammation (CFA) to a greater extent than normal (i.e.  more 
likely to express GR or zif268). In addition, the injection of FG into the parabrachial nucleus 
may have labelled other descending fibres that just transverse the injection site.  Therefore, 
some of the labelled lamina I projection neurons may not be Ll-Pb neurons.
6.4.6 Ablation of serotonergic axons with 5, 7 DHT
The use of 5, 7 DHT successfully depleted serotonin in the dorsal horn. However, the absence 
of descending serotonergic  axons  may  have resulted  in compensatory  events  in the dorsal 
horn leading to long-term adaptations. Studies have shown that 5, 7 DHT can lead to gliosis.
136Astroglia increases during inflammation (Frankfurt et al,  1991;  Brezun and  Daszuta, 2000) 
and have been suggested to have a role in chronic pain by releasing inflammatory cytokines 
(DeLeo and Yezierski, 2001; Watkins et al, 2003; Guo et al, 2007). 5, 7 DHT can also affect 
noradrenergic neurons. Although we did not check the noradrenergic population in the dorsal 
horn following intrathecal  5, 7 DHT, desipramine, can protect noradrenergic (NA) neurons 
from the effects of 5, 7 DHT (Sawynok and Reid,  1996; Choi et al, 2004). In addition, as far 
as we are aware there is little or no evidence to indicate that other descending monoaminergic 
neurons are affected  by  5,  7  DHT.  Therefore,  we  are  fairly  confident that monoaminergic 
systems (other than serotonin) remained intact following 5, 7 DHT.
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Figure  6.1.  Molecular events that occurred  following  peripheral  inflammation  in  lamina  I  projection  neurons.  Noxious 
stimuli can increase  intracellular calcium  levels via the AMPA receptors (those  lacking the GluR2 subunit), the NMDA 
receptor and from  intracellular stores. A rise in the calcium concentration activates  protein  kinases that can switch on 
molecular  pathways  including  the  MAPK  pathway  (yellow  boxes).  The  MAPK  pathway  is  important  for  gene 
transcription  and  can  lead  to  the  expression  of  the  immediate  early  gene  zif268  within  an  hour.  Zif268  when 
translated,  positively  modulates the  expression  of the  glucocorticoid  receptor (GR)  and  the  repression  of serum  and 
glucocorticoid inducible kinase  1   (SGK1), possibly by binding onto the ERE binding domain.
137CHAPTER 7 
General Conclusions7. GENERAL CONCLUSIONS
Peripheral inflammation leads to an increase in transcriptional events in the dorsal horn. Our 
results suggest that zif268  plays a central role in gene regulation,  in particular in lamina I 
projection neurons during inflammatory pain. The increase of zif268 can lead initially to the 
repression of SGK1  and increase expression of GR (Fig 6.1). GR is then capable of causing 
multiple  changes  to  transcriptional  events  in  the  dorsal  horn  following  activation  by 
circulating  corticosterone  involving  increased  activation  of the  NMDA  receptor  subunits 
(Wang et al, 2005), EAAC1 (Wang et al, 2006) and voltage gated calcium channels (Takasaki 
et al, 2005). Once zif268 expression returns to baseline (post 6h) and following the relief of 
MeCP2  repression,  SGK1  expression  increases resulting  in  increased  neuronal  excitability 
(Geranton et al, in press). Neuronal changes regulated by changes in SGK1  expression may 
include  regulating  glutamate transporter and  GluRl  expression  in the  dorsal  hom  (Strutz- 
Seebohm et al, 2006).
This thesis has shown that zif268 in the dorsal hom following CFA injection into the hindpaw 
is essential for the maintenance of chronic pain. Zif268 regulates the expression of both SGK 
and GR. As both of these molecules have independently been shown to be pro-nociceptive it 
would be worthwhile exploring these genes as potential targets for new analgesic drugs.
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